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ABSTRACT 
 
 
Introduction. Total knee arthroplasty (TKA) is an effective treatment for end-stage 
osteoarthritis of the knee. While many patients have positive functional and pain 
outcomes following primary TKA, a subset of patients have suboptimal outcomes, such 
as unexplained pain or aseptic loosening of the implant components necessitating 
revision of the index procedure. The understanding of the exact etiology of these 
suboptimal outcomes of primary TKA is in its infancy. In order to elucidate the etiology 
of failure in primary TKAs, a baseline for the factors contributing to arthroplasty failure 
and dissatisfaction must first be established. The purpose of this study was to investigate 
the relationship between soft tissue laxity, inflammatory cytokine concentrations, tissue 
metal concentrations, and wear scores of well-functioning implants retrieved from 
cadaveric specimens to determine the role of each of these factors in implant 
survivorship. It was hypothesized that decreased joint laxity would increase metal 
concentrations in the periprosthetic tissue, that cytokines specifically tied to the innate 
immune system would be elevated in laxer joints, and, lastly, that elevated inflammatory 
cytokines in the synovial fluid would be associated with elevated periprosthetic tissue 
metal concentrations.  
 
Methodology. A total of 33 cadaveric specimens with primary TKA were obtained from 
two sources, the Medical Education and Research Institute (Memphis, TN) and 
RestoreLife USA (Elizabethton, TN), as part of institution review board approved multi-
institutional orthopaedic retrieval program. Prior to testing and retrieval, 
fluoroscopically-assisted radiographs were taken to assess if any evidence of 
radiolucencies were present and all replacements were determined to be well-fixed per 
the images. Synovial fluid was then aspirated from the joint, processed, and stored in a -
80˚C freezer. Each specimen was mounted into a custom knee testing platform and the IE 
rotation, varus-valgus (VV) deflection, and AP translation was measured at 0˚, 30˚, 60˚, 
and 90˚ of flexion. After collection of the laxity data, tissue samples were collected from 
the supra- and infra-patellar regions, the medial and lateral gutter, and from the tibia. The 
polyethylene inserts were assessed for wear on the condylar, backside, and stabilizing 
post surfaces, when applicable, and the femoral condyle was assessed for damage. A 
bead-based multiplex assay using the Luminex MAGPIX platform (R&D Systems, 
Minneapolis, MN) was performed on the synovial aspirates for simultaneous detection of 
various inflammatory cytokines including: IL-1, IL-6, MCP-1, and MIP-3. Inductively 
coupled plasma mass spectrometry (ICP-MS) was performed at Brooks Applied Labs 
(Bothel, WA) on the periprosthetic tissue samples for determination of tissue cobalt (Co), 
chromium (Cr), and titanium (Ti) concentrations. Finally, statistical analysis was 
conducted using SigmaPlot (Systat Software, Chicago, IL) to elucidate whether any 
correlations existed between the aforementioned factors. 
 
Results. Decreased IE laxity at full extension was inversely correlated with increased Co 
concentrations in the periprosthetic tissues (=-0.64, p=0.02) with a sample size (n) of 13 
and a 95% confidence interval (CI) from -0.88 to -0.14. At 90 of flexion, anterior laxity 
was inversely correlated with Co concentrations (=-0.66, p=0.03, n=11, 95% CI: -0.90 
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to -0.10). At 60 of flexion, anterior laxity was inversely correlated with Cr 
concentrations (=-0.63, p=0.03, n=13, 95% CI: -0.88 to -0.12). Anterior laxity at 90 of 
flexion was also inversely correlated with Cr concentrations (=-0.81, p=0.003, n=11, 
95% CI: -0.95 to -0.41). Lastly, posterior laxity at 90 of flexion was inversely correlated 
with Cr concentrations in the periprosthetic tissues (=-0.74, p=0.01, n=11, 95% CI: -
0.93 to -0.25). At 60 of flexion, IE rotational laxity was inversely correlated with IL-1 
concentrations (=-0.55, p=0.02, n=18, 95% CI: -0.81 to -0.11). At 60 of flexion, VV 
laxity was inversely correlated with TNF- concentrations (=-0.78, p=2x10-4 , n=14, 
95% CI -0.93 to -0.43). Additionally, VV laxity was inversely correlated with IL-1 
concentrations (=-0.48, p=0.04, n=18, 95% CI: -0.77 to -0.02) at 60 of flexion. At full 
extension, VV laxity was inversely correlated with IL-6 concentrations (=-0.46, p=0.04, 
n=19, 95% CI: -0.76 to -0.01). Anterior laxity was directly correlated with IL-6 
concentrations (=0.53, p=0.02, n=18, 95% CI: 0.08 to 0.80) at 90 of flexion. 
Additionally, anterior laxity was directly correlated with MCP-1 concentrations (=0.62, 
p=0.006, n=18, 95% CI: 0.22 to 0.84) at 90 of flexion. Cr was inversely correlated with 
IL-6 (=-0.52, p=0.01, n=21, 95% CI: -0.78 to -0.11). Cr was also inversely correlated 
with MIP-3 (=-0.46, p=0.04, n=21, 95% CI: -0.74 to -0.04). 
 
Discussion. The specimens included in this study consisted of primary TKA implants 
that were retrieved at necropsy and were determined to be well-fixed per fluoroscopic 
analysis. The first objective of this study was to establish a baseline of different factors 
that likely contribute to failure of primary total knee replacements. This study provided 
semi-quantitative assessment of wear of the condylar surface, backside surface, and 
stabilizing post, when applicable, and of damage to the bearing surface of the femoral 
components. Joint laxity was measured using a custom knee testing platform that had 
been previously studied and utilized in published journal articles and theses. 
Inflammatory cytokine profiles in the synovial fluid samples were presented and 
measureable levels of metal debris was found in the periprosthetic tissue samples. The 
second objective of this study was to determine if any significant relationships arose in 
correlation analysis of the latter three aforementioned factors. An inverse trend was 
observed between joint laxity and tissue metal concentrations, such that decreased laxity 
induced metal release from the implant components. A direct trend was observed 
specifically between increased anteroposterior laxity and elevated inflammatory 
cytokines. Lastly, an inverse trend was found between decreased tissue metal 
concentrations and increased inflammatory cytokines. The third, and future, objective of 
this study is to utilize these measurements and observations for comparison with failed 
implants retrieved at time of revision. While some meaningful relationships were 
observed in this study, there were several limitations that must be noted. Firstly, this 
study had a relatively small sample size. Secondly, the cohort included a wide range of 
implants including cruciate-retaining, posterior-stabilized, fixed bearing, mobile bearing, 
monoblock, and modular designs fabricated from different materials. 
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CHAPTER 1.    INTRODUCTION 
 
 
Premise 
 
 Total joint replacements (TJR) are an effective treatment for end-stage 
osteoarthritis and are among the most commonly performed operations in the United 
States, with approximately 1 million procedures per year (1). An estimated 332,000 total 
hip arthroplasties (THA) and 719,000 total knee arthroplasties (TKA) occurred in 2010 
alone, with 10-15% of these operations being revision procedures (1). The number of 
primary TKAs is projected to grow 673% to 3.48 million procedures by the year 2030 
whereas the number of revision TKAs is projected to grow by 601% between the years 
2005 and 2030, from 38,300 to 268,200 annual procedures (2). Increasing incidence of 
primary TKAs is likely due to increasing longevity of the population, decreasing age at 
arthroplasty, and excellent pain and functional outcomes associated with these 
procedures. 
 
 A number of patients, however, have suboptimal outcomes as indicated by 
increasing number of revisions or from patient reported outcome measures. Only 85% of 
patients reported satisfaction following primary TKA (3). Up to 20% of patients report 
long-term pain after TKA, which is dramatically more than that which is reported 
following THA (4-6). Common causes of failure include: aseptic component loosening, 
infection, ligament/flexion instability, periprosthetic fracture, arthrofibrosis, 
patellofemoral maltracking, abnormal joint line problems, and metal hypersensitivity (7). 
Oftentimes, failure of an index procedure is multifactorial; Mulhall et al. (8) analyzed the 
etiologies of failure in 318 knee replacements and found that 64.4% had more than one 
identifiable cause. Clinically, revision arthroplasty is a complex procedure associated 
with higher complication rates, extended hospitalization, unsatisfactory functional 
outcomes, and relatively shorter implant survival compared to primary procedures (7). In 
order to elucidate the etiology of failure in primary TKAs, a baseline for the factors 
contributing to arthroplasty failure and dissatisfaction must first be established. The 
purpose of this study was to investigate the relationship between soft tissue laxity, 
inflammatory cytokine concentrations, tissue metal concentrations, and wear scores of 
well-functioning implants retrieved from cadaveric specimens to determine the role of 
each of these factors in implant survivorship. 
 
 
Functional Anatomy and Kinematics of the Natural Knee 
 
 The knee is one of the largest and most complex joints in the body. It is composed 
of three compartments with different articulations: the patellofemoral joint and the medial 
and lateral tibiofemoral joint. The patellofemoral joint is the articulation between the 
patella and the femoral trochlear groove. The patella is covered with articular cartilage 
and articulates with the trochlear groove of the femur. The primary function of the patella 
is to increase the lever arm of the extensor mechanism around the knee, improving the 
efficiency of quadriceps contraction (9). The knee extensor mechanism is a complex 
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structure formed by the quadriceps femoris muscle group, quadriceps femoris tendon, 
patella, patellar tendon, retinaculum, and surrounding soft tissue structures that help 
stabilize the patellofemoral joint and the knee. The quadriceps femoris tendon connects 
the rectus femoris, vastus lateralis, vastus medialis, and vastus intermedius, which make 
up the quadriceps femoris, to the patella. Continuous with the quadriceps femoris tendon 
is the patellar ligament that connects from the patella to the tibial tuberosity. The 
quadriceps femoris tendon and patellar ligament transmit tensile forces generated by the 
quadriceps to the tibia. The patella is stabilized in the middle of the knee by the medial 
and lateral retinaculum. Patellofemoral stability is maintained by a combination of the 
articular surface geometry and soft-tissue restraints. 
 
 The tibiofemoral joint functions to transmit body weight from the femur to the 
tibia. On the distal end of the femur are two rounded condyles that project posteriorly 
beyond the shaft, forming a J-shaped curve that guides movement of the joint. The 
femoral and tibial condyles are covered with articular cartilage which protects the bone 
and enables easy articulation at the joint. The menisci, two C-shaped layers of 
fibrocartilage, are located between the articulating surfaces and act as shock absorbers 
that cushion the joint. All remaining surfaces of the knee are in capsular attachment and 
are covered by the synovial membrane that secretes the synovial fluid which is 
responsible for cartilage nutrition, the removal of metabolites from the joint, joint 
lubrication, and the provision of immune cells that are involved in the removal of foreign 
materials and organisms from the joint (10). Stability of the tibiofemoral joint is 
dependent upon many static and dynamic elements. The primary static stabilizers are the 
ligaments of the knee: the anterior cruciate ligament (ACL), posterior cruciate ligament 
(PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL). All of 
these structures, shown in Figure 1-1, work in concert to provide stability and painless 
function in a healthy knee joint. 
 
 Knee motion is much more complex than simple flexion and extension about a 
fixed transverse axis like a simple hinge; instead, knee motion during normal gait occurs 
in three separate planes and is referred to as “triaxial motion”(9). Flexion of the knee, 
which occurs about a constantly changing center of rotation, is a function of the articular 
geometry of the knee and the ligamentous restraints (9). Freeman et al. (11)  described 
sagittal plane condylar geometry as a sequence of arcs with different radii that interact 
with a flat medial and convex lateral tibial plateau. In a study of in vivo knee kinematics 
using fluoroscopic video surveillance with three-dimensional computed tomography (CT) 
scans, Dennis et al. (12) described this flexion axis as varying in a helical fashion in a 
normal knee. When plotted, the path of this changing center of rotation describes a J 
shaped curve that mirrors the sagittal curvature of the femoral condyles.  
 
 Flexion is achieved by a complex coupled mechanism in which the femoral 
condyles simultaneously glide and roll back on the tibial plateaus about multiple 
simultaneous axes, known as “posterior rollback”. In an in vivo fluoroscopic analysis of 
normal human gait, Komistek et al. (13) found that posterior rollback was substantially 
greater at the lateral femorotibial articulation than medially, thereby creating a medial 
pivot type of axial rotational pattern in which the tibia internally rotates relative to the  
 3 
 
 
 
Figure 1-1. Anatomical stabilizing structures of knee joint 
Reprinted with permission. National Institute of Arthritis and Musculoskeletal and Skin 
Diseases. Medial view of the knee showing anatomical features. May 2001. Accessed 18 
August 2017.  
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femur as flexion increases. At full extension, the femur is internally rotated with respect 
to the tibia and is located anteriorly to the mid-point of the tibial plateau. As the knee 
flexes, the lateral condyle of the femur consistently translates posteriorly on the lateral 
tibial plateau with increasing flexion (12, 13). On the other hand, the medial condyle has 
a less consistent motion pattern that includes posterior translation and anterior slide 
during knee flexion, which leads to a reduced overall posterior translation of the medial 
condyle on the tibial plateau. Because the medial tibial plateau articular surface is longer 
than the lateral tibial plateau surface, extension is achieved by 5 external rotation of the 
tibia in the last 15 of extension in the “screw home” mechanism, which results in the 
tightening of both cruciate ligaments, locking the knee in place providing maximal 
stability with respect to the femur and decreasing the work performed by the quadriceps 
femoris while standing. This pattern of medially based pivoting of the knee explains the 
observed external rotation of the tibia on the femur during extension, known as the 
“screw-home mechanism,” and the internal rotation of the tibia during knee flexion (9).  
 
 
Grood and Suntay Joint Coordinate System 
 
 A thorough understanding of joint kinematics is important in the diagnosis of joint 
disorders resulting from injury or disease, in the quantitative assessment of treatment, in 
the design of better prosthetic devices, and in the general study of gait (14). However, in 
1983, two researchers found that the traditional characterization of motion was not easily 
understood by clinicians, whose understanding of such material is pivotal to proper 
diagnosis and treatment (14). To bridge the understanding and communication of knee 
kinematics between physicians and biomechanical engineers, Grood and Suntay (14) 
sought to establish a basis for description and measurement of the six motion components 
in the experimental study of knee joint kinematics.  
 
 A joint coordinate system (JCS) is a reference system for a particular joint (the 
knee) in relation to global coordinate systems of the whole body (the anatomic axes) and 
in relation to local coordinate systems of other joints. The relative motion of two body 
segments, such as the distal end of the femur and the proximal end of the tibia, can be 
defined by a JCS, which is described by two segment-fixed axes and a mutually 
orthogonal floating axis. Angular rotation of these bodies is about one or more of these 
spatial axes. In developing a JCS for the knee, Grood and Suntay (14) stated that is first 
necessary to specify: 1) the Cartesian coordinate system fixed in each bone used to 
describe its shape; 2) the body-fixed axes and the reference axes of the JCS used to 
describe the relative motion between the two bones; and 3) the location of the translation 
reference point. The Grood and Suntay JCS served as convention behind the methods 
used to quantify knee kinematics and their relationship to joint laxity in this study.  
 
 The z-axis, along the tibial mechanical axis, was selected as the tibial body fixed 
axis and was defined as a vector extending from the origin at the center of the medial and 
lateral malleoli to the intercondylar eminence between the medial and lateral tibial 
condyles. The z-axis is deemed positive upwards from the origin and negative 
downwards towards the origin. The tibial y-axis was selected as the reference axis and 
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was oriented anteriorly, which was defined as the cross-product of the fixed axis (z-axis) 
with a line connecting the approximate center of each plateau. The third and final axis of 
the tibial body fixed system, the x-axis, was obtained by the cross-product of the 
reference axis (y-axis) and the fixed axis (z-axis), such that the x-axis is positive to the 
right and, therefore, oriented laterally in the right knee and medially in the left knee. The 
femoral body fixed system was specified to originate from intercondylar notch between 
the medial and lateral femoral condyles. The Z-axis, along the femoral mechanical axis, 
was defined as a vector extending from this origin at the intercondylar notch to the center 
of the femoral head. The femoral Y-axis was selected as the reference axis and was 
oriented anteriorly, as defined by the cross product of the femoral body fixed axis (Z-
axis) with a line connecting the two points on the posterior surface of the femoral 
condyles when the knee was in full extension. Finally, X-axis was selected as the femoral 
body fixed axis and was obtained by the cross-product of the reference axis (Y axis) and 
the Z-axis. In summary, the JCS of the knee was composed of two body fixed axes: the 
tibial z-axis and the femoral X-axis, and one floating axis as defined by the cross-product 
of the two body fixed axes that is positive in the anterior direction.  
 
 Once the body fixed systems and JCS axes were established, the relative joint 
rotations between the bones then could be defined with reference to the JCS, as depicted 
in Figure 1-2. Flexion/extension occurred about the femoral body fixed axis, the X-axis. 
The angle of flexion was defined as the angle between the floating axis and the femoral 
reference axis, the Y-axis. Internal/external rotation occurred about the tibial body fixed 
axis, the z-axis. The angle of internal/external rotation was defined as the angle between 
the floating axis and the tibial reference axis, the y-axis. Abduction/adduction occurred 
about the floating axis. The angle of abduction/adduction or the varus/valgus deflection 
angle is the angle formed between the femoral body fixed axis, the X-axis, and the tibial 
body fixed axis, the z-axis, minus /2, so that the varus/valgus angle will be set to 0 in 
full extension. Regardless whether the knee in question was right or left, flexion was 
defined as positive and extension as negative. For the other rotations, the sign 
conventions differed between right and left knees because the tibial x-axis was always 
designated positive to the right. In a right knee, external rotation and abduction (or varus 
deflection) of the tibia with respect to the femur was deemed positive, while internal 
rotation and adduction (valgus deflection) was deemed negative. In a left knee, these 
conventions were reversed such that external rotation and abduction (varus deflection) 
were negative while internal rotation and adduction (valgus deflection) were positive.  
 
 Grood and Suntay (14) also described the three translational motions of the joint: 
medial/lateral, anterior/posterior, and axial. They defined these three joint translations by 
a vector extending between the tibial and femoral origins with vector components defined 
within the JCS. The three components of the translational vector were designated by S1, 
S2, and S3. Used to determine the medial/lateral translational motion, S1 was defined as 
the distance from the femoral origin along the femoral body fixed axis, the X-axis, to the 
intersection of the X-axis and the floating axis. S2, which was used to determine the 
anterior/posterior translation of the tibia with respect to the femur, was defined as the 
distance between the femoral body fixed axis, the X-axis, and the tibial body fixed axis, 
the z-axis, along their common perpendicular, the floating axis. Grood and Suntay (14)  
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Figure 1-2. Motions of the knee as defined by the Grood and Suntay (1) joint 
coordinate system  
Reprinted with permission. Amiri S, Wilson DR. A computational modeling approach for 
investigating soft tissue balancing in bicruciate retaining knee arthroplasty. Comput Math 
Methods Med; 2012. 
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designated anterior translation of the tibia with respect to the femur as positive while 
posterior translation was negative. Lastly, S3, which determined the axial motion of the 
joint (i.e. the vertical motion), was defined as the distance between the tibial origin along 
the tibial body fixed axis, the z-axis, to the intersection of the z-axis and the floating axis.  
 
 
Indications for TKA 
 
 In a healthy knee, all of the aforementioned structures facilitate painless function 
of the knee joint. However, there are many arthritic conditions that destroy or damage 
one or more of the joint structures causing pain, muscle weakness, and reduced function, 
prompting many to seek replacement surgery. Osteoarthritis (OA) is a degenerative 
disease in which the articular cartilage is worn away. This is caused by a disruption in the 
factors—such as inflammatory cytokines and proteases—that regulate the dynamic 
equilibrium between the continual, ongoing formation and breakdown of cartilaginous 
matrix. When the catabolic influences exceed the anabolic influences, chondrocytes can 
no longer compensate for the continuous breakdown of the matrix and gradual 
degradation occurs. As the cartilage degrades, bone on bone articulation results in the 
formation of osteophytes and narrowing of the joint space causing pain and stiffness. 
Post-traumatic arthritis is a form of OA that occurs after a traumatic injury to the knee 
joint, such as a fracture or ligament tear. These injuries often result in chronic 
inflammation or affect the natural alignment of the knee, gradually damaging the articular 
cartilage. Often, those who suffer trauma at a young age are susceptible to developing 
arthritis earlier than those who naturally develop OA (15). Rheumatoid arthritis (RA) is a 
chronic systemic autoimmune disease of unknown cause that primarily involves joints. In 
RA, the immune system attacks the synovial membrane, causing it to become chronically 
inflamed and thickened, which can damage the cartilage eventually leading to cartilage 
loss. Like OA, RA is believed to be mediated by cytokines and matrix metalloproteinases 
(16).  
 
 The primary indication for TKA is to relieve pain caused by severe arthritis, with 
or without significant deformity. Persons with severe arthritis may report joint pain, 
stiffness, and difficulty with mobility; oftentimes to the point that the reduced function 
interferes with activities of daily living and compromises the quality of life (17). Other 
sources of knee and leg pain must be sought and systematically excluded. Radiographic 
findings must correlate with a clear clinical impression of knee arthritis. The 
classification for OA described by Kellgren and Lawrence is the most widely used 
radiological classification to identify and grade OA. Kellgren and Lawrence defined the 
progression of OA in five grades (0, normal, to 4, severe) and combined it with important 
radiological changes evident at each stage including: formation of osteophytes on the 
joint margins or in ligamentous attachments; narrowing of the joint space associated with 
sclerosis of subchondral bone; cystic areas with sclerotic walls situated in the 
subchondral bone; and altered shape of bone ends (18, 19). Typically, patients with 
Kellgren and Lawrence Grade 3 or 4 OA qualify for TKA. Furthermore, conservative 
treatment measures should be exhausted prior to considering surgery. Conservative 
measures may include: patient education and lifestyle modification, rehabilitation through 
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physical therapy, anti-inflammatory medications, and intraarticular injections (9, 20). 
Several studies have found an inverse relationship between severity of OA based on pre-
operative radiographs and satisfaction following TKA (21-25). More plainly, performing 
a TKA on patients with early-grade arthritis may put those patients at a higher risk for 
pain and dissatisfaction. As such, these guidelines are essential in ensuring optimal pain 
and function outcomes for patients following primary TKA. 
 
 While the primary indication for TKA is to relieve pain and restore function in 
patients suffering from severe arthritis, deformity can become the principal indication for 
arthroplasty in patients with moderate arthritis and variable levels of pain when the 
progression of deformity begins to threaten the expected outcome of an anticipated 
arthroplasty (9). Flexion contracture, or stiffness upon extension, is a common deformity 
encountered in TKA (26). When fully extended, the knee can bear weight without 
constant muscle energy expenditure. In patients with a flexion contracture, a large 
amount of energy is needed from the quadriceps to help the knee bear load and remain 
stable. This causes standing, walking, and stair climbing to be abnormally tiring, reducing 
overall knee flexion (27, 28). For contractures of 10 or more, particular techniques, 
performed in a specified order, may be necessary to correct the flexion contracture. 
However, previous studies have indicated that patients with large flexion contractures 
preoperatively, greater than 20, are more likely to experience a flexion contracture 
postoperatively (27, 29). Similarly, excessive varus or valgus laxity is a deformity that 
poses a risk of compromising the outcome of arthroplasty as its severity progresses. A 
varus knee has displacement of the distal tibia toward the midline of the body in the 
coronal plane, in which the mechanical axis of the limb lies medially, resulting in a 
“bow-legged” appearance. On the other hand, a valgus knee occurs when the distal tibia 
rotates away from the midline, in which the mechanical axis of the limb lies laterally, 
resulting in a “knock-kneed” appearance. As the severity of the varus or valgus deformity 
progresses, a constrained condylar type of prosthesis may be necessary to prevent 
subsequent instability in the coronal plane. Complications of varus/valgus constrained 
designs have been well documented and result from the large stressed transmitted to the 
highly constrained implant (30-32). Intervening before this degree of laxity is reached 
allows the use of a prosthesis that lacks coronal plane constraint and has a more favorable 
expected survivorship (9). 
 
 
Implant Design Factors Related to Implant Wear 
 
 TKA is a safe and efficacious operation that relieves pain and improves function 
(1, 2, 33). Originally, this operation was intended for elderly patients with severe end-
stage arthritis of the knee. However, more recently, TKA has been extended to younger, 
more active patients with higher demands in their lifestyles. Kurtz et al. (34) projected 
that by 2030, patients under the age of 65 could account for 55% of the demand for 
primary TKA; furthermore, this data suggests that growth in use of TKA occurs in 
patients primarily between the ages of 45 to 65. These patients often voice high 
expectations prior to surgery with respect to restoration of function and even return to 
leisure activities; leisure activities range between low intensity, such as walking or 
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bowling, to high intensity, such as basketball or snow skiing (35). Regardless of the 
expectations of elderly or younger patients, the base requirement of a TKA is to restore 
basic knee function.  
 
 To accomplish this goal, the TKA must replicate normal knee motion 
characteristics. Many design variations of the femoral components and tibial inserts have 
been proposed to achieve this elusive feat. However, every TKA has a finite lifespan as 
demonstrated by the projection that patients below the age of 65 that have received 
primary TKA could account for 62% of the demand for revision TKA by 2030 (34). This 
lifespan is dependent upon the ability of the implant materials to withstand the physical 
demands of the patient. Successful outcomes as well as implant longevity following 
primary TKA are believed to be dependent on implant-specific factors including the 
design, materials, and the manufacturing or sterilization technique. This section will 
provide an overview of the evolution of TKA prostheses to the current designs employed, 
the materials utilized, and how each factor may influence wear of the implant.  
 
 
Evolution of Implant Designs 
 
 The first attempt of treating patients affected by knee arthropathies with joint 
replacement dates back to the mid-nineteenth century. In 1860, Verneuil proposed 
interpositional arthroplasty and attempted to build an artificial knee using the articular 
capsule to recreate the joint. In 1880, the German surgeon, Thermistocles Gluck, 
imagined the first primitive hinge joints made of ivory. However, despite his proposed 
system of joint replacement, the first part of the twentieth century only used 
interpositional arthroplasty using autologous tissues or metallic surfaces placed between 
the articulating surfaces of the joint. In the 1950s, Walldius developed a hinged 
prosthesis that replaced the joint surfaces of the femur and tibia (36). In the mid-to-late 
1960s, Gunston developed polycentric knee arthroplasty by adopting the concepts of low 
friction replacements proposed by Charnley; additionally, he introduced the first 
cemented surface arthroplasty of the knee joint (37). 
 
In the late 1960s, Drs. Freeman and Swanson were the first to approach condylar 
total knee design from a predominantly functional perspective (38). In 1970, Drs. Walker, 
Insall, Ranawat, and Inglis, at the Hospital for Special Surgery in New York, City, 
combined their respective design and surgical experienced to develop the duocondylar 
prosthesis. The Duocondylar was an anatomical, symmetric, cemented knee that 
preserved both cruciate ligaments (39). The lessons learned from the Duocondylar 
prosthesis design led to the development of the second generation of designs to come 
from the Hospital for Special Surgery—the anatomically designed duopatellar prosthesis 
and the functionally design total condylar prosthesis (40). 
 
 Simultaneous with the development of the Insall et al. (40) total condylar 
prosthesis was the introduction of the duopatellar prosthesis. This design preserved the 
PCL and resembles the shape of a normal knee joint with the sagittal plane contour of the 
femoral component being anatomically shaped (39, 41). The early tibial prosthesis model 
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was separated into medial and lateral parts, but a model was later developed that 
connected the bilateral parts. The patellar component was similar to that used in the Insall 
total condylar knee. The duopatellar prosthesis evolved into the kinematic prosthesis, 
which was widely used in the 1980s (9). 
 
 Influenced largely by the previous Freeman-Swanson design, the Insall et al. (40) 
total condylar design sacrificed both cruciate ligaments with sagittal plane stability 
maintained by the articular surface geometry. The femoral component, made of a cobalt-
chromium alloy, had symmetric condyles with a double curve and a flat patellar trochlear 
groove. The tibial prosthesis was made of polyethylene, had good conformity in flexion 
and extension, had anterior and posterior lips in the tibial joint surface, and had an 
eminence in the mid joint surface which provides anteroposterior and mediolateral 
stability. The tibial prosthesis also had a stem which allowed it to endure asymmetric 
loading. The patellar component was dome shaped and was composed of polyethylene 
with a fixation lug in the center which is fixed to the patella with bone cement. This 
original cemented total condylar prosthesis set the standard for survivorship of TKA (9). 
 
 While the total condylar prosthesis constituted the beginnings of modern TKA, 
the design was not without fault. It had a tendency to subluxate posteriorly in flexion if 
the flexion gap was larger than the extension gap. Moreover, the lack of femoral rollback 
by the implant severely diminished flexion if the PCL was not functioning. To correct 
these problems, the Insall-Burnstein PCL-substituting or posterior-stabilized (PS) design 
was developed in 1978 (42). A central cam mechanism was added to the articular surface 
geometry of the total condylar prosthesis; it interacted with a central post on the tibial 
articular surface and effectively reproduced femoral rollback allowing further flexion. In 
the Insall-Burnstein design, the post and cam were symmetric in nature (43). The post 
was positioned centrally on the tibial insert and the cam was located posteriorly on the 
femoral condyles. The Insall-Burnstein design engaged the cam on the post at 
approximately 60 of flexion, driving femoral rollback of the condyles on the tibial insert 
in a symmetric manner with increasing flexion until edge loading occurred around 120 
of flexion. As the first PS design, this cam-post configuration was the basis for all PS 
implants to follow. Most current total knee designs are derivatives of the Insall-Burnstein 
PS/CR and kinematic designs (9). 
 
 
Modern TKA Design 
 
 Today, many different TKA designs exist to address patient-specific needs. Two 
major design types of TKA used today are CR implants, in which the ACL is resected but 
the PCL is preserved, and PS implants, in which both of the cruciate ligaments are 
sacrificed but the function of the PCL is mimicked by a post and cam design. Although 
debated and investigated for many years, the superiority of one design (PS or CR) over 
the other remains undetermined. In 2005, a Cochrane systematic review on this topic was 
published including eight clinical trials comparing clinical, functional, radiographical, 
and quality of life outcome measures in patients who had received PS or CR prostheses; 
meta-analysis did not reveal a clear difference between the two treatments. The authors 
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found that the inconclusiveness of their initial review prevented them from giving clear 
advice on whether to retain and to sacrifice the PCL (44). In 2013, an updated version of 
the review was published and expanded to include 17 total randomized controlled trials, 
seven of which were included in the initial review. Again, the authors were unable to 
discern a difference between clinical, functional, and pain outcomes between the two 
implant designs and attributed the inconclusiveness to the variability of the 
methodological quality and the quality of reporting found in the trials (45).  
 
 When clear clinical evidence prompting resection of the PCL is absent, the 
selection of PS versus CR designs in TKA is largely based on the surgeon’s personal 
philosophy regarding the matter, surgical training, and experience. Advocates of PCL 
retention have cited maintenance of normal knee kinematics, protection of the bone-
cement interfaces from shear stresses, increased proprioception, and enhanced inherent 
stability (46-51). Furthermore, supporters claim that there is greater passive knee range of 
motion and enhanced quadriceps muscle power via the PCL-controlled femoral rollback 
mechanism (52-54). On the other hand, proponents of PCL substitution argue that 
resection of the PCL makes ligament balancing easier and allows for a more conforming 
femorotibial articulation, which may reduce polyethylene wear (42, 55). Additionally, 
those surgeons state that a more controlled replication of the rollback mechanism can be 
created by modifications of the prosthetic design (56). Finally, sacrifice of the PCL is 
sometimes necessary to balance knees with severe varus/valgus or flexion contracture 
deformities; therefore, PS designs are integral in the treatment of patients with such 
deformities. 
 
 In studies comparing kinematic patterns of native knees to knees after TKA, the 
normal motion was usually not reproduced by the modern TKA designs. During in vivo 
fluoroscopic analysis of normal knees, CR TKA knees, and PS TKA knees, Dennis et al. 
(12) revealed a number of differences in the observed kinematic patterns. The femur of 
the normal knee contacts the tibia anterior to the midpoint in the sagittal plane in full 
extension and translates posteriorly during flexion. The femur of the PS TKA knee 
contacts the tibia anteriorly, slightly less than the normal knee, and rolls back posteriorly 
during flexion similar to the normal knees. The femurs of the CR TKA knees contact the 
tibia posteriorly in extension and then translate anteriorly during midflexion; this 
phenomenon, termed paradoxical motion, is kinematically opposite of the normal knees 
and may be a factor in premature polyethylene wear (12). In a multicenter analysis of 
subjects with PS TKA and CR TKA, Dennis et al. (57) reported data remarkably similar 
to the previous study, showing a lack of customary posterior femoral rollback in CR 
TKA, instead showing paradoxical anterior translation with flexion. Posterior femoral 
rollback, less than that in normal knees, was routinely observed in PS TKA knees and 
was attributed to engagement of the femoral component cam with the tibial post (57). In 
another multicenter analysis, Dennis et al. (58) studied the axial rotation patterns of 
patients with normal knees and patients with fixed and mobile bearing PS TKA and CR 
TKA. While over 33 implants designs were included, the magnitude of internal rotation 
was much less than the normal knees on average (58). Furthermore, they found that all 
TKA subgroups had at least 19% of patients displaying reverse axial rotational pattern 
during deep knee bend and at least 31% during gait. Whereas the pivot location in a 
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normal knee is located medially, the effective pivot location observed by Dennis et al. 
(58) was variable, including on the medial side, the center, and the lateral side. Normal 
axial rotational patterns are essential for proper patellar tracking, reduction of 
patellofemoral shear forces, and maximization of knee flexion (58). Blaha et al. (59) 
posited that the anterior/posterior stability of the medial side of the normal knee is not 
usually present in a total knee when the knee is flexed. He proposed that a TKA designed 
to have a stable medial side combined with a lateral side that accommodates rotation of 
the tibia around the medial side through interaction of a spherical-shaped femoral 
component and a medially conforming tibial component may better replicate the 
kinematic patterns of a normal knee and confer better stability throughout gait (59).  
 
 Although CR or PS implants are generally regarded as a generic “type” of TKA, 
there are numerous designs available and each of these designs can vary considerably in 
the coronal and sagittal radii of their bearing surfaces and, in the case of PS implants, in 
the configuration of their cam-post mechanism. Variations in radii and cam-post 
mechanism are likely to impact the kinematic patterns and overall performance of the 
implant designs. Traditional TKA designs utilized multiple discreet radii to define the 
sagittal plane curvature of the femoral component; this geometry was meant to replicate 
the function of the natural knee joint by following the J-curve principle. A large primary 
distal radius was used as the principal load bearing surface during low flexion, high 
frequency activities, such as standing or gait, to reduce stress on the tibial insert. A 
smaller posterior radius of curvature reduced implant conformity and enabled the 
necessary knee rotation and rollback to facilitate deep knee flexion (60). In these 
traditional multi-radius designs, the distal radius instantaneously shifts to a smaller 
posterior radius at a specific flexion angle, typically between 15 and 30. However, this 
abrupt reduction in J-curve radii in midflexion caused abrupt changes in the center of 
rotation of the femur and abrupt reductions in tibiofemoral conformity, leading to a 
decrease in stability at midflexion (61). Using a deep knee bend simulator to assess the 
kinematics of multi-radius designs, Clary et al. (61) found that the sudden reduction in 
the radii of curvature of the femoral condyle was the underlying cause of the clinically 
“paradoxical” anterior femoral translation that is often observed in both PS and CR 
knees, although reportedly occurs more frequently in PCL-retaining knees (62, 63). 
Anterior motion of the femur on the tibia has the potential to adversely impact outcomes 
in several ways; anterior positioning of the femur reduces tibiofemoral range of motion, 
whereas relative tibiofemoral sliding increases the potential for insert wear while 
reducing quadriceps moment arms and efficiency (63-66) . 
 
 While it has long been held that flexion occurs about a constantly changing center 
of rotation, which is the basis for multi-radius designs, Hollister et al. (67) proposed 
instead that knee motion occurs about a single, fixed flexion/extension axis located in the 
posterior condyles. It was postulated that this single, fixed flexion/extension axis may be 
approximated by the transepicondylar axis (67). To ensure consistent tension in the 
collateral ligaments throughout the functional range of movement and to address the 
midflexion instability observed in multi-radius designs, the first “single radius” femoral 
component was introduced in 1996 based on this premise (Scorpio; Stryker, Mahwah, 
NJ). Somewhat of a misnomer, the term single radius implies that a sudden radius 
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transition does not exist, which is not the case. Instead, the transition from distal to 
posterior radii occurs earlier in the flexion cycle, typically around 10 of flexion. Using 
fluoroscopic evaluation of in vivo kinematics of patients with single radius and multi-
radius CR implants, Kessler et al. (68) found that the single radius design is more stable 
in terms of varus/valgus laxity than the dual radius design in midflexion. When 
comparing the multi-radius and single radius PS TKA designs, Mahoney et al. (65) and 
Ostermeier et al.(69) found that the single radius design provided a more posterior 
flexion/extension axis which lengthened the extensor mechanism arms, decreasing the 
quadriceps muscle force while reducing the joint reaction force. In a study of 16 patients 
with single radius PS TKA, Shimizu et al. (70) reported that the single radius implants 
did not show any paradoxical anterior femoral movement until 70 of flexion. The 
femoral component was kinematically stabilized in mid-flexion ranges and posterior 
femoral rollback occurred in deeper knee flexion with this design (70).  
 
 In addition to varying the sagittal shape of femoral components, the positioning 
and shape of the post-cam mechanism varies greatly among PS implant designs affecting 
the guided or constrained motion of the femur on the tibia. The post-cam mechanism was 
introduced to prevent posterior subluxation of the tibia and to increase posterior femoral 
translation in PCL-substituting TKA designs (42). Li et al. (71) evaluated the kinematics 
of PS TKA under simulated muscle loads and demonstrated that knee motion after post-
cam engagement was independent of muscle loads. This finding indicated that the post-
cam mechanism plays a critical role in knee kinematics. Consequently, it is important to 
understand how different variations in positioning or geometry of the post-cam design 
will affect knee motion. In a review of post and cam design variations, Mihalko et al. (72) 
summarized how the differences in positioning and shape effects the kinematics and wear 
of the PS designs. A centrally located post will interact with an anteriorly located cam 
sooner during the flexion arc and the cam will move up the post with further degrees of 
flexion, decreasing the jump height and increasing risk of posterior dislocation, a rare by 
severe complication (72-74). On the other hand, a centrally positioned post will interact 
with a more posteriorly positioned cam later in the flexion arc and the cam-post contact 
point will remain towards the base of the post even in deep flexion, thereby maximizing 
the jump height and minimizing risk of posterior dislocation (72, 74, 75). If the post is 
moved or angled posteriorly, a posteriorly situated cam will engage the post sooner in the 
flexion arc and will position the femoral condylar contact points more posteriorly as well 
(72, 73, 75). Cam and post geometry in the transverse plane also affects tibiofemoral 
kinematics. In contemporary PS prostheses, the post-cam design features can typically be 
categorized into flat-on-flat or curve-on-curve surfaces (76). A post with a rectangular 
cross-section will constrain rotation of the femur on the tibia in the transverse plane to an 
extent, affecting the internal/external rotational laxity. The restrictive nature of the 
rectangular shape will likely cause edge loading of the cam or even the condylar edges of 
the femoral component, thereby potentially increasing polyethylene wear (72, 76). A post 
with rounded geometry in the transverse plane may reduce internal/external rotational 
constraint decreasing the likelihood of burnishing and edge wear (72-74, 76).  
 
 The contemporary TKA tibial component can either be a fixed or mobile bearing 
design and the difference between these two designs is dictated by conformity. 
 14 
Conformity of an implant is defined as the difference between the corresponding femoral 
and tibial curvature in the sagittal or coronal plane (77). Conformity has a direct impact 
on the performance of a TKA, particularly with respect to tibiofemoral contact mechanics 
and kinematics. However, oftentimes, the implications of conformity on the contact 
mechanics and kinematics of the prosthetic components is conflicting. Fixed bearing 
TKA with a high conformity bearing surface provides low contact stress but restricts 
motion of the tibiofemoral articulation skewing the kinematic patterns and producing 
high torque at the bone-implant interface. Conversely, a low conformity fixed bearing 
surfaces allows for greater freedom of motion but increases contact stresses in the tibial 
insert which increases polyethylene wear (78-80). The kinematic conflict between low 
stress articulations and free rotation cannot be solved in a fixed bearing design because 
the modular tibial insert is locked within the tibial baseplate. As such, mobile bearing 
inserts were introduced with the aim to reduce polyethylene wear and component 
loosening (81, 82). The mobile bearing TKA design offers the advantage of allowing 
increased implant conformity and contact area without dramatically increasing stresses 
transmitted to the tibial insert or fixation interface (83). By increasing sagittal plane 
conformity in mobile bearing TKA, in vivo fluoroscopic analyses have demonstrated 
improved control of AP translation with reduced paradoxical anterior femoral translation, 
particularly during gait (57). In a study of axial rotation in fixed and mobile bearing 
knees, Dennis et al. (58) found that the average magnitudes of axial rotation in the two 
cohorts were similar; however, the site of rotation differed. Similarly, Komistek et al. 
(84) and D’Lima et al. (85) observed that the mobile bearing TKAs typically rotated in 
conjunction with the femoral component. Therefore, in TKA designs with a rotating 
platform, axial rotation typically occurs on the inferior surface of the tibial insert, 
whereas rotation obviously occurs on the superior surface in fixed bearing TKA. This 
likely plays a role in reduction of polyethylene wear after mobile bearing TKA because 
the shear forces on the superior aspect of the bearing are reduced.  
 
 Building upon the aforementioned principles factors, Walker et al. (86) 
incorporated various design features of TKA implants in an attempt to achieve normal 
knee motion characteristics. Two reference TKA models were included and consisted of 
a simple multi-radius condylar replacement in which the PCL is resected with partially 
conforming bearing surface and a posterior-stabilized simple multi-radius condylar 
design with a partially conforming bearing surface. As with the previous studies, the 
simple condylar replacement demonstrated lack of posterior femoral displacement and 
external rotation with flexion as well as the occurrence of the paradoxical anterior 
translation when a shear force was applied (86). This highlighted the fact that even when 
the PCL is absent, this paradoxical motion can still occur. The PS simple condylar design 
with partially conforming bearing surface was able to achieve posterior femoral 
displacement once the cam and post engaged at the set point of 90 flexion (86). 
However, the PS design did demonstrate anterior displacement in the range of 30 to 75 
of flexion. Moreover, both “reference” designs displayed average internal femoral 
rotation throughout the neutral path motions indicating that the posterior displacement of 
the medial side exceeded that of the lateral side, which was contrary to the kinematic 
patterns of the natural knees (86).  
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 The next two design variations Walker et al. (86) investigated were multi-radius 
femoral components that were to facilitate posterior femoral rollback through a patellar 
groove as opposed to a post and cam mechanism. It must be noted that these two designs 
would require resection of the PCL. In implant model S, the central ramp guides the 
posterior femoral displacement at flexion angles past 60. Model T utilized the same 
femoral component as model S but included a tibial insert that is more dished medially, 
which induced a medial pivot that allowed for external rotation of the femur with flexion. 
In essence, model T included variations that would potentially allow for posterior femoral 
rollback and external rotation of the femur with flexion. The basic symmetric ramp 
model, model S, was able to produce posterior femoral displacement with flexion; 
however, when an anterior shear force was applied, the design did demonstrate a 
paradoxical anterior motion, albeit only 3 mm which was a vast improvement over the 
prior two models (86). In model T, the more medially dished tibial insert did facilitate 
progressive external rotation of the femur with flexion; however, this design also 
demonstrated 3 mm of paradoxical anterior displacement (86).  
 
 Finally, to address the observed paradoxical anterior displacement observed in the 
four previous designs, Walker et al. (86) applied the single radius principle to models U 
and V. In model U, the posterior radius was continued anteriorly to form a profile for 
medial and lateral recesses. The tibial surface from model S was altered to include medial 
and lateral anterior pads, that corresponded to the recesses of the femoral component 
where the larger anterior radius transitioned to the smaller posterior radius. Walker et al. 
(86) hypothesized that the femoral-tibial conformity in the sagittal plane would prevent 
anterior displacement up to 60 of flexion; at which point, the central patellar groove, or 
ramp, can guide posterior femoral rollback. In model V, the single radius principle was 
also applied; however, the medial side had a recess which the lateral side did not. Using 
the same medial pivot principle as the tibial insert for model T, the tibial insert of model 
was less dished laterally and more dished medially with the addition of a medial pad that 
corresponded to the medial femoral recess. Walker et al. (86) hypothesized that this 
design would not only eliminate the paradoxical anterior femoral displacement, but also 
allow for additional rotational freedom in extension. As predicted, the anterior recesses of 
the single radius design of model U and V virtually eliminated the paradoxical motion. 
However, the provision of both medial and lateral recesses in model U limited the 
freedom of internal/external rotation in extension to only a few degrees. By providing 
only a medial recess, model V was able to have anterior-posterior stability on the medial 
side, coupled with rotational freedom throughout the entire flexion cycle (86).  
 
 To date, no TKA design has been developed that perfectly reproduced normal 
knee motion. Currently, there are numerous TKA designs on the market. Each of the 
designs varies slightly in hopes that it will be able to recapture natural knee kinematics. 
The variety of TKA designs currently on the market suggests there is still not a consensus 
amongst designers and manufacturers on the effects of geometry on wear and kinematics 
(79). However, investigational studies, such as the one discussed above by Walker et al. 
(86), brings the orthopedic and engineering community one step closer to achieving that 
elusive goal.  
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Implant Materials 
 
 While there are many variations of knee implants on the market today, a modern 
TKA prosthesis typically consists of a femoral component, a tibial component, a tibial 
insert, and a patellar component as shown in Figure 1-3. Femoral components on the 
distal end of the femur are typically made of cobalt-chromium-molybdenum (CoCrMo) 
alloy, but can also be fabricated with ceramic materials, such as alumina or zirconia. The 
tibial baseplate on the proximal end of the tibia is made of a metal alloy, either titanium-
aluminum-vanadium (TiAlV) or CoCrMo. The metal byproducts released from the 
implants are mainly due to combined effects of mechanical wear and corrosion (87). The 
prostheses are fixed to the bone using polymethylmethacrylate (PMMA), also called bone 
cement. More recent designs forego cement fixation and are press-fit with a porous 
coating that is intended to induce biological fixation through osseointegration. The tibial 
insert, which sits atop of the tibial baseplate and articulates with the femoral component, 
and the patellar button, which is used to resurface the posterior side of the patella, are 
composed of ultra-high-molecular-weight polyethylene (UHMWPE). Tibial insert wear 
occurs from a combination of rolling, sliding, and rotational motions on the bearing 
surface, which may lead to delamination, pitting, and fatigue failure of the tibial insert 
surface. Polyethylene wear also has been observed on the undersurface, or backside, of 
modular tibial knee inserts (88, 89). Additionally, modes of sterilization, such as gamma 
radiation, used when manufacturing the polyethylene inserts have been shown to cause 
increased wear by introducing oxidation to the insert when placed in the body, causing 
delamination of the component surface as well as subsurface damage (90, 91). 
 
 
Surgical Factors Related to Implant Wear 
 
 An estimated 20 or more surgical steps are completed during arthroplasty, and at 
least 5 or more variations of each step exist. Taking these estimations into account, over 3 
million different variations in surgical technique can potentially occur in primary TKA. 
Successful outcomes following primary TKA and long-term implant durability are 
believed to be dependent on the aforementioned implant-specific factors as well as 
surgical factors. During the procedure, the surgeon must adhere to the following 
principles to ensure optimal outcomes: appropriate sizing of the individual components, 
alignment of the components to restore the chosen reference axis, recreation of equally 
balanced soft tissues and gaps in flexion and extension, and optimal patellofemoral 
tracking. While each of these factors were not specifically assessed in this study, their 
role in the etiology of failure were noted in this section. 
 
 
Proper Alignment of Components to Restore a Reference Axis 
  
 Rotational positioning of femoral and tibial components is regarded as a critical 
aspect of TKA because malrotation of the components may lead to patellofemoral 
problems, flexion instability, excessive wear of UHMWPE insert or post, stiffness, and 
abnormal gait patterns (92). Proper alignment is believed to decrease both the mechanical  
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Figure 1-3. Total Knee Arthroplasty components  
Reprinted with permission.  Manner PW. Knee replacement implants. OrthoInfo.© 
American Academy of Orthopaedic Surgeons. http://orthoinfo.aaos.org. Accessed 18 
August 2017. 
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and shear stresses placed on the bearing surfaces, as well as the bone-implant interfaces 
(80). Various alignment axes and surgical techniques have been proposed to attain the 
goal of proper alignment of TKA components. There are three alignment philosophies 
currently suggested for use in TKA: anatomical, mechanical and kinematic alignment 
methods. Each of these philosophies use a different reference axis from which the distal 
femoral and proximal tibial cuts are based.  
 
 The anatomical axis of the lower extremity is defined in relation to the 
intramedullary canals of the femur and tibia. On antero-posterior evaluation, the 
anatomical and mechanical axes of the tibia coincide exactly, but, in the femur, the two 
axes make an angle of 5 to 7 degrees (˚) (93). Originally described by Hungerford and 
Krackow (94), anatomic alignment sought to position the femoral and tibial components 
in such a way as to recreate the joint line. This optimal alignment, they believed, was 2 to 
3˚ varus in relation to the mechanical axis of the lower extremity (94). Per this reference 
axis, the proximal tibia was cut at 3˚ varus to the anatomical axis of the tibia and the 
distal femur was cut at an angle that was the difference between the anatomic and 
mechanical axis of the femur, approximately 8 to 9˚ valgus (94). When combined, the 
total alignment was approximately 6˚ valgus that approaches the normal tibiofemoral 
angle and provided for a joint line that is parallel to the ground during normal gait (94).  
 
 The method of mechanical axis alignment in TKA was first described by John 
Insall (95). The mechanical axis of the lower extremity passes from the center of the 
femoral head to the center of the talar dome in the ankle (93). Insall et al. (95) posited 
that the mechanical axis approximates normal knee alignment and is easily identifiable. 
Furthermore, he suggested that the increased forces across the medial joint component in 
an anatomically aligned knee lead to medial tibial plateau fixation failure (95). Even 
though the joint loading forces between compartments are even during the stance phase 
of gait, joint forces will become uneven during the gait phase due to a laterally directed 
ground reaction force (96). As such, when using the mechanical axis alignment method, 
the surgeon first makes a distal femoral cut at a valgus angle of typically 5 to 7˚ to the 
mechanical axis of the femur, generally removing the same amount of bone that is to be 
replaced by the femoral component. However, if a PS prosthesis is used, an additional 
distal femoral resection of 2 millimeters (mm) can be performed to equal the increase in 
the flexion gap that occurs when the PCL is removed (97).  
 
Because the anterior and posterior femoral cuts determine the rotation of the 
femoral component and the shape of the flexion gap, surgeons must take care during 
resection to maintain correct alignment of the femoral component in the transverse plane 
(9). With respect to femoral component alignment, excessive external rotation increases 
the flexion gap medially by facilitating tightening of the lateral ligaments by over-
stuffing the lateral flexion gap and loosening of the medial ligaments in flexion which 
can result in flexion instability (98, 99). In other words, increased external rotation of the 
femoral component increases internal rotational laxity and constrains external rotational 
laxity in flexion. Contrarily, internal rotation of the femoral component can cause lateral 
patellar tilt/subluxation,  patellofemoral instability resulting in dislocation, pain, and 
patellar component failure (100). Many reference points, correlating to different 
 19 
anatomical landmarks, have been proposed and are used to determine femoral component 
rotation, including: the transepicondylar axis, the anteroposterior axis, the posterior 
femoral condyles, and the tibial cut first technique, also known as the “flexion gap 
balancing” technique. Regardless of the method used for rotational alignment, the 
thickness of the bone resected from the posterior aspect of the femoral condyles should 
equal the thickness of the posterior condyles of the femoral component. The surgeon 
completes the distal femoral preparation for a CR prosthesis by making anterior and 
posterior chamfer cuts for the implant. If a PS design is used instead, the bone is removed 
for the intercondylar box to accommodate the housing for the post and cam mechanism. 
 
 Studies have demonstrated that malalignment of the tibial component in the 
transverse plane is related to chronic pain. More specifically, increased internal rotation 
of the tibial component has been correlated with chronic pain (101, 102). Relative 
internal rotation of the tibial component effectively increases the Q angle and changes the 
force vector on the extensor mechanism. Barrack et al. (102) proposed that the abnormal 
stress on the patella due and the surrounding soft tissue may explain the peripatellar pain 
reported by patients following TKA. The “traditional” method for tibial component 
alignment involves using the tibial tubercle as a landmark and placing the center of the 
tibial component at the medial third of the tubercle. However, since the tubercle is rotated 
externally relative to the tibial plateau, this method has been shown to create a tendency 
for external rotation of the tibial component (103). Additional landmarks that have been 
proposed to determine proper tibial component alignment include: the “Akagi” line (104), 
the central third of the tibial tubercle (105), the postero-lateral tibial corner (106), and the 
anterior tibial contour (107). Once proper tibial component alignment is achieved, the 
proximal end of the tibia is cut perpendicular to its mechanical axis with a cutting block 
oriented by an intramedullary or extramedullary guide in both the anatomical and 
mechanical axes techniques. The amount of posterior slope depends on the implant 
system being used and the amount of tibial resection is dependent on which side of the 
joint is used for reference, i.e. the more or less arthritic side (9). 
 
 Using anatomical landmarks for the rotational alignment of the femoral and tibial 
components is a widely accepted method. However, determining the component positions 
separately can lead to rotational mismatch between the femoral and tibial components. 
Retrieval and biomechanical studies have reported that femoro-tibial rotational 
mismatches alter kinematics of the joint causing increased contact stress on the tibial 
insert and patellar button leading to accelerated UHMWPE wear as well as femoro-tibial 
subluxation and patellofemoral dysfunction (102, 108, 109). To address this disadvantage 
of all anatomical landmark techniques, the range-of-motion (ROM) technique was 
introduced in which the rotational alignment of the tibial tray is determined through 
conformity to the femoral component when the knee is put through a series of full 
flexion-extension cycles (110). However a study conducted by Ikeuchi et al. (110) found 
that the ROM technique resulted in more internal rotation of the tibial component than 
when anatomical landmarks were used.  
 
 Historically, the two aforementioned alignment strategies have been used to 
replicate the mechanical axis of the lower extremity by positioning of the components. 
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Recently, following the research by Hollister et al. (67), Howell et al. (111) proposed a 
technique, deemed the “kinematically aligned” TKA. Kinematic alignment in TKA is 
based on the 3 functional kinematic axes about which the knee rotates as described by 
Hollister et al. (67). The first axis is a transverse axis, defined by the transepicondylar 
axis of the femur, in which the tibia flexes and extends. The second axis is a transverse 
axis located anterior, proximal, and parallel to the first transverse axis which depicts the 
motion in which the patella flexes and extends in relation to the femur. The third axis, a 
longitudinal axis, is perpendicular to the 2 previous axes and dictated the dynamic 
movement of internal and external rotation of the tibia in relation to the femur. In 
kinematic alignment, the principles for placing the components are as follows: 1) co-
aligning the transverse axis of the best-fitting femoral component with the primary 
transverse axis in the femur about which the tibia flexes and extends; 2) removing 
osteophytes to restore ligament length, motion, and stability; and 3) placing the tibial 
component so that the longitudinal axis of the tibia is perpendicular to the transverse axis 
as described by the transepicondylar axis (112). This method strives to reproduce near-
normal knee function by aligning the articular surfaces of the femoral and tibial 
components to the normal or pre-arthritic joint lines of the knee (111, 113). To do this, 
the femoral component is placed in a slightly more valgus and internally rotated position, 
while the tibial component is placed in a slightly more varus and internally rotated 
position, compared with the placement of the implants in a mechanically aligned TKA 
(112, 113).  
 
 
Recreation of Soft Tissue Gaps in Flexion and Extension 
 
 Soft tissue balancing, or obtaining proper ligament tension, during TKA is a 
paramount step to assuring longevity of the replacement because it is critical to 
maintaining the stability of the implant and joint post-operation. The typical surgical 
approach to properly balance a knee during TKA involves ensuring an equal gap distance 
of the medial and lateral compartments in both extension and flexion restoring the knee to 
proper alignment (114, 115). This is accomplished by releasing ligaments on the medial 
or lateral side of the knee, depending on which side is tighter. In a varus deformity, the 
medial soft tissues are tighter than the lateral side. This deforming is most commonly 
found in the OA knee and multiple techniques have been described for its correction. In 
both a PS and CR prosthesis, the MCL is typically released to balance tension of the 
ligaments and gap distance of the joint. In a valgus deformity, the lateral soft tissues are 
tighter than the medial side. This deformity is most common in patients with RA and 
inflammatory arthropathies. The three-layer anatomy of the lateral side of the knee joint 
makes its soft-tissue balancing more complex than those with varus deformity. 
Depending on the extent of the valgus deformity, surgeons may release the LCL, iliotibial 
band, popliteus tendon, or the tendon of the lateral head of the gastrocnemius (9). 
 
 
 Instead of ligament release, the pie-crusting technique has been introduced as a 
tool to correct varus or valgus deformities with a milder affect than ligament release 
(114). During balancing, the contracted side of the soft-tissue sleeve is assessed for tight 
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structures and then the surgeon applies multiple stabs with a scalpel blade or large needle 
parallel to the joint line to effectively elongate the areas of the soft-tissue sleeve that are 
under undue tension. The advantage of pie-crusting, especially on the lateral soft-tissue 
sleeve, is that is leaves a supporting tether that prevents a larger gap opening on the 
lateral side of knee in flexion. Regardless of the balancing technique used, the surgeon 
must be sure to check the tissue and gap balancing in both extension and flexion as laxity 
of some structures changes with motion of the joint (9). 
 
 Suboptimal soft tissue and gap balancing may be implicated in the etiology of 
some of the most common indications for revision—loosening, excessive wear, 
instability, and malalignment (116-122). If the soft tissues are not balanced such that the 
lateral and medial joint gaps are equal throughout a range of flexion angles, it may lead to 
increased loading in one compartment such that the implant will not be able to function 
as intended. Excessive ligamentous laxity has been reported to increase anterior-posterior 
(AP) translation and internal-external (IE) rotation which leads to force concentrations 
that are outside of the intended design parameters of the TKA components and that 
exceed the material properties of the tibial insert facilitating increased UHMWPE wear 
(78, 123-126). There is a paucity of literature evaluating the relationship between joint 
laxity and metallic wear debris production following TKA. As such, optimal ligament 
laxity has yet to be clearly defined and is largely subjective, based on the surgeon’s 
experience and intraoperative assessment. 
 
 
Proper Patellofemoral Tracking 
 
 In addition to proper alignment of components and tissue balancing, the surgeon 
must ensure proper patellofemoral tracking. Patellar maltracking may result from 
component malpositioning and limb malalignment, prosthetic design, improper patellar 
preparation, or soft-tissue imbalance (127). As previously discussed, patellofemoral 
instability may result from internal malrotation of the femoral or tibial components. 
However, any alteration in knee kinematics and joint balance that increases the tightness 
of the lateral retinacular structures or increases the Q angle of the extensor mechanism to 
produce a laterally directed muscle vector may cause patellofemoral instability (9, 127). 
 
 If the patella is to be resurfaced, the prosthetic patella should be medialized to 
approximate the median eminence of the natural patella. Centralization of the prosthetic 
button requires the bony patella to track medially which forces it to function with a 
higher Q angle. Surgeons use the “no thumb” test of patellar tracking to determine 
adequate patellar stability. The reduced patella is observed within the femoral trochlea 
throughout the range of motion before retinacular closure. If the patellar button tracks 
congruently with minimal to no pressure applied to the lateral side of the patella, 
patellofemoral tracking is adequate and the surgeon can proceed with component 
implantation (9). If the patella does not properly track, a lateral retinacular release may be 
performed. Additionally, studies have shown that deflating the tourniquet prior to the “no 
thumb” test may attenuate the need for lateral release (128-130). As such, it is customary 
for surgeons to deflate the tourniquet prior to assessing patellar tracking.  
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Biological Responses to Wear Debris 
 
 In general, modern materials for joint replacements are well tolerated by the body 
as long as they are in bulk form, are mechanically stable, and are not infected. However, 
normal usage of the joint following implantation results in the wear of the bulk material 
resulting in the production of debris. When wear products are generated, they may exist 
in one of two forms: insoluble, particulate debris and soluble, metallic ions. Particulate 
wear debris—polymers, ceramics, or metals—range in size from nanometers to 
millimeters whereas metal ions exist in soluble forms that may bind to serum proteins, 
remain in solution, or disseminate systemically (131). Polyethylene particles range in size 
between 0.23 to 1 micrometers (µm), with an approximate mean size of 0.5 µm (131). 
Metal particulate debris is generally an order of magnitude smaller with a mean size of 
0.05 µm (131). The production of these particles may incite adverse inflammatory 
reactions that are carried out by a variety of cells. However, the mechanisms of the 
biological response to the wear debris are complex and not well understood. 
 
 
Innate Immune Response to Wear Debris 
 
 Debris from joint replacements, whether polymeric or metallic, stimulates the 
ingress of polymorphonuclear leukocytes (neutrophils, basophils, and eosinophils) and 
macrophages into the local site (132). Macrophages are believed to dominate the 
inflammatory events and recognition of wear particles by macrophages involves 
scavenger receptors that act as phagocytic receptors mediating direct non-opsonic 
phagocytosis of pathogenic microbes by macrophages (133). Depending on the size of 
the particulate debris, interaction with the macrophages may occur in one of three ways. 
Small particles, less than 150 nanometers (nm) in size, are ingested by pinocytosis or 
endocytosis and do not cause cellular activation. Particles ranging in size from 150 nm to 
10 µm are phagocytosed. Larger particles, greater than 10 µm in size cannot be 
phagocytosed and instead may interact with cells through pattern recognition receptors 
(PRRs), including nucleotide oligomerization domain-like receptors and toll-like 
receptors (134-137). PRRs are important in innate immunity as first-line defense for 
recognition of microbial patterns called pathogen-associated molecular patterns (133). 
 
 In response to stimulation via debris phagocytosis or interaction with PRRs, 
macrophages express chemokines, cytokines, proteolytic enzymes (matrix 
metalloproteinases, or MMPs), reactive oxygen and nitrogen species, prostaglandin E2 
(PGE2), and other substances of inflammation (138). Proinflammatory cytokines such as 
tumor necrosis factor (TNF)-, interleukin (IL)-1, and IL-6, among others, sequentially 
lead to increased production of RANKL (receptor activator of nuclear factor-B ligand) 
(135). The RANK/RANKL/osteoprotegerin (OPG) pathway directly regulates osteoclast 
activity and bone resorption. Overactivity of RANK/RANKL system and increased 
expression of these inflammatory molecules have been demonstrated in aseptic and septic 
loosened THAs, suggesting a role in prosthetic failure (139). Additionally, in adaptive 
immune responses, such as delayed type hypersensitivity (DTH), macrophages can 
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activate T-cells through antigen presentation, which will be discussed further in the next 
section. While the mechanisms of the biological response to wear debris have yet to be 
delineated, this chronic inflammatory scenario ultimately leads to upregulation of 
pathways leading to bone destruction and downregulation of pathways leading to bone 
formation. 
 
 
Delayed-type Hypersensitivity 
 
 The prevalence of metal sensitivity among the general population is 
approximately 10 to 15%. Nickel is the most common metal sensitizer, with 
approximately 14% of the population demonstrating dermal reactivity, followed by Co 
and Cr (140). The prevalence of metal sensitivity among patients with well-functioning 
and poor functioning implants has been reported to be approximately 25% and 60%, 
respectively, as measured by dermal patch testing (140). Delayed cell-mediated 
hypersensitivity may be implicated as a cause of tissue damage and loosening in 
instances of low wear. Due to their small size, metal ions can bind to serum proteins 
forming a hapten-protein complex (140, 141). The binding of metal ions alters the protein 
conformation so that immunogenic neo-epitopes are formed (87). These metal-protein 
complexes are considered to be candidate antigens for eliciting DTH responses (140). At 
the same time, macrophages can also phagocytose metal haptens, processing them along 
the endolysosomal route and finally presenting haptens on class II major 
histocompatibility complex (MHC-II) molecules.  
 
 It is also postulated that metal ions can also activate T cell receptors directly (87). 
Once the T-helper cells are antigen-activated, they secrete a variety of cytokines that 
recruit and activate macrophages, monocytes, neutrophils, and other inflammatory cells. 
Activated macrophages, because of their increased ability to present MHC-II and secrete 
certain cytokines, can trigger the activation of more TDTH cells, which in turn activate 
more macrophages; this self-perpetuating response can create extensive tissue damage 
(140). The specific T-cell subpopulation, the cellular mechanism of recognition and 
activation, and the antigenic metal-protein determinants elicited by these metals remain 
incompletely characterized. DTH reactions may cause the tissue damage and loosening 
observed in instances of low wear. 
 
 
Adverse Local Tissue Reactions 
 
 Adverse local tissue reaction (ALTR) refers to untoward histological reactions 
(often associated with clinical manifestations) that occur when metal implants corrode 
(142, 143). Evidence of direct inflammatory cell-induced corrosion of non-modular 
femoral components has been previously reported (144-146), although it remains a 
controversial topic. When metallic particles are phagocytosed by macrophages and giant 
cells, the acidic intramedullary environment of the lysosomes facilitate corrosion of the 
CoCrMo particles, producing high intracellular levels of ions, which may cause cell 
death. In excess, metallic corrosion products may cause adverse local tissue responses or 
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systemic toxicity. Furthermore, it has been demonstrated that metallic debris, in ionic 
form, decreases the proliferation of osteoblasts; as such, metal wear by-products may 
play a role in the etiology of osteolysis (147-150). 
 
 ALTR may present as metallosis, aseptic lymphocytic vasculitis-associated 
lesions (ALVAL), pseudotumors, or osteolysis. Metallosis, shown in Figure 1-4, is the 
macroscopic staining of the soft tissues and is associated with abnormal wear, such as 
micromotion at modular junctions or when the non-metal bearing fails facilitating metal-
on-metal articulation in TKA or THA (151, 152). ALVAL describes a periprosthetic 
inflammatory reaction that is similar to a type IV hypersensitivity response; it is 
characterized by soft tissue necrosis, lymphocytic infiltration including perivascular 
cuffing, and abnormal joint fluid (142). Pseudotumors are large cystic masses that may be 
cystic, solid, or a combination; they are usually, but not always, symptomatic, and 
histology tends to show much more extensive lymphocyte infiltration and tissue necrosis 
than ALVAL (142, 153). It has been suggested that these abnormal soft-tissue reactions 
may be attributed to two etiologies: wear-related cytotoxicity and hypersensitivity (154). 
Although ALTRs were originally believed to be associated with metal-on-metal THAs, 
clinicians and researchers continue to present case reports and studies in which patients 
with metal-on-polyethylene THA or TKA have metallosis (151, 152), pseudotumor 
formation (155), elevated tissue metal concentrations (140), and elevated systemic metal 
levels (156-158) highlighting the need for further research into the wear of metallic 
orthopaedic components. 
 
 
Systemic Effects and Associated Toxicity of Metallic Debris 
 
 Because many of these metal ions are naturally occurring in the human body and 
are required for normal physiology, the normal human serum concentrations must first be 
established. Cobalt, whose reference value is 0.8 microgram per liter (µg/L) in serum, is 
an essential cofactor in vitamin B12 metabolism. Chromium, an essential trace element, 
is required for maintenance of proper carbohydrate and lipid metabolism and exists in 
valence states ranging from -2 to +6, with hexavalent chromium, Cr6+, and trivalent 
chromium, Cr3+, being the most prevalent forms. While Cr3+ is the most prevalent form 
found in food and is generally regarded as nontoxic, Cr6+, a strong oxidizing agent, is 
classified by WHO as a class 1 human carcinogen (159). Normal serum level of Cr is 
approximately 0.15 µg/L.  
 
 In recent past, excessive metal wear has been a concern for patients who have 
received metal-on-metal hip replacements because of the adverse immune reactions, such 
as hypersensitivity, metallosis, and pseudotumor formation, that have been reported (149, 
160, 161). As such, certain cutoff values have been established that may be indicative of 
excessive wear or ALTR. Serum Co concentrations exceeding 1 µg/L is typically 
associated with excessive wear in a poorly functioning prosthesis (131). Serum 
concentrations of Cr greater than 0.6 µg/L suggests significant prosthesis wear (162). 
Plummer et al. (163) reported average serum Co and Cr concentrations of 11.2 µg/L and 
2.2 µg/L in patients with ALTR and trunnionosis at the modular head-neck junction,  
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Figure 1-4. Specimen RLU0426161B-L, retrieved in this study, presented with 
metallosis 
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whereas McGrory et al. (164) reported average serum Co and Cr concentrations as low as 
5.4 µg/L and 0.75 µg/L in a similar cohort of patients. Large doses of Co can produce 
adverse clinical manifestations such as polycythemia, hypothyroidism, cardiomyopathy, 
and carcinogenesis (142). In excessive levels, chromium can lead to nephropathy, 
hypersensitivity, and carcinogenesis (140, 165). 
 
 Titanium alloys are commonly used in medical applications due to their 
osteoconductive and corrosion resistant properties. Normal human serum level of Ti is 
less than 4.1 µg/L. While Ti is not an essential trace metal required for normal 
homeostasis like Co and Cr, patients with Ti-base alloy implants have demonstrated 
elevated levels in joint pseudocapsules as well as elevated spleen and liver concentrations 
(131). Furthermore, titanium particles appear have been demonstrated to be more 
inflammatory than Co, Cr, UHMWPE, or alumina particles and induce pro-inflammatory 
cytokine production, include IL-6, TNF-α, and monocyte chemotactic protein (MCP) -1 
(166), all of which are implicated in mediating osteolysis. The systemic release of 
metallic ions is a major concern and requires diligent monitoring, although acute and 
forthright toxicity is exceedingly rare. 
 
In a prospective study, Lons et al. (156) sought to quantify metallic ion release 
after TKA. In their cohort, average preoperative Co, Cr, and Ti blood levels were 0.22 
µg/L, 0.45 µg/L, and 2.94 µg/L. At 1 year following the index procedure, average Co, Cr, 
and Ti blood levels increased significantly to 1.41 µg/L, 1.27 µg/L, and 4.08 µg/L, 
exceeding the normally occurring reference values. Additionally, a few clinical studies 
have reported increased systemic metal ion levels in TKA patients following loosening or 
malfunctioning of the implant (156, 167). These studies highlight the ability for clinically 
significant metal release in metal-on-polyethylene non-modular primary TKA. As such, 
the present study sought to further investigate the release of metallic debris in primary 
TKA.  
 
 
Inflammatory Cytokines as Biomarkers of Inflammation and Osteolysis 
 
 Many studies have assessed the prognostic and diagnostic utility of various 
inflammatory cytokines as biomarkers in improving evaluation of suboptimal outcomes 
following total joint replacement. Prior to selecting which cytokines to test in this study, 
previous studies were consulted to establish that each of these cytokines had been 
demonstrated to induce an inflammatory or immune response when exposed to wear 
debris. The majority of research on potential biomarkers that was found in literature used 
patients with THA. Furthermore, the studies that were consulted used synovial-like 
interface membrane, surrounding periprosthetic tissue, or serum as their medium for 
cytokine analysis. It is difficult to conclude if elevated serum cytokine levels are result of 
events at the total joint replacement interface or if other inflammatory processes are 
contributing to the cytokine release (168). As such, this study sought to investigate the 
concentrations of various inflammatory cytokines present in synovial fluid in well-
functioning cadaveric primary TKAs. 
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 Because TNF-α and IL-1 were the first cytokines shown to stimulate bone 
resorption in vitro, these inflammatory cytokines have been at the center of the search to 
identify a biomarker for damage in total joint replacements. TNF-α  has a catabolic effect 
on bone, indirectly supporting the survival and differentiation of osteoclasts (169). IL-1β 
induces differentiation and proliferation of osteoclasts as well as the production of MMPs 
and PGE2 from fibroblasts and synovial cells (170). In vitro studies have also 
demonstrated that wear particles generated from TKA implants stimulate macrophages to 
produce IL-6, which is believed to have a regulatory role in maintaining the inflammatory 
response within the bone-implant interface as well as having an adverse effect on bone 
remodeling and mediating the effects of IL-1β and TNF-α during human osteoclast 
formation (171, 172). Consistent with these in vitro findings, several clinical studies have 
demonstrated increased production of these cytokines in periprosthetic tissues and fluids 
of loosened prostheses (166, 173, 174). 
 
 Chemokines are an important subset of cytokines that produce chemotactic agents 
for the purpose of cell recruitment. The chemokines particular to implant aseptic 
loosening pathology include IL-8, MCP-1, and macrophage inflammatory protein (MIP-
1α). IL-8 has been demonstrated in vitro to be secreted by peri-implant cells such as 
macrophages and mesenchymal stem cells when exposed to different types of wear 
particles like Ti, CoCr, and polyethylene (175). Nakashima et al. (176) observed MCP-1 
and MIP-1𝛼 expression in all tissue samples from failed arthroplasties, establishing their 
presence in the inflammatory cascade of arthroplasty failure. Moreover, they were able to 
induce expression of MIP-1𝛼 and MCP-1 by macrophages in cell culture after exposure 
to different types of wear particles (176). MCP-1 is potently chemotactic for monocytes 
but can also recruit macrophages, natural killer cells and T cells. A study by Dasa et al. 
(177) revealed elevated MCP-1 concentrations in revision samples of aseptically 
loosened TKAs  when compared to OA and RA synovial fluid samples, demonstrating its 
potential as a biomarker for inflammation and osteolysis. MIP-1𝛼 has a less clear role in 
implant debris-induced inflammation. Produced by a variety of peri-implant cell types, it 
is believed to likely be a central feature of adaptive immune responses via T-cells and B-
cells to implant debris (178). 
 
 In addition to these major cytokines and chemokines associated with implant 
failure, granulocyte macrophage-colony stimulating factor (GM-CSF) and macrophage-
colony stimulating factor (M-CSF) have both been suggested as mediators of the 
inflammatory cascade. GM-CSF is a hematopoietic growth factor with a regulatory effect 
on the transformation of immature macrophages into multinucleated giant cells that 
exhibit phenotypic and functional characteristics of osteoclasts (179). M-CSF is 
considered to be an essential mediator of osteoclast formation and release of M-CSF by 
activated cells in the peri-implant region is likely to be an important factor osteolysis 
(171). Recently, both GM-CSF and M-CSF have been implicated macrophage 
polarization. Macrophages exposed to lipopolysaccharide, IFN-γ, or GM-CSF assume a 
pro-inflammatory phenotype known as classical macrophage activation or M1 
polarization. In contrast, macrophages exposed to IL-4, IL-13, or M-CSF assume an anti-
inflammatory phenotype known as alternative macrophage activation or M2 polarization 
(180). M1 macrophages are effective in antigen presentation and killing of phagocytosed 
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pathogens and also produce inflammatory cytokines and chemokines, whereas M2 
macrophages produce anti-inflammatory cytokines and instead participate in tissue 
regeneration and angiogenesis by secreting various growth factors and extracellular 
matrix precursors (181). 
 
 While the aforementioned inflammatory cytokines are involved in the innate 
immune response, several cytokines, including IFN-γ and IL-2, mediate the adaptive 
immune response via lymphocytes. The type of lymphocytes that dominate the implant 
debris-associated responses are T helper cells, which are divided into two subtypes: Th1 
cells that are critical in macrophage activation and Th2 cells that are engaged in B cell 
activation and humoral immunity. Th1 cells, characterized by production of IFN-γ and 
IL-2, have been implicated as mediating metal DTH responses. While it has been difficult 
to readily identify these responses in peri-implant tissues by such signature cytokines, 
some studies using mRNA detection instead of tissue immunohistochemistry have shown 
the increased expression of these Th1 cytokines (182, 183). 
 
 
Objectives, Hypotheses, and Rationale 
 
 As total knee arthroplasty continues to be one of the most commonly performed 
orthopaedic procedures performed annually, revision arthroplasties will continue to 
increase as well. The understanding of the etiology of aseptic implant loosening is still in 
its infancy and implant retrieval studies are of utmost importance to expanding this 
understanding. Of the implant retrieval programs in existence, most analyze failed 
implants retrieved at time of revision surgery. In choosing to solely analyze well-
functioning implants retrieved at time of necropsy, the first objective of this study was to 
provide a baseline measurement of certain implant, surgical, and biological factors—such 
as polyethylene wear scores, femoral component damage scores, soft tissue laxity 
profiles, periprosthetic tissue metal concentrations, and inflammatory cytokine 
concentration in synovial fluid—that dictate the longevity and success of a TKA. The 
second objective was to compare the laxity profiles, periprosthetic tissue metal 
concentrations, and synovial fluid cytokine concentrations to determine if a correlation 
existed between each factor. Additionally, the tibial insert wear scores and the femoral 
component damage scores will be presented but not analyzed for comparison due to their 
subjective nature. The final and future objective of this study is to utilize these “baseline 
measurements” for comparison against failed implants retrieved at time of revision to 
elucidate if any meaningful relationships emerge. To this end, the following hypotheses 
were tested: 
 
(a)  Elevated tissue metal concentrations will be associated with decreased joint 
laxity. In other words, an inverse correlation will exist between periprosthetic 
tissue metal concentrations and joint laxity profiles. A more constrained laxity 
profile will cause increased contact pressures between the articulating surfaces 
facilitating abrasive and adhesive wear via third body particles and the subsequent 
release of Co and Cr particles or ions. Additionally, higher loads in the transverse 
plane will cause backside wear of the UHMWPE tibial insert against the TiAlV 
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alloy or CoCrMo alloy baseplate inducing the release of Ti, Co, or Cr particles or 
ions. 
 
(b)  Elevated synovial fluid inflammatory cytokine concentrations will be associated 
with increased joint laxity. In other words, a positive correlation will exist 
between synovial fluid inflammatory cytokine concentrations and joint laxity 
profiles. A laxer joint profile has been demonstrated to increase UHMWPE wear 
of the tibial insert. Increased UHMWPE debris production will incite an 
inflammatory response mediated by the innate immune system. As such, 
cytokines specifically tied to the innate immune system will be elevated. It must 
be noted that an increase in inflammatory cytokines may also be caused by 
metallic debris. 
  
(c)  Elevated inflammatory cytokines in the synovial fluid will be associated with 
elevated periprosthetic tissue metal concentrations. In other words, a positive 
correlation will exist between tissue metal concentrations and inflammatory 
cytokine concentrations in the synovial fluid. Increased metal debris production 
will incite an inflammatory response that may be innate, adaptive, or a 
combination of the two in nature. Regardless of the type of immune response, 
macrophages are activated when challenged with wear debris and release 
inflammatory cytokines in response. It must be noted that an increase in 
inflammatory cytokines may also be caused by UHMWPE debris. 
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CHAPTER 2.    METHODOLOGY 
 
 
Experimental Overview 
 
 The purpose of this study was to determine whether a correlation exists between 
laxity, inflammatory cytokines, tissue metal ion content, and wear scoring in well-
functioning necropsy specimens to establish a baseline role of each of these factors in 
implant survivorship. Due to the many facets of this investigation, this section will 
provide a brief overview outlining the processes involved in the data collection and 
processing. Total knee arthroplasty necropsy specimens were retrieved from Medical 
Education and Research Institute (Memphis, TN) and RestoreLife USA (Elizabethton, 
TN) with prior institution review board approval.  
 
 Dissection and retrieval were performed by a fellowship-trained, board-certified 
orthopaedic surgeon, Dr. William Mihalko. All superfluous skin and muscles tissue was 
excised from the area surrounding the joint capsule while carefully preserving the 
ligaments and other structures that contribute to stability of the joint. The joint center was 
identified and transverse cuts were made 180 mm superior and inferior to joint center 
along femur and tibia using a sagittal saw (Stryker Corporation, Kalamazoo, MI). The 
fibula was also transected 100 mm from the joint center (114, 184-189). 
 
 After retrieval, the specimens were labeled and placed in biohazard bags to be 
stored in the freezer until further testing. Thirty-six hours prior to testing, the specimens 
were removed from the freezer and thawed in a refrigerator. Before testing, fluoroscopy 
images (OrthoScan HD Model 1000-0001, OrthoScan, Scottsdale, AZ) were taken to 
assess if radiographic signs of osteolysis were present and all replacements were 
determined to be well-fixed per the images. Synovial fluid was aspirated from the joint 
using a syringe, centrifuged at 1,600 revolutions per minute (rpm) for 20 minutes to 
remove cell particulates, aliquoted into 1.5 milliliters (mL) micro-centrifuge tubes, and 
stored in a -80˚C freezer.  
 
 Following synovial fluid collection, laxity testing was performed on a custom 
knee testing platform which has been previously studied and reported in published 
journal articles and theses (114, 184-193). Each specimen was mounted into the testing 
platform and the IE rotation, varus-valgus (VV) deflection, and AP translation was tested 
at 0˚, 30˚, 60˚, and 90˚ of flexion. At each flexion angle, the specimen was subjected to a 
1.5 Newton-meter (Nm) IE rotational torque, 10 Nm VV torque, and a 35 Newton (N) AP 
directed force, and the corresponding deflection data was recorded using a custom 
LabVIEW program (National Instruments, Austin, TX) that had been previously detailed 
and validated (184).  
 
 After collection of the laxity data, a medial parapatellar incision was made to gain 
access to the TKA components. Tissue samples were collected from the supra- and infra-
patellar regions, the medial and lateral gutter, and from the tibia as depicted in Figure  
2-1. Tissue was placed into collection tubes and stored at -80˚C. The tissue-implant  
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Figure 2-1. Periprosthetic tissue collection locations  
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interface was assessed noting any abnormal conditions at time of retrieval. The implant 
was then removed from the bone using a chisel and hammer as recommended by ASTM 
Standard F561-13 (194), placed into biohazard bags, and shipped to Drexel University 
(Philadelphia, PA) for cleaning and wear scoring.  
 
 At Drexel University, the implants were cleaned per ASTM Standard F561-13 
(194). Polyethylene inserts were analyzed for wear using the protocol proposed by Hood 
et al. (195) and the femoral condyle damage was assessed as previously described by 
Arnholt et al (196).  
 
 A bead-based multiplex assay using the Luminex MAGPIX platform (R&D 
Systems, Minneapolis, MN) was performed on the synovial aspirates for simultaneous 
detection of human TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, M-
CSF, IFN-γ, and IL-2. Inductively coupled plasma mass spectrometry (ICP-MS) was 
performed at Brooks Applied Labs (Bothel, WA) on the periprosthetic tissue samples for 
determination of tissue metal concentrations. Finally, statistical analysis was conducted 
using SigmaPlot (Systat Software, Chicago, IL) to elucidate whether any correlations 
existed between the aforementioned factors.  
 
 The steps in this protocol were summarized in Figure 2-2 for each cadaveric 
TKA specimen. Procedures 2, 4, 5, 7, 8, and 9 will be explained in greater detail in the 
following sections. 
 
 
Fluoroscopic Analysis 
 
 Prior to laxity testing and implant retrieval, fluoroscopically-assisted radiographs 
of each specimen were taken to assess if radiolucent signs of osteolysis were present. 
Since very small degrees of obliquity can obscure radiolucent lines adjacent to 
prostheses, fluoroscopy is useful for obtaining radiographs with clear visualization of the 
bone-prosthesis interface (197-200). An OrthoScan HD (Model 1000-0001, OrthoScan, 
Scottsdale, AZ) was utilized and standard AP and lateral views of each specimen were 
taken. Fluoroscopic radiographs of each specimen are included in the Appendix A 
(Figures A-1 through A-33). Fixation of the tibial component was examined in the AP 
and lateral planes. The beam was centered on the knee and rotation of the knee was set so 
that the pegs of the prosthetic component were symmetrical. To best visualize the fixation 
of the tibial bone-implant interface, vertical height of the tibial component was 
minimized such that the surface appeared two-dimensional, thereby ensuring that the 
beam was parallel to the interface. Fixation of the femoral component is examined in the 
lateral plane only. When assessing the fixation of the femoral component, the anterior 
and posterior bone-implant interfaces as well as the distal interfaces were examined. 
Again, the knee was aligned in the lateral plane such that the component was 
superimposed creating a two-dimensional view. All specimens were determined to be 
well-fixed per the absence of radiolucencies using the previously described and validated 
fluoroscopically-assisted radiographic technique (197-200). 
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Figure 2-2. Summary of retrieval analysis process 
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Laxity Testing 
 
 Laxity testing was performed on a custom knee testing platform, designed and 
manufactured in 1991 by Paul McLeod, shown in Figure 2-3. This testing apparatus was 
acquired by Dr. John William’s laboratory at the University of Memphis in 2009 where it 
was restored to full working condition by 2010 through major efforts from Dr. Williams’ 
graduate students: John Connor (190), Devin Conner (192), David Knox (191), and Jason 
Lindsey (193). Dr. Williams and the aforementioned students replaced bearings, 
transducers, and electronics, converted data acquisition platform from the original 1980s 
software to modern data acquisition software, and developed new programs for the 
kinematic analysis. It was then transferred to Dr. William Mihalko’s laboratory at the 
University of Tennessee Health Science Center in April 2013. In 2014, Erik Woodard 
used the platform in his thesis, and, building upon Dr. Williams’ students previous work, 
Erik further developed the programs that processed the data (184).  
 
 One of the functions of the knee testing platform is to measure the laxity or, 
conversely, the stiffness of the knee at various flexion angles. For this purpose, the knee 
was held at a fixed flexion angle and a pre-determined torque or force was applied at the 
tibial end while the resulting rotation or displacement was recorded. Cable connections 
on the knee testing machine provided data outputs from five force transducers and five 
angle potentiometers. The signals from the transducers and potentiometers travelled to 
their specific boards and were amplified before travelling through an analog to digital 
converter and an input/output board to a 12-bit data acquisition device which digitized 
the signals and displayed them in the custom LabVIEW program. The LabVIEW files 
were converted to Excel files and then run through a previously developed Matlab 
(Mathworks Inc, Natick, MA) program to extract data of interest and perform 
interpolations to identify points of interest in the data from the files (184).  
 
 Prior to testing, the femur and tibia were transversely cut approximately 180 mm 
from the joint center. The femur and tibia were centered using six pointed screws in metal 
pots coated with petroleum jelly and aluminum foil, for ease of removal. Once the femur 
and tibia were secured in place in their respective pots, urethane epoxy (Goldenwest 
MFG Inc, Cedar Ridge, CA) was poured into the pot and allowed to set for 30 minutes 
until completely hardened. The specimens were mounted in the machine with the tibia 
secured vertically and the femoral coupling locked in a neutral position as defined by the 
tibial position. Neutral rotation was defined as placing the femoral epicondylar axis 
perpendicular to the centerline of the machine. Because some specimens demonstrated 
flexion contracture, full extension was not always obtained and was instead defined as the 
minimum flexion angle of the knee specimen.  
 
 Specimens were tested throughout 0˚, 30˚, 60˚, and 90˚ flexion. An applied 
upward body weight force of 30 N was placed under the tibia to maintain joint contact 
during all tests. Each test was performed 3 times to pre-condition the specimen, and data 
was recorded on the fourth iteration. At each flexion angle, a 1.5 Nm IE rotational torque 
was applied about the tibial axis while the femur was fixed and the tibia free to rotate  
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Figure 2-3. Custom knee testing platform in Dr. William Mihalko’s lab  
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about the joint center in the coronal plane. The deflection in degrees at ± 1.5 Nm IE 
torque in the transverse plane referenced from the normal neutral position was recorded 
to determine rotational laxity. A 10 Nm VV torque was also applied to each specimen at 
the distal end of the tibia, while internal-external rotation was unconstrained. The angular 
deflection in degrees at ± 10 Nm of VV torque in the coronal plane referenced from 
normal neutral position was recorded to determine the valgus laxity for each test. Lastly, 
a device, which attached to the tibia, was used to apply a 35 N AP shear force 
perpendicular to the tibial axis. Both coronal motion and axial rotation of the tibia were 
unconstrained during this test. The displacement of the tibia relative to the femur at ± 35 
N was recorded to determine the AP laxity of each specimen. For all tests, sign 
conventions followed the Grood and Suntay coordinate system which specifies anterior 
displacement of the tibia in relation to the femur as positive, posterior displacement as 
negative, internal rotation as negative, external rotation as positive, varus motion as 
negative, and valgus motion as positive (14). While the tibia and femur each have a 
separate coordinate system, it is only necessary to define tibial motion in its own 
coordinate system since the femur is fixed throughout each test.  
 
 
Implant Cleaning 
 
 The retrieved implants were cleaned using a method designed by Drexel 
University in accordance with ASTM Standard F561-13 (194, 196). Upon receipt of the 
shipment, implants were removed from biohazard packaging, examined to ensure all 
parts were present, and photographed for inventory with implant number visible. Each 
component was rinsed in cold water in a biohazard sink to wash away loose tissue. A 
1:10 ratio of Discide detergent (AliMed, Dedham, MA) to water solution was prepared in 
a mixing cup and implants were placed in the solution for a 20 minutes soak. Implants 
were removed from the solution and brushes were then used to carefully remove 
remaining tissue from implant ensuring that the implant surface was not damaged or 
scratched. Next, the components were placed in a 1:10 ratio of bleach to water solution 
for a 20 minutes bath after which brushes were again used to remove loose debris. 
Following the bleach bath, the implant components were no longer considered a 
biohazard and were placed in a clean mixing cup. For the polyethylene components, the 
cleaning process ended at this stage. The metallic femoral and tibial components were 
then placed in a clean mixing cup filled with water. The cups were then placed in the 
ultrasonicator for 25 minutes. After the time period, the water was drained and refilled 
and the cups were replaced in the ultrasonicator for an additional 25 minutes water to 
remove any loose debris. The implants were then laid out on Versidry sheets (Thermo 
Fisher Scientific Inc, Rochester, NY) overnight to dry within the fume hood. The 
components were then packaged into separate bags to avoid scratching and labeled to 
await visual inspection for wear and damage scoring.  
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Wear Scoring 
 
 After the cleaning process, wear was semi-quantitatively assessed by inspecting 
the articulating surfaces using a modified method of that proposed by Hood et al in 1983 
(195). The superior side of the tibial insert, which articulates with the femoral condyles, 
was divided into 8 zones with 4 quadrants on each condyle as shown in Figure 2-4. The 
inferior side of the tibial insert, which is in direct contact with the tibial tray and should 
be fixed unless it is a mobile bearing design, was divided into 8 zones similar to the 
divisions shown in Figure 2-3. For PS implants, the stabilizing post was divided into 
anterior, posterior, medial, and lateral zones. Each zone was inspected using a light 
microscope with 10x magnification, when necessary, for 7 modes of damage: burnishing, 
pitting, delamination, abrasion, embedded debris, scratching, and surface deformation. 
Burnishing refers to highly polished areas on the articulating surface whereas pitting 
describes irregularly shaped depressions in the articulating surface measuring 
approximately 2 to 3 mm across and 1 to 2 mm in depth. Delamination wear is the 
removal of large sheets of polyethylene from the surface and abrasion is large areas with 
a shredded or tufted appearance often caused by contact with bone or cement. Embedded 
debris damage describes areas containing metal or PMMA debris deposited into the 
polyethylene surface. Scratching damage consists of areas containing indented lines 
generally found in the anteroposterior direction. Lastly, surface deformation refers to any 
permanent deformation of the surface of the insert and is typically caused by cold flow or 
creep of the polyethylene. Each section was graded for each wear mode and given a score 
of 0 to 3 based on the levels of damage present. A score of 0 was used to indicate that the 
damage mode was not present on that section of the insert, while 1 denoted damage 
covering less than 10% of the section, 2 denoted damage covering 10-50%, and 3 
indicated damage was present on over 50% of the section, as summarized in Table 2-1. 
Two independent observers inspected each implant and any significant discrepancy 
between observers were resolved in a meeting among the investigators. The two total 
scores were averaged for a final total score. The condylar scores were then summed to 
find the total condylar wear score, with a maximum possible score of 168. The backside 
scores were summed to find the total backside wear score, with a maximum possible 
score of 168. When applicable, the post wear scores were summed to find the total post 
wear score, with a maximum possible score of 84.  
 
 Similarly, the bearing surface of the CoCr femoral component was divided into 4 
quadrants; zones 1 and 2 denote medial and lateral posterior surfaces whereas zones 3 
and 4 denote medial and lateral anterior surfaces, as shown in Figure 2-5. Each section 
was assessed for three damage modes: scratching, indentations or lacerations, and pitting. 
As summarized in Table 2-2, a score of 1 described damage that covered less than 10% 
of the section, a score of 2 indicated damage present over 10-30% of the surface, a score 
of 3 meant damage covering 30-50% of the section, and a score of 4 was given when 
damage covered more than 50% of the surface. The maximum possible damage score was 
a score of 16. 
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Figure 2-4. Technique used to divide the bearing and backside surface of tibial 
insert into 8 sections for wear scoring 
 
 
 
Table 2-1. Summary of the polyethylene wear score quantification as proposed 
by Hood et al. 
 
Score Criteria 
0 Wear mode absent 
1 Wear mode covers less than 10% of regional area 
2 Wear mode covers 10-50% of regional area 
3 Wear mode covers greater than 50% of regional area 
 
Source: Hood RW, Wright TM, Burstein AH. Retrieval analysis of total knee prostheses: 
a method and its application to 48 total condylar prostheses. Journal of Biomedical 
Materials Research Part A. 1983;17(5):829-42. 
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Figure 2-5. Scoring method for the femoral component. 
 
Note: The femoral component bearing surface was split into posterior (1 and 2) and 
anterior (3 and 4) regions for damage scoring 
 
 
 
Table 2-2. Criteria for femoral component damage scoring 
 
Damage Score Criteria 
Minimal 1 0 to 1 surface scratches with minimal coverage and 
no apparent corrosion 
Mild 2 Penetrating scratches on > 10% surface, very faint 
scratching with large surface coverage, or small 
localized area of corrosion 
Moderate 3 Penetrating scratches on > 30% surface, faint 
scratching with larger surface coverage and < 20% 
areas of deeper gouging into the bulk material, or 
area of corrosion on the surface > 30% 
Severe 4 Penetrating scratches on majority (> 50%) of 
surface, or major area of corrosion > 50% 
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Cytokine Assay 
 
 Synovial aspirates were collected from the necropsy knees with well-fixed 
primary total knee replacement after IRB approval. A magnetic bead-based multiplex 
assay using the Luminex MAGPIX platform (R&D Systems, Minneapolis, MN) was 
performed for simultaneous detection of the following human analytes: TNF-α, IL-1β, 
IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, M-CSF, IFN-γ, and IL-2. Per the 
instructions, the standards, calibrator diluent RD6-52, synovial samples, and diluent 
RD2-1 were brought to room temperature. The Certificate of Analysis provided with the 
kit was followed in order to reconstitute each standard cocktail with RD6-52 diluent. The 
reconstituted standards were left under gentle agitation for 15 minutes after which the 
standards 1 through 6 were created according to the directions in the booklet. The RD6-
52 diluent was then added to dilute each sample by a factor of 2, using 80 microliters 
(µL) of synovial sample and 80 µL if diluent, resulting in 160 µL solution in each 
microparticle cocktail. The lights were turned off and the microparticle cocktail was 
centrifuged for 30 seconds at 1,000 G. The cocktails were then gently vortexed and then 
diluted with RD2-1. The standards and microparticle cocktails were added to their 
corresponding wells on the 96-well plate and covered with a foil seal before incubation 
for two hours at room temperature on a microplate shaker. During this period, the wash 
buffer was created by adding 20 mL wash buffer concentrate to 480 mL deionized water. 
After the 2 hours incubation period with the lights still off, a magnet was placed on the 
bottom of the microplate and the plate was then shaken over a sunk to remove the liquid. 
Each well was filled with 100 µL if wash buffer which was then shaken out. This step 
was repeated a total of three times. The biotin antibody cocktail was then centrifuged and 
diluted with the RD2-1 diluent. Each well received 50 µL of the diluted biotin cocktail 
before the microplate was incubated for 1 hour at 800 rpm under a foil seal. The 
streptavidin cocktail was then prepared by mixing 220 µL with 5.35 µL of wash buffer. 
After the 1 hour incubation period, the wells were washed with wash buffer three times in 
the same manner as discussed previously and then 50 µL of the prepared streptavidin 
cocktail was added to each well. The microplate was then incubated for 30 minutes at 
room temperature at 800 rpm. After the incubation period, the wells were then washed 
three times again as previously described. Finally, 100 µL of wash buffer was added to 
each well and incubated for 2 minutes at 800 rpm before the plate was analyzed using the 
Luminex MAGPIX platform which reported each cytokine concentration in picograms 
per milliliter (pg/mL).  
 
 
ICP-MS Analysis 
 
 ICP-MS is an analytical technique used to measure elemental determinations in a 
material. Tissue samples were collected from the medial and lateral gutters, supra- and 
infra-patellar regions, and from along the tibia-implant interface. Each of these tissue 
samples were digested using a modified method from Kerger et al. (201). 
 
Prior to acid digestion to prepare the samples for analysis, the laboratory equipment 
had to be prepared. An acid solution of 5 to 10% trace metal nitric acid was combined with 
 41 
18 mega ohm ultrapure water to rinse and soak the sample containers, digest vessel, and 
any equipment that may come into direct contact with samples or fluids during the acid 
digestion. Minor tools were washed twice and then dried with Kimtech wipes (Kimberly-
Clark Professional, Rosswell, GA) whereas tools that would come in direct contact with 
the samples were soaked overnight in the solution and then were dried.  
 
 After preparing the laboratory space and equipment, the tissue samples were cut 
to 25 milligrams in size using a ceramic knife and plastic tweezers. Care was taken to 
ensure the samples did not contact any form of metal. A water bath was set to 95° 
Celsius, and centrifuge tubes were labeled to identify the samples. The samples were then 
washed with 18 mega-ohm ultrapure water to remove ethanol and were placed in the 
correctly labeled tube. The acid solution was created by adding 2 mL of 70% trace metal 
grade nitric acid to each tube under a fume hood. Next, 1 mL of hydrogen peroxide was 
added to each tube followed by 3 mL of 37% trace metal grade hydrochloric acid, also 
under the fume hood. Three samples of only acid solution were also prepared in 3 tubes 
with no tissue samples as blank samples. The hydrogen peroxide was allowed to react as 
the water bath heated to the correct temperature. Once heated, the tubes were placed in 
the water bath for a 2 hours incubation period. After the 2 hours, the tubes were removed 
and placed in the fume hood for 30 minutes to cool. After the cooling period, an addition 
1 mL of hydrogen peroxide was added to each tube and given 30 minutes to react. The 
tubes were then placed back into the water bath for an additional incubation period of 2 to 
3 hours.  
 
 The samples were then placed into labeled 2 mL micro-centrifuge tubes to be sent 
to Brooks Applied Labs (Bothell, WA). Each tube received 1 mL of the sample and acid 
mixture and 1 mL of 18 mega-ohm ultrapure water. The remaining sample was diluted to 
a 15 mL volume with the 18 mega-ohm ultrapure water. The method for analysis used by 
Brooks Applied Labs was validated using the Luts-1 certified reference material from the 
National Research Council of Canada. This material is a solid biological matrix that 
contains certified quantities of cobalt and chromium. 
 
 Once Brooks Applied Labs completed the analysis, the data was first checked to 
ensure the blank samples had low levels of metal. Any amount of metal in the blank 
sample was considered to be a contamination. If the contaminants were low in value and 
consistent between the blanks, they were averaged and the average was subtracted from 
the remaining samples. This allows the final data to be represented without the 
background noise present due to uncontrollable contamination. The data was then 
reported in µg/L.  
 
 
Statistical Analyses 
 
 Before statistical analyses were performed, the data was analyzed for normality. 
Using Microsoft Excel (Microsoft, Redmond, WA), a Shapiro-Wilk normality test 
revealed that the data sets were not normally distributed. As such, these data sets were 
reported as median and interquartile ranges (IQR). A nonparametric Wilcoxon Signed-
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Rank Test for paired samples was performed on the tibial insert wear and femoral 
component scores to determine if any significant difference existed between the scores 
given by the two observers. Additionally, Mann-Whitney rank sum test was performed to 
determine if significant differences in laxity, particularly AP and IE laxity, existed 
between PS and CR implants. Because the wear and damage scores were subjective, 
ordinal data, no correlation analyses were performed between those data sets and the 
objective, nominal data sets of the laxity, cytokine, and tissue metal measurements. Using 
SigmaPlot statistical software, the nonparametric Spearman’s rank correlation test was 
performed with an assumed significance of =0.05 to determine if significant 
correlations existed between the remaining parameters. 
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CHAPTER 3.    RESULTS 
 
 
Clinical and Implant Information 
 
 In total, 35 necropsy specimens were retrieved. However, 2 specimens were 
excluded from analysis: a unicompartmental implant and a modular revision implant. The 
final sample size was 33 well-functioning primary TKA specimens. Full clinical 
information was not available for all implants; the average age at autopsy was 76 years 
(range: 62 to 94 years of age) and there were 12 males, 22 females, and 1 unknown 
gender included in the cohort. The implant lifespan in situ when available was included 
in the summary of the implant information presented in Table 3-1. All femoral 
components were CoCrMo alloy except for DRLU0104160-R, a Smith & Nephew 
(Memphis, TN) Genesis II design with an Oxinium femoral component, and 
RLU1018161B, a Zimmer (Warsaw, IN) Miller-Galante II design with a TiAlV femoral 
component. With respect to fixation, 28 femoral components were cemented while 5 
were uncemented and well-fixed with porous titanium (n=1), small beads (n=3), or fiber 
mesh (n=1). The tibial components retrieved in this study included 2 monoblock designs 
(RLU0722161B-L—an all-polyethylene design and RLU1121161A-L—a compression-
molded, non-modular monoblock design), 18 TiAlV tibial baseplates, and 14 CoCrMo 
tibial baseplates. With respect to tibial component fixation, 29 tibial trays were cemented 
while 4 were uncemented and well-fixed with porous titanium (n=1), small beads (n=2), 
and fiber mesh (n=1). Of the 33 specimens retrieved, 26 were fixed bearing implant 
systems, 5 were mobile bearing implant systems, and, as previously mentioned, 2 were 
monoblock implant systems. 15 of the retrieved implants were PS while 18 were CR 
designs. The sterilization methods of the retrieved tibial inserts included: gamma air 
(n=8), gamma inert (n=19), ethylene oxide (n=3; Smith & Nephew, Memphis, TN), X3 
(n=1; Stryker, Kalamazoo, MI), ArCom (n=1; Zimmer Biomet, Warsaw, IN), and 
Duracon (n=1; Stryker Howmedica, Kalamazoo, MI). The X3 sterilized insert 
(RLU0829162C-R) was the only highly-cross linked UHMWPE tibial insert in the 
cohort. All implants had resurfaced patellas with polyethylene patellar buttons except for 
specimen DRLU051714-L, a Zimmer Natural Knee implant system (Warsaw, IN).  
 
 
Implant Wear and Damage Assessment 
 
 A nonparametric Wilcoxon Signed-Rank Test for paired samples revealed that 
there was no significant difference between the two scorers of the femoral component 
damage or polyethylene wear analysis. Thirty-two tibial inserts were available to be 
assessed for wear on the condylar, backside, post surface (when applicable) as shown in 
Table 3-2, which includes the sterilization technique of each tibial insert. As previously 
stated, the maximum condylar wear score that could be given was a score of 168 while 
the maximum possible score for each of the 7 damage modes was 24. The median wear 
score for the condylar region of the insert was a score of 38 (IQR: 11), with a range of 
scores from 27 (RLU0426162B-R, shown in Figure 3-1) to 64 (DRLU081315-R).  
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Table 3-1. Implant information of study cohort including manufacturer, design, 
and time in situ (years) 
 
Specimen Manufacturer Design Time in Situ 
DRLU051714-L Zimmer Natural Knee > 10 
DRLU081315-R Zimmer Nexgen Legacy PS (LPS)  20 
DRLU030815-R Zimmer Nexgen LPS Flex 15 
DRLU121515-R Zimmer Nexgen LPS Flex > 10 
DRLU010416-R  Smith & Nephew Genesis II 21 
DRLU112815-R Stryker Scorpio 11 
DRLU101615-R Stryker Scorpio Flex CR 22 
RLU1016151A-L Stryker Scorpio 21 
2013-678L Depuy Low Contact Stress (LCS) Mobile Bearing -- 
RLU0510162A-R Zimmer Nexgen LPS Flex 7 
RLU0728161A-L Smith & Nephew Unknown 27 
RLU0309161B-L Depuy Anatomic Modular Knee (AMK) 45 
RLU0722161B-L Cintor Division of Codman Unknown 40 
RLU0126161C-L Smith & Nephew Genesis II -- 
RLU0510161A-L Zimmer Nexgen LPS Flex 6 
RLU0426161B-L Depuy LCS Mobile Bearing -- 
RLU0126162C-R Smith & Nephew Genesis II -- 
RLU0720161B-L Depuy Press Fit Condylar (PFC) Sigma 13 
RLU1028161B-L Zimmer Miller-Galante (MG) II 37 
RLU1115162B-R Zimmer Nexgen LPS Flex 11 
RLU0913162A-R Zimmer Insall Burnstein (IB) PS II 45 
RLU0426162B-R Depuy LCS Mobile Bearing -- 
RLU0829162C-R Stryker Triathlon CR < 11 
16-04-765R Biomet Vanguard -- 
16-10-1103R Depuy Sigma Mobile Bearing -- 
16-10-1103L Depuy Sigma Mobile Bearing -- 
RLU0204172A-R Stryker Triathlon PS 19 
RLU0317172B-R Stryker Triathlon CR 15 
RLU0319171A-L Stryker Howmedica Duracon 15 
RLU1121161A-L Biomet Anatomical Graduated Component (AGC) 27 
RLU1121162A-R Johnson & Johnson Press Fit Condylar (PFC)  27 
RLU1125161A-L Zimmer Natural Knee 22 
RLU1125162A-R Zimmer Natural Knee 21 
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Table 3-2. Summary of total tibial insert wear scores by location  
 
Specimen Condyle Backside Post 
Sterilization 
Method 
DRLU051714-L 27 44 -- Gamma Inert 
DRLU081315-R 64 34 22 Gamma Inert 
DRLU030815-R 31 48 2 Gamma Inert 
DRLU121515-R 36 46 7 Gamma Inert 
DRLU010416-R 47 U/A -- EtO 
DRLU112815-R 32 31 5 Gamma Inert 
DRLU101615-R U/A 16 -- Gamma Inert 
RLU1016151A-L 51 19 -- Gamma Air 
2013-678L 42 41 -- Gamma Inert 
RLU0510162A-R 42 57 12 Gamma Inert 
RLU0728161A-L 36 21 -- Gamma Air 
RLU0309161B-L 37 32 -- Gamma Air 
RLU0722161B-L 42 U/A -- Gamma Air 
RLU0126161C-L 42 18 6 EtO 
RLU0510161A-L 38 52 9 Gamma Inert 
RLU0426161B-L 42 32 -- Gamma Inert 
RLU0126162C-R 36 17 5 EtO 
RLU0720161B-L 29 23 -- Gamma Inert 
RLU1028161B-L 57 84 -- Gamma Air 
RLU1115162B-R 31 25 2 Gamma Inert 
RLU0913162A-R 58 56 16 Gamma Air 
RLU0426162B-R 31 59 -- Gamma Inert 
RLU0829162C-R 41 23 -- X3 
16-04-765R 44 13 8 ArCom 
16-10-1103R 30 33 9 Gamma Inert 
16-10-1103L 40 57 12 Gamma Inert 
RLU0204172A-R 33 16 7 Gamma Inert 
RLU0317172B-R 43 12 -- Gamma Inert 
RLU0319171A-L 35 11 -- Duration 
RLU1121161A-L 54 U/A -- Gamma Air 
RLU1121162A-R 54 U/A 15 Gamma Air 
RLU1125161A-L 45 32 -- Gamma Inert 
RLU1125162A-R 41 8 -- Gamma Inert 
Median 41 32 8  
IQR 9 28 7  
 
Data points denoted by “--” signifies that the implant in question was a CR design that 
would not have a post 
“U/A” signifies that those scores were unavailable 
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Figure 3-1. Specimen RLU0426162B-R tibial insert 
 
Note: The implant received a score of 27 out 168 and had least amount of total condylar 
wear. 
 
  
 47 
Burnishing was the most common type of damage with a median score of 20 (IQR: 4, 
range: 15 to 24). Pitting and scratching followed with median scores of 8 (IQR: 5, range 4 
to 23) and 9 (IQR: 3, range: 4 to 17), respectively. Two implants had moderate to severe 
delamination with total scores of 17 (RLU1016151A-L) and 22 (RLU1028161B-L, 
shown in Figure 3-2), while the rest demonstrated minimal delamination of the condylar 
surface. Very few of the implants had minimal abrasion, surface deformation, or 
embedded debris.  
 
 The maximum backside wear score that could be given was a score of 168 with a 
maximum possible score of 24 for each of the 7 damage modes. The median wear score 
for the backside region of the insert was a score of 32 (IQR: 28), with a range of scores 
from 13 (16-04-765R) to 84 (RLU1028161B-L). Again, burnishing was the most 
common mode of damage with a median score of 9 (IQR: 15, range 0 to 24). Scratching 
and pitting followed with median scores of 7 (IQR: 8, range 0 to 24) and (IQR: 9, range: 
2 to 24). Fifteen implants demonstrated mild to moderate backside surface deformation 
with a median score of 9 (IQR: 4, range: 3 to 15). One specimen had moderate 
delamination with a score of 12, but no specimens had backside abrasion or embedded 
debris. 
 
 As previously mentioned, 15 of the 32 retrieved TKAs were PS designs. The 7 
wear modes were assessed on this additional interface to determine if the stabilizing post 
contributes to the production of polyethylene debris. The maximum possible wear score 
for the post of each PS implant was a score of 84 while each wear mode had a possible 
maximum score of 12. The median wear score of the stabilizing post was a score of 8 
(IQR: 7), with a range from 2 (RLU1115162B-R and DRLU030815-R) to 22 
(DRLU081315-R). The most prominent wear mode was burnishing with a median score 
of 6 (IQR: 4, range 0 to 10). Specimen RLU1121162A-R demonstrated severe wear on 
the anterior surface of the stabilizing post, as shown in Figure 3-3, and received a total 
wear score of 15 for the post surface. The remainder of the wear modes were nonexistent 
or minimal on the stabilizing post surfaces.  
 
 Twenty-nine femoral components were analyzed for damage. For each 
component, the maximum possible damage score was 16. The median damage score was 
a score of 5 with an interquartile range of 4. Minimal damage (score of 1) was observed 
in 31% (n=9/29) femoral components. The femoral component of specimen 
RLU0829162C-R, shown in Figure 3-4, was among those with minimal damage with a 
total score of 4. Mild damage (score of 2) was observed in 45% (n=13/29) femoral 
components. Moderate damage (score of 3) was observed in 21% (n=6/29) femoral 
components. Severe damage (score of 4) was observed on 1 of the 29 (3%) femoral 
components. The femoral component of specimen RLU1028161B-L had the most severe 
damage with a score of 14, shown in Figure 3-5. This implant exhibits severe scratching 
along both its medial and lateral bearing surface which garnered damage scores of 3 for 
the lateral and medial anterior surface and damage scores of 4 for the lateral and medial 
posterior surfaces. Of the study samples, 70% of the specimens demonstrated mild to 
severe damage in at least one quadrant (score ≥ 2). 
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Figure 3-2. Specimen RLU1028161B-L tibial insert 
 
Note: The implant received a score of 22 out of 24 and demonstrated severe delamination 
accompanied by oxidation. 
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Figure 3-3. Specimen RLU1121162A-R tibial insert 
 
Note: Tibial insert post demonstrates severe anterior impingement wear. 
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Figure 3-4. Specimen RLU0829162C-R femoral component 
 
Note: This implant exhibited minimal damage with lowest possible total score of 4. 
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Figure 3-5. Specimen RLU1028161B-L femoral component  
 
Note: This implant exhibited severe damage with a total score of 14 out of 16.  
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Laxity 
 
 Laxity profiles were measured for 23 cadaveric primary TKA specimens. 
Specimens exhibited large variations in laxity. Some specimens were not able to reach 
full extension or 90˚ of flexion. All laxity values reported in this discussion and in the 
tables follow the Grood and Suntay sign conventions. Mann-Whitney rank sum test was 
performed to determine if significant differences in laxity existed between PS and CR 
implants. 
 
 As shown in Table 3-3, internal rotation ranged from -4.59 to -29.11˚ at full 
extension, -8.99 to -31.39˚ at 30˚ flexion, -1.92 to -35.05˚ at 60˚ flexion, and -4.70 to -
42.92˚ at 90˚ flexion. External rotation ranged from 4.01 to 28.05˚ at full extension, 11.70 
to 32.76˚ at 30˚ flexion, 1.59 to 39.82˚ at 60˚ flexion, and 1.24 to 44.62˚ at 90˚ flexion. At 
full extension and 90˚ of flexion, the median internal rotational laxity was 0.53˚ and 0.88˚ 
greater than the median external rotational laxity, whereas, at 30˚ and 60˚ of flexion, the 
median external rotational laxity was 0.28˚ and 0.72˚ greater than the median internal 
rotational laxity, respectively. Mann-Whitney rank sum test revealed significant 
differences in the measured external laxity at full extension (p=0.01) and 30˚ of flexion 
(p=0.04) between the PS and CR implants. At full extension, the PS specimens had a 
median external rotation of 14.16˚ (IQR: 5.02˚) while the CR specimens had a median 
external rotation of 7.43˚ (IQR: 2.07˚). At 30˚ of flexion, the PS specimens had a median 
external rotation of 20.35˚ (IQR: 5.07˚) while the CR specimens had a median external 
rotation of 15.70˚ (IQR: 3.99˚). There were not any statistically significant differences in 
internal or external rotation at the remaining flexion angles between the PS and CR 
implants. 
  
 As shown in Table 3-4, varus deflection ranged from -1.07 to -10.76˚ at full 
extension, -3.24 to -13.53˚ at 30˚ flexion, -2.71 to -18.12˚ at 60˚ flexion, and -3.24 to -
25.26˚ at 90˚ flexion. Valgus deflection ranged from 0.61 to 7.98˚ at full extension, 2.29 
to 14.90˚ at 30˚ flexion, 1.67 to 26.57˚ at 60˚ flexion, and 2.68 to 38.49˚ at 90˚ flexion. At 
0˚, 30˚, 60˚, 90˚, the median varus laxity was 1.22˚, 3.25˚, 2.16˚, and 3.58˚ greater than 
the median valgus laxity, respectively. Mann-Whitney rank sum test did not reveal any 
significant differences in varus or valgus deflection across the flexion angles between the 
PS and CR implants. 
 
 As shown in Table 3-5, anterior displacement ranged from 0.13 to 9.37 mm at 
full extension, 0.54 to 7.69 mm at 30˚ flexion, 0.01 to 10.77 mm at 60˚ flexion, and 0.01 
to 6.51 mm at 90˚ flexion. Posterior displacement ranged from -1.06 to -6.64 mm at full 
extension, -0.25 to -24.23 mm at 30˚ flexion, -0.16 to -16.91 mm at 60˚ flexion, and -0.04 
to -18.04 mm at 90˚ flexion. At 0˚, 30˚, 60˚, 90˚, the median posterior displacement was 
0.51, 0.34, 1.41, and 1.49 mm greater than the median anterior displacement, 
respectively. Mann-Whitney rank sum test revealed a significant difference in the 
measured posterior laxity at 30˚ of flexion between the PS and CR implants (p=0.007). 
The PS specimens had a median posterior displacement of -9.83 mm (IQR: 7.29 mm) 
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Table 3-3. Summary of internal and external rotational laxity at each flexion 
angle for each specimen 
 
  Internal Rotation ( ˚ )  External Rotation ( ˚ ) 
Specimen  0˚ 30˚ 60˚ 90˚  0˚ 30˚ 60˚ 90˚ 
RLU0510162A-R  -16.62 -17.62 -24.47 -25.17  14.16 20.35 20.59 22.68 
RLU0728161A-L  -6.81 -13.28 -18.00 -24.60  7.43 15.60 22.42 26.29 
RLU0722161B-L  -11.01 -17.09 -1.92 ---  11.35 13.02 1.59 --- 
RLU0126161C-L  -20.56 -22.77 -20.71 ---  15.50 20.44 22.52 --- 
RLU0510161A-L  -14.16 -13.02 -15.10 -17.65  12.69 22.92 22.12 20.93 
RLU0426161B-L  -7.09 -18.55 -21.73 -21.81  7.43 18.37 19.38 20.97 
RLU0126162C-R  -6.48 -15.69 -16.98 -18.50  11.62 18.97 18.27 16.51 
RLU0720161B-L  -7.51 -16.82 -19.52 -19.21  8.22 17.37 17.77 17.28 
RLU1028161B-L  --- -8.99 -9.23 -14.12  --- 12.01 9.40 17.37 
RLU1115162B-R  -5.76 -13.17 -16.44 -9.71  4.01 11.70 14.06 15.48 
RLU0913162A-R  -4.59 -10.84 -3.48 -21.28  28.05 25.20 39.82 35.88 
RLU0426162B-R  -11.29 -19.36 -21.69 -25.30  15.46 21.68 23.58 16.96 
RLU0829162C-R  -9.96 -21.11 -22.79 -27.01  5.92 15.80 18.67 20.06 
16-04-765R  -16.06 -12.69 -12.28 -4.70  13.59 21.10 7.89 1.24 
16-10-1103R  -13.71 -16.70 -17.91 -12.24  17.71 17.29 12.61 13.42 
16-10-1103L  -29.11 -31.39 -35.05 -38.24  24.49 32.76 33.74 37.38 
RLU0204172A-R  --- -11.58 -14.27 -17.24  --- 12.49 16.45 18.52 
RLU0317172B-R  -7.20 -17.33 -18.26 -24.07  6.25 15.48 20.82 27.38 
RLU0319171A-L  -11.67 -15.99 -23.45 -26.38  6.64 13.78 15.37 16.16 
RLU1121161A-L  -10.41 -20.73 -25.60 -28.78  6.58 12.19 20.24 30.23 
RLU1121162A-R  --- -18.59 -26.96 -42.92  --- 16.60 25.88 44.62 
RLU1125161A-L  -12.94 -18.06 -29.44 -36.75  8.37 17.58 25.05 34.31 
RLU1125162A-R  -9.09 -19.99 -28.79 -5.20  9.00 17.59 32.25 30.13 
Median  -10.71 -17.09 -19.52 -21.81  10.18 17.37 20.24 20.93 
IQR  6.65 5.70 8.19 9.14  7.26 5.76 7.14 13.18 
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Table 3-4. Summary of varus and valgus laxity at each flexion angle for each 
specimen 
 
  Varus Deflection ( ˚ )  Valgus Deflection ( ˚ ) 
Specimen  0˚ 30˚ 60˚ 90˚  0˚ 30˚ 60˚ 90˚ 
RLU0510162A-R  -3.64 -5.12 -4.47 -11.96  3.10 3.76 6.12 3.06 
RLU0728161A-L  -2.64 -3.90 -8.43 -3.24  2.24 4.08 4.70 3.19 
RLU0722161B-L  -6.54 -9.20 -2.71 ---  3.95 6.52 1.67 --- 
RLU0126161C-L  -6.24 -7.91 -11.98 ---  3.55 5.73 7.89 --- 
RLU0510161A-L  -6.72 -7.06 -6.43 -9.27  0.61 2.96 5.14 3.95 
RLU0426161B-L  -4.64 -8.99 -9.19 -10.38  3.32 3.34 6.34 6.75 
RLU0126162C-R  -3.82 -6.55 -8.02 -11.57  3.64 4.25 6.82 5.45 
RLU0720161B-L  -3.23 -9.69 -10.27 -6.74  1.77 3.75 4.26 9.53 
RLU1028161B-L  --- -7.25 -8.00 -7.99  --- 4.18 6.57 8.64 
RLU1115162B-R  -4.03 -7.50 -8.53 -11.64  1.63 4.73 7.43 5.84 
RLU0913162A-R  -7.12 -9.26 -18.12 -13.16  2.77 3.84 6.46 19.68 
RLU0426162B-R  -8.56 -8.65 -8.36 -4.46  3.97 5.09 5.88 4.82 
RLU0829162C-R  -9.10 -10.10 -13.29 -22.89  4.04 5.52 10.69 9.01 
16-04-765R  -3.89 -9.15 -8.51 -4.00  7.98 4.43 5.33 2.85 
16-10-1103R  -5.32 -7.51 -8.53 -9.36  2.89 2.57 4.36 3.25 
16-10-1103L  -10.76 -13.53 -17.29 -15.93  7.54 9.61 13.28 24.22 
RLU0204172A-R  --- -3.24 -7.61 -9.47  --- 2.82 4.73 7.63 
RLU0317172B-R  -2.47 -5.14 -6.30 -13.15  2.05 2.29 5.52 8.35 
RLU0319171A-L  -1.07 -3.68 -4.43 -9.80  5.41 6.24 8.59 14.42 
RLU1121161A-L  -2.17 -5.52 -9.74 -15.92  2.26 5.09 11.87 13.29 
RLU1121162A-R  --- -12.69 -14.59 -25.26  --- 14.90 9.42 38.49 
RLU1125161A-L  -9.34 -6.57 -3.18 -10.34  3.84 4.04 2.56 6.20 
RLU1125162A-R  -4.68 -8.21 -9.72 -9.15  5.28 6.92 8.74 2.68 
Median  -4.66 -7.51 -8.51 -10.34  3.44 4.25 6.34 6.75 
IQR  3.28 3.13 2.98 4.00  1.73 1.87 3.72 5.57 
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Table 3-5. Summary of anterior and posterior laxity at each flexion angle for 
each specimen 
 
  Anterior Displacement (mm)  Posterior Displacement (mm) 
Specimen  0˚ 30˚ 60˚ 90˚  0˚ 30˚ 60˚ 90˚ 
RLU0510162A-R  --- --- --- ---  --- --- --- --- 
RLU0728161A-L  --- --- --- ---  --- --- --- --- 
RLU0722161B-L  4.54 3.14 0.79 ---  -2.89 -7.41 -0.24 --- 
RLU0126161C-L  2.49 3.25 0.27 ---  -2.28 -1.26 -0.26 --- 
RLU0510161A-L  3.51 4.72 2.21 2.33  -3.02 -5.50 -0.92 -7.94 
RLU0426161B-L  2.68 5.35 2.71 1.60  -3.64 -3.23 -6.24 -9.02 
RLU0126162C-R  3.47 7.69 4.59 1.46  -3.38 -9.40 -3.34 -4.87 
RLU0720161B-L  1.00 5.34 3.48 2.48  -1.24 -4.57 -5.12 -4.52 
RLU1028161B-L  --- 5.07 1.65 1.62  --- -0.25 -3.64 -2.95 
RLU1115162B-R  2.44 7.29 1.94 1.44  -1.45 -13.37 -7.22 -3.02 
RLU0913162A-R  9.37 5.34 6.33 6.51  -5.63 -10.26 -14.77 -8.09 
RLU0426162B-R  0.13 0.54 1.62 0.06  -2.60 -2.89 -1.13 -0.11 
RLU0829162C-R  1.12 2.31 0.01 0.04  -2.12 -1.40 -0.22 -0.04 
16-04-765R  3.94 4.77 2.35 0.35  -4.44 -10.65 -3.94 -0.35 
16-10-1103R  1.99 3.99 2.41 0.88  -3.56 -5.37 -3.20 -1.61 
16-10-1103L  1.82 5.18 5.16 1.86  -6.64 -24.23 -9.30 -11.44 
RLU0204172A_R  --- 3.73 0.37 2.12  --- -4.58 -4.94 -0.54 
RLU0317172B_R  3.59 2.98 1.36 1.86  -1.06 -1.68 -0.16 -1.14 
RLU0319171A_L  3.99 5.51 4.70 0.94  -2.14 -5.06 -16.91 -8.95 
RLU1121161A_L  1.78 2.55 10.77 3.27  -3.62 -8.31 -9.21 -18.04 
RLU1121162A_R  --- 2.25 0.34 0.40  --- -21.16 -0.80 -1.98 
RLU1125161A_L  2.64 2.25 1.93 0.01  -3.14 -2.62 -1.18 -0.26 
RLU1125162A_R  1.83 5.35 0.69 0.02  -4.43 -0.46 -0.32 -0.28 
Median  2.57 4.72 1.94 1.49  -3.08 -5.06 -3.34 -2.95 
IQR  1.74 2.36 2.69 1.62  1.46 6.78 5.45 7.57 
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while the CR specimens had a median posterior displacement of -2.89 mm (IQR: 3.28 
mm). There were not any statistically significant differences in anterior or posterior 
displacement at the remaining flexion angles between the PS and CR implants. 
 
 
Inflammatory Cytokines 
 
 The inflammatory cytokine concentrations in the synovial fluid of 32 specimens 
were measured using two separate cytokine assays, as presented in Table 3-6. The first 
assay screened for TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, M-
CSF, IFN-γ, and IL-2. In the second assay, MIP-1α, GM-CSF, and IFN-γ were omitted 
because none of the specimens had concentrations above the detectable limit in the first 
assay (MIP-1α <181 pg/mL, GM-CSF <11.9 pg/mL, and IFN-γ <299 pg/mL).  
 
 The range of detection for TNF-α was 8.9 to 2,170 pg/mL; 8 specimens were 
below the minimum detection limit for TNF-α (<8.9 pg/mL) while the remaining 14 
specimens were barely about the minimum detection limit. The range of detection for IL-
1β was 16.3 to 3,950 pg/mL; 3 specimens were below the minimum detection limit for 
IL-1β (<16.3). The range of detection for IL-6 was 4.9 to 1,180 pg/mL; 5 specimens were 
above the maximum detection limit for IL-6 (>1,180 pg/mL). The detection range for IL-
8 was 4.7 to 1,140 pg/mL; all but 2 of the specimens had concentrations of IL-8 that 
exceeded the maximum detection limit of the assay platform (>1,140 pg/mL). The range 
of detection for MCP-1 was 98 to 7,940 pg/mL; 7 specimens were above the maximum 
detection limit for MCP-1 (>7,940 pg/mL). The detection range for MIP-3α was 7.9 to 
1,920 pg/mL; 2 specimens had concentrations above the maximum detection limit 
(>1,920 pg/mL) while 1 specimen was below the minimum detection limit (<7.9 pg/mL).  
All specimens had concentrations of M-CSF that were within the detection range, 514 to 
124,810 pg/mL. The minimum and maximum M-CSF concentration were 5,566 pg/mL 
and 63,135 pg/mL, respectively.  
 
 
Tissue Metal Concentrations 
 
 Periprosthetic tissues from 23 necropsy specimens were available for ICP-MS 
analysis, as shown in Table 3-7 which includes the femoral component and tibial 
baseplate materials. Statistical analysis revealed no significant difference between the 
tissue locations and the metal concentrations; the concentrations were reported as 
averages of all five tissue collection locations: the supra- and infra-patellar regions, the 
medial and lateral gutters, and the tibial tuberosity. Specimens DRLU081315-R and 
RLU1028161B-L had elevated concentrations of Ti in their periprosthetic tissues 
(1,136.3 g/L and 12,775.1 g/L, respectively). Specimen RLU1028161B-L was an 
uncemented TKA with Ti fiber mesh coating on the femoral component, the tibial tray, 
and the metal-backing of the patellar button. Specimen RLU0426161B-L had extremely 
elevated tissue concentrations of Co (28,705.3 g/L) and Cr (66,532.2 g/L); this 
specimen also presented with severe metallosis, as shown previously in Figure 1-5.  
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Table 3-6. Concentrations of inflammatory cytokines for cadaveric specimens 
(pg/mL) 
 
Specimen TNF-α IL-1 IL-6 IL-8 MCP-1 MIP-3α M-CSF IL-2 
DRLU051714-L 13.8 45.9 345 >1140 >7940 105 19308 36.8 
DRLU081315-R 11.1 201 41.6 >1140 2384 58.5 37827 <35 
DRLU030815-R 18.8 44.9 51.1 >1140 >7940 341 36977 75.6 
DRLU121515-R 8.9 32.9 28.6 >1140 2465 18.8 39802 <35 
DRLU010416-R 15.6 324 >1180 >1140 2033 >1920 20708 <35 
DRLU112815-R 25.7 248 136 >1140 >7940 402 25495 49.9 
DRLU101615-R <8.9 151 103 >1140 235 108 48829 <35 
RLU1016151A-L <8.9 408 60.0 >1140 <98 <7.9 63135 <35 
2013-678L 12.0 328 47.1 >1140 >7940 131 37272 38.0 
RLU0510162A-R 13.8 50.3 180 >1140 716 649 11472 <35 
RLU0728161A-L <8.9 21.1 279 1077 1514 48.6 27263 <35 
RLU0722161B-L 23.8 962 >1180 >1140 >7940 473 25296 84.2 
RLU0126161C-L 9.3 52.0 218 >1140 1660 238 5566 <35 
RLU0510161A-L 16.0 84.6 135 >1140 1739 361 16623 <35 
RLU0426161B-L <8.9 16.9 62.9 >1140 3055 93.7 27070 <35 
RLU0126162C-R <8.9 31.0 238 >1140 500 198 8362 <35 
RLU0720161B-L 12.0 204 109 >1140 3388 143 45793 <35 
RLU1028161B-L 10.9 50.0 92.5 >1140 3930 18.2 28538 <35 
RLU1115162B-R <8.9 <16.3 79.5 >1140 773 191 13145 <35 
RLU0913162A-R 9.3 71.5 862 >1140 >7940 27.7 29092 46.4 
RLU0426162B-R <8.9 <16.3 37.3 >1140 1333 116 28094 <35 
RLU0829162C-R <8.9 <16.3 70.1 623 567 38.1 16681 <35 
16-04-765R 10.7 310 132 >1140 213 26.1 56552 <35 
16-10-1103R 14.3 372 >1180 >1140 598 >1920 37681 39.8 
RLU0204172A-R 12.5 35.3 26.9 >1140 >7940 22.0 32826 53.6 
RLU0317172B-R 15.4 74.8 >1180 >1140 990 159 55165 37.9 
RLU0319171A-L 15.9 210 75.3 >1140 1948 26.8 40339 42.1 
RLU1121161A-L 13.3 29.7 >1180 >1140 416 78.5 31780 46.7 
RLU1121162A-R 11.0 46.2 119 >1140 1021 10.5 57380 <35 
RLU1125161A-L <8.9 <16.3 14.8 >1140 195 33.9 25511 <35 
RLU1125162A-R <8.9 23.0 28.7 >1140 251 41.4 38353 <35 
Median 12.9 73.2 114 --- 1739 108 30436 --- 
IQR 4.5 177 238 --- 5277 254 14566 --- 
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Table 3-7. Periprosthetic tissue metal concentrations reported in (g/L) 
 
Specimen Cobalt Chromium Titanium 
Condyle 
Material 
Tray 
Material 
DRLU051714-L 16.4 46.6 44.3 CoCrMo TiAlV 
DRLU081315-R 56.6 87.8 1136.3 CoCrMo TiAlV 
DRLU030815-R 14.8 37.3 37.1 CoCrMo TiAlV 
DRLU121515-R 4.2 301.6 50.9 CoCrMo TiAlV 
DRLU010416-R 0.4 7.4 4.4 Oxinium TiAlV 
DRLU112815-R 18.4 76.8 2.3 CoCrMo CoCrMo 
DRLU101615-R 49.1 134.7 3.2 CoCrMo CoCrMo 
RLU0510162A-R 1.6 23.5 46.8 CoCrMo TiAlV 
RLU0728161A-L 75.1 91.7 9.6 CoCrMo TiAlV 
RLU0309161B-L 3.5 7.4 3.8 CoCrMo TiAlV 
RLU0722161B-L 23.3 21.3 4.3 CoCrMo UHMWPE 
RLU0126161C-L 48.2 188.5 6.9 CoCrMo TiAlV 
RLU0510161A-L 1.8 13.4 51.6 CoCrMo TiAlV 
RLU0426161B-L 28705.3 66532.2 3.5 CoCrMo CoCrMo 
RLU0126162C-R 39.1 111.3 16.2 CoCrMo TiAlV 
RLU1028161B-L 0.7 23.4 12775.1 CoCrMo TiAlV 
RLU1115162B-R 146.4 38.3 28.9 TiAlV TiAlV 
RLU0913162A-R 1.3 5.1 98.7 CoCrMo TiAlV 
RLU0426162B-R 51.2 38.5 7.3 CoCrMo TiAlV 
RLU0829162C-R 39.0 154.1 8.8 CoCrMo CoCrMo 
16-04-765R 6.3 55.2 9.8 CoCrMo CoCrMo 
16-10-1103R 10.0 21.3 0.6 CoCrMo CoCrMo 
16-10-1103L 2.0 11.8 0.5 CoCrMo CoCrMo 
Median 16.4 38.5 9.6   
IQR 45.9 80.2 41.5   
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Correlation of Study Parameters 
 
 In the following sections, comparisons of the data sets were presented in graphical 
form. For internal/external rotational laxity and varus/valgus laxity, the data was 
presented as the sum of the absolute value of the two poles. For anterior and posterior 
laxity, the data was presented separately so that it was not skewed by the sample 
population containing both PS and CR implants. PS and CR implants were plotted with 
different symbols as indicated in the legend of each figure. 
 
 Because the data was not normally distributed, nonparametric Spearman Rank 
correlation analysis was performed. In Spearman rank correlation analysis, the ranks of 
each data point in the two data sets were calculated and then the difference in rank of data 
points between data sets was then used to compute the correlation coefficient. A 
coefficient of +1 indicated a perfect positive correlation and a coefficient of -1 indicated a 
perfect negative correlation. Spearman correlation coefficients () with respective p-
values (p) were included in tabular form. As previously mentioned, three specimens had 
extremely elevated Ti, Co, or Cr levels. These outliers were removed in the respective 
comparisons. 
 
 
Hypothesis (a)—Laxity and Tissue Metal Concentrations 
 
 Graphical representation of the comparison between the joint laxity and tissue 
metal concentrations was presented in Appendix B, Figures B-1 through B-24. 
Spearman rank correlation analysis of the comparison between IE rotational laxity and 
tissue metal concentrations identified one significant relationship as reported in Table 
3-8. Decreased IE laxity at full extension was inversely correlated with increased Co 
concentrations in the periprosthetic tissues (=-0.64, p=0.02). This comparison, shown in 
Figure B-1A, had a sample size of 13 and a 95% confidence interval from -0.88 to -0.14.  
 
 While spearman rank correlation analysis of VV laxity and tissue metal content 
did not reveal any statistically significant relationships, as shown in Table 3-9, VV laxity 
was moderately correlated with Ti in periprosthetic tissues at full extension and 30 of 
flexion. At full extension, decreased VV laxity correlated with increased Ti content in the 
periprosthetic tissues (Figure B-11A, =-0.46, p=0.09) with a sample size of 13 and a 
95% confidence interval from -0.79 and 0.09. Similarly, at 30 of flexion, decreased VV 
laxity correlated with increased Ti concentrations (Figure B-11B, =-0.49, p=0.07) with a 
sample size of 14 and a 95% confidence interval from -0.81 to 0.05.  
 
 Spearman rank correlation analysis identified four significant relationships 
between AP laxity and tissue metal concentrations as reported in Table 3-10. At 90 of 
flexion, anterior laxity was inversely correlated with Co concentrations (Figure B-14B, 
=-0.66, p=0.03) with a sample size of 11 and a 95% confidence interval from -0.90 to -
0.10. At 60 of flexion, anterior laxity was inversely correlated with Cr concentrations 
(Figure B-18A, =-0.63, p=0.03) with a sample size of 13 and a 95% confidence interval 
from -0.88 to -0.12. Anterior laxity at 90 of flexion was also inversely correlated with Cr  
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Table 3-8. Spearman correlation coefficients () for IE rotational laxity and 
periprosthetic tissue metal concentrations 
 
  Internal/External Rotational Laxity  
Metal  0˚ 30˚ 60˚ 90˚  
Co  -0.64* -0.07 -0.01 -0.21  
Cr  -0.42 0.01 -0.05 -0.27  
Ti  -0.15 -0.28 -0.06 -0.07  
 
*p=0.02 
 
 
 
Table 3-9. Spearman correlation coefficients () for VV laxity and periprosthetic 
tissue metal concentrations 
 
  Varus/Valgus Laxity  
Metal  0˚ 30˚ 60˚ 90˚  
Co  -0.22 0.09 -0.13 -0.27  
Cr  -0.07 0.002 0.03 -0.33  
Ti  -0.46 -0.49 -0.11 0.02  
 
 
 
Table 3-10. Spearman correlation coefficients () for AP laxity and periprosthetic 
tissue metal concentrations  
 
  Anterior Laxity  Posterior Laxity  
Metal  0˚ 30˚ 60˚ 90˚  0˚ 30˚ 60˚ 90˚  
Co  -0.50 -0.22 -0.45 -0.66***  -0.38 -0.01 -0.34 -0.43  
Cr  -0.28 -0.28 -0.63*** -0.81*  -0.52 -0.41 -0.50 -0.74**  
Ti  0.45 0.29 0.04 0.34  -0.20 0.20 0.13 -0.02  
 
*p=0.003 
**p=0.01 
***p=0.03 
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concentrations (Figure B-18B, =-0.81, p=0.003) with a sample size of 11 and a 95% 
confidence interval from -0.95 to -0.41. Lastly, posterior laxity at 90 of flexion was 
inversely correlated with Cr concentrations in the periprosthetic tissues (Figure B-20B, 
=-0.74, p=0.01) with a sample size of 11 and a 95% confidence interval from -0.93 to -
0.25.  
 
 
Hypothesis (b)—Laxity and Inflammatory Cytokines  
 
 Graphical representations of each laxity and cytokine comparison was shown in 
Appendix C in Figures C-1 through C-48. Spearman rank correlation analysis revealed 
only one statistically significant correlation between IE rotational laxity and 
inflammatory cytokines in the joint synovial fluid, as shown in Table 3-11. At 60 of 
flexion, IE rotational laxity was inversely correlated with IL-1 concentrations (Figure C-
4A, =-0.55, p=0.02) with a sample size of 18 and a 95% confidence interval from -0.81 
to -0.11.  
 
 As shown in Table 3-12, Spearman rank correlation analysis identified two 
statistically significant relationships between VV laxity and concentrations of 
inflammatory cytokines in the synovial fluid. At 60 of flexion, VV laxity was inversely 
correlated with TNF- concentrations (Figure C-14A, =-0.78, p=2x10-4). This strong 
correlation had a sample size of 14 and a 95% confidence interval from -0.93 to -0.43. 
However, it must be noted that levels of TNF- were barely above the minimum 
detection limit; as such, this correlation was likely clinically insignificant. Additionally, 
VV laxity was inversely correlated with IL-1 concentrations (Figure C-16A, =-0.48, 
p=0.04) at 60 of flexion with a sample size of 18 and a 95% confidence interval from -
0.77 to -0.02. At full extension, VV laxity was inversely correlated with IL-6 
concentrations (Figure C-17A, =-0.46, p=0.04) with a sample size of 19 and a 95% 
confidence interval from -0.76 to -0.01.  
 
 Spearman rank correlation analysis revealed two statistically significant 
relationships, as shown in Table 3-13. Anterior laxity was directly correlated with IL-6 
concentrations (Figure C-34B, =0.53, p=0.02) at 90 of flexion with a sample size of 18 
and a 95% confidence interval from 0.08 to 0.80. Additionally, anterior laxity was 
directly correlated with MCP-1 concentrations (Figure C-38B, =0.62, p=0.006) at 90 of 
flexion with a sample size of 18 and a 95% confidence interval 0.22 to 0.84. While not 
statistically significant, posterior laxity was directly correlated with IL-6 at 30 and 90 
of flexion. At 30 of flexion, increased posterior laxity correlated with increased IL-6 
concentrations in the synovial fluid (Figure C-35B, =0.39, p=0.09) with a sample size of 
20 and a 95% confidence interval from -0.06 to 0.71. At 90 of flexion, increased 
posterior laxity correlated with increased IL-6 concentrations in the synovial fluid (Figure 
C-36B, =0.46, p=0.06) with a sample size of 18 and a 95% confidence interval from -
0.01 to 0.76.  
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Table 3-11. Spearman correlation coefficients () for IE laxity and inflammatory 
cytokine concentrations in the synovial fluid 
 
  Internal/External Rotational Laxity  
Cytokine  0˚ 30˚ 60˚ 90˚  
TNF-  -0.46 -0.30 -0.23 0.07  
IL-1  0.42 -0.14 -0.55* -0.33  
IL-6  0.16 -0.16 -0.24 0.13  
MCP-1  0.05 -0.24 -0.36 0.02  
MIP-3  0.17 0.27 -0.17 -0.19  
M-CSF  -0.16 -0.30 0.04 0.04  
 
*p=0.02 
 
 
 
Table 3-12. Spearman correlation coefficients () for VV laxity and inflammatory 
cytokine concentrations in the synovial fluid 
 
  Varus/Valgus Laxity  
Cytokine  0˚ 30˚ 60˚ 90˚  
TNF-  -0.19 -0.41 -0.78* -0.18  
IL-1  0.30 0.11 -0.48** -0.10  
IL-6  -0.46** -0.16 -0.05 0.07  
MCP-1  -0.22 -0.04 -0.06 0.21  
MIP-3  -0.24 -0.12 -0.35 -0.30  
M-CSF  -0.14 0.01 0.07 0.08  
 
*p=2x10-4 
**p=0.04 
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Table 3-13. Spearman correlation coefficients () for AP laxity and inflammatory 
cytokine concentrations in the synovial fluid 
 
  Anterior Laxity  Posterior Laxity  
Cytokine  0˚ 30˚ 60˚ 90˚  0˚ 30˚ 60˚ 90˚  
TNF-  0.11 -0.16 0.04 0.03  -0.39 -0.03 -0.24 0.22  
IL-1  0.40 -0.14 0.03 -0.06  -0.31 0.22 -0.14 -0.19  
IL-6  0.36 -0.03 0.30 0.53**  0.02 0.39 -0.10 0.46  
MCP-1  0.32 0.13 0.00 0.62*  -0.23 -0.02 0.20 0.38  
MIP-3  -0.11 0.10 0.08 0.14  -0.30 0.01 -0.30 0.16  
M-CSF  0.05 -0.09 0.10 0.01  0.12 0.12 0.14 -0.08  
 
*p=0.006 
**p=0.02 
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Hypothesis (c)—Tissue Metal Concentrations and Inflammatory Cytokines 
 
 Graphical representation of the comparison between inflammatory cytokines and 
tissue metal concentrations was presented in Appendix D in Figures D-1 through D-18. 
Spearman rank correlation analysis with outliers removed identified only two statistically 
significant relationships between tissue metal concentrations and inflammatory cytokines 
as reported in Table 3-14. As shown in Figure D-9, Cr was inversely correlated with IL-6 
(=-0.52, p=0.01) with a sample size of 21 and a 95% confidence interval from -0.78 to -
0.11. Cr was also inversely correlated with MIP-3 (Figure D-11, =-0.46, p=0.04) with 
a sample size of 21 and a 95% confidence interval from -0.74 to -0.04. While not 
statistically significant, Spearman rank correlation analysis also revealed four other 
inverse correlations. In Figure D-8, periprosthetic tissue Cr content was inversely 
correlated with IL-1 concentrations in the synovial fluid (=-0.41, p=0.09) with a 
sample size of 18 and a 95% confidence interval from -0.74 to 0.07. The measured Cr 
concentrations was also inversely correlated with MCP-1 concentrations (Figure D-10, 
=-0.40, p=0.07) with a sample size of 21 and a 95% confidence interval from -0.71 and 
0.04. Increased Ti concentrations was correlated with decreased IL-1 concentrations 
(Figure D-14, =-0.41, p=0.09) with a sample size of 17 and a 95% confidence interval 
from -0.74 to -0.09. Lastly, Ti was inversely correlated with MIP-3 concentrations in 
the synovial fluid (Figure D-17, =-0.40, p=0.08) with a sample size of 20 and a 95% 
confidence interval from -0.71 to 0.05.  
 
 
 
Table 3-14. Spearman correlation coefficients () for tissue metal concentrations 
and inflammatory cytokine concentrations in the synovial fluid with outliers 
removed 
 
Cytokine Co Cr Ti 
TNF- 0.19 -0.23 -0.44 
IL-1 -0.11 -0.41 -0.41 
IL-6 -0.32 -0.52* -0.22 
MCP-1 -0.31 -0.40 0.08 
MIP-3 -0.14 -0.46** -0.40 
M-CSF -0.10 -0.02 -0.21 
 
*p=0.01 
**p=0.04 
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CHAPTER 4.    DISCUSSION 
 
 
 The specimens included in this study consisted of primary TKA implants that 
were retrieved at necropsy and were determined to be well-fixed per fluoroscopic 
analysis. The first objective of this study was to establish a baseline of different factors 
that likely contribute to failure of primary total knee replacements. This study provided 
semi-quantitative assessment of wear of the condylar surface, backside surface, and 
stabilizing post, when applicable, and of damage to the bearing surface of the femoral 
components. Joint laxity was measured using a custom knee testing platform that had 
been previously studied and utilized by published articles and theses in literature (114, 
184-193). Inflammatory cytokine profiles in the synovial fluid samples were presented 
and measurable levels of metal debris was found in the periprosthetic tissue samples. The 
second objective of this study was to determine if any significant relationships arose in 
correlation analysis of the latter three aforementioned factors. An inverse trend was 
observed between joint laxity and tissue metal concentrations, such that decreased laxity 
induced metal release from the implant components. A direct trend was observed 
specifically between increased anteroposterior laxity and elevated inflammatory 
cytokines. Lastly, an inverse trend was found between decreased tissue metal 
concentrations and increased inflammatory cytokines. The third, and future, objective of 
this study is to utilize these measurements and observations for comparison with failed 
implants retrieved at time of revision. 
 
 
Implant Wear and Damage Assessment 
 
 Wear in TKA is inevitable. While the current knowledge of the mechanisms 
involved in debris-induced TKA failure is still in its infancy, it is believed that excessive 
polyethylene wear particles stimulate a cascade of biological events that lead to 
degradation of bone and inhibition of bone formation (131, 132, 137, 166, 169, 171, 202, 
203). This wear and biologic response pathway is termed osteolysis, and oftentimes 
necessitates revision of the index procedure. Orthopedic implant retrieval programs are of 
utmost importance in expanding the understanding of the etiology of aseptic implant 
loosening. While most retrieval programs analyze failed implants retrieved at time of 
revision, the implants in this study were retrieved at necropsy and were deemed to be 
well-functioning primary TKAs based on fluoroscopic analysis. In order to assess how 
soft tissue laxity, periprosthetic tissue metal concentrations, and inflammatory cytokines 
concentrations in the synovial fluid contribute to the interaction between human 
physiology and the implant, the degree of wear and damage to the implant systems 
themselves first were established.  
 
 The modes of wear can be grouped by the following mechanisms: adhesive wear, 
abrasive wear, and fatigue wear. Characteristic of adhesive or abrasive wear, burnishing 
of the condylar, backside, and post surfaces may result from cyclic loading and 
micromotion which leads to progressive buffing of the original matte surface finish. As in 
many other retrieval studies, burnishing was the most common wear mode on every 
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assessed surface (32). From a biological perspective, burnishing produces wear debris 
that is within the size range that may stimulate an inflammatory response. Pitting, a 
mechanism of fatigue wear, is sometimes referred to as “cratering” and involves the 
liberation of millimeter-sized pieces of wear debris from the articulating surface. The 
wear debris produced by pitting is considered to be too large to provoke an osteolytic 
response; as such, pitting is believed to be a more benign wear mechanism than adhesive 
or abrasive wear, which produces micrometer-sized debris (204). Scratching is a mode of 
abrasive wear produced by plowing of microscopic asperities on the opposing metallic 
surface or by third body debris (204). Pitting and scratching were common wear 
mechanisms observed on all insert surfaces. Burnishing, pitting, and scratching were the 
predominant wear modes for all surfaces assessed.  
 
 Tibial insert wear on the condylar surface, backside surface, and stabilizing post, 
when applicable, was assessed using a modified Hood et al. (195) method. While the 
predominant modes of wear included burnishing, pitting, and scratching for all surfaces 
assessed, there were 2 implants with severe delamination on the condylar surface and 11 
implants with mild to severe backside surface deformation. Specimen DRLU081315-R, a 
posterior-stabilized, fixed bearing tibial insert sterilized with gamma radiation in an inert 
gas environment, had the highest condylar wear with a total score of 64. Severe 
burnishing was identified on the condylar and backside surfaces, with the maximum 
possible score of 24. Additionally, this implant had the highest wear of the stabilizing 
post with a total score of 22; burnishing was the predominant mode of wear (score of 10 
out of 12) followed by abrasion (score of 5 out of 12). Specimen RLU0913162A-R, a 
posterior-stabilized, fixed bearing tibial insert sterilized with gamma radiation in air, 
demonstrated the second highest condylar wear with a total score of 58, moderate 
backside wear with a total score of 56, and the second highest wear of the stabilizing post 
with a total score of 16. Specimen RLU1028161B-L, a fixed bearing tibial insert 
sterilized with gamma radiation in air, had a total condylar wear score of 57 with severe 
condylar delamination (score of 22 out of 24) accompanied by oxidation. This implant 
had the highest backside wear with a total score of 84; the modes of burnishing, pitting, 
and scratching each had the maximum score of 24, while the mode of surface 
deformation had a score of 12.  
 
 Many factors contribute to wear of the tibial insert on all aforementioned surfaces, 
including but not limited to: patient-specific factors such as body mass index and 
duration of implantation (195, 205-207); surgical-related factors such as ligament 
balancing or alignment of the components (78, 123-125, 208, 209); and lastly implant-
specific factors such as method of fabrication, mode of sterilization, and design (210-
212). In this study, duration of implantation was not a statistically significant factor 
(p>0.05) in the degree of wear. However, this is likely due to the fact that these were all 
well-functioning specimens retrieved at necropsy instead of revision. The contribution of 
ligament balancing will be discussed further in context of measured laxity in the 
following sections. The mode of fabrication was not available for the implants and thus 
was not considered in this study, but the mode of sterilization was available for the 
implants.  
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 Gamma irradiation in air was the method utilized by most to sterilize UHMWPE 
for use in both total hip and total knee arthroplasty components prior to 2000 (204). 
However, oxidative degradation of the polyethylene components occurred following 
gamma radiation sterilization in air and prolonged shelf storage in air (213, 214). 
Additionally, oxidation during long-term shelf aging following gamma irradiation was 
discovered to cause a loss in mechanical properties and in some cases, more rapid 
polyethylene wear often through delamination, especially with respect to TKA (205, 211, 
215, 216). Repeated cyclic loading of the UHMWPE, which results in subsurface fatigue 
and failure of the UHMWPE tibial insert, causes delamination wear (216, 217). 
Delamination is often associated with production of large amounts of debris and gross 
component failure. To address the concern of oxidation in gamma-air sterilized implants, 
orthopaedic manufacturers in the mid-to-late 1990s discontinued gamma sterilization in 
air and introduced gamma sterilization in low-oxygen or inert gas environment in 
combination with barrier packaging to reduce risk of oxidation prior to implantation 
(204). Although many biomechanical and material factors induce and accelerate 
delamination failure, stabilization of UHMWPE through sterilization without irradiation 
or irradiation sterilization in an inert atmosphere is thought to eliminate subsurface 
oxidation which contributes to delamination. Specimen RLU1028161B-L, in Figure 3-2, 
illustrates the detrimental effects of oxidation caused by gamma-air sterilization. 
 
 The contemporary TKA tibial component can either be a fixed or mobile bearing 
design. Mobile bearing designs were introduced to provide congruity of the tibiofemoral 
articular surface and to allow relative movement between the lower surface of the 
polyethylene insert and the metal tibial baseplate for reduction of the constraint force (81, 
82, 218). Because the contact forces are theoretically reduced on the articular surface 
mobile bearing knees, the risk of polyethylene wear may also be reduced. However, the 
articulation between the inferior surface of the tibial insert and the superior surface of the 
tibial tray provides an additional source of wear debris generation. Lu et al. (218) found 
that while the polyethylene wear on the superior surface was in fact reduced with the 
mobile bearing design, there was a higher incidence of high-grade wear patterns, such as 
scratching, pitting, embedded debris, and delamination (218). A student’s t-test revealed 
that the differences in condylar and backside wear scores between mobile bearing and 
fixed bearing implants in this cohort were not statistically significant (p>0.05). Moreover, 
the incidence of “high-grade” wear patterns on the backside surface, as mentioned in the 
study by Lu et al. (218) was not statistically significant with respect to fixed bearing 
versus mobile bearing designs. Again, this is likely due to the fact that the implants in this 
cohort are well-functioning implants.  
 
 Although the articulating surface of polyethylene insert was thought to be the 
main source of debris generated in total knee arthroplasty, the tibial tray-insert interface 
has also been established as a contributing source of polyethylene debris (89, 206, 208, 
210, 219) and in many cases has been related to tibial osteolysis (89, 220, 221). Factors 
influencing backside interface micromotion and the resultant wear include: implant 
design, tibial tray material (CoCrMo or TiAlV), locking mechanism design in fixed 
bearing tibial components, and surface roughness (222, 223). Previous studies have 
indicated that the backside surface of a fixed bearing tibial insert can still move relative 
 68 
to the tray despite being secured to the tibial tray with a locking mechanism (206, 224, 
225). This present study gives further evidence of micromotion occurring between fixed 
bearing tibial insert-tray designs.  
 
 While burnishing was the predominant mode of wear on the backside surface, 
pitting and scratching were also observed. Surace et al. (210) proposed that pitting on the 
backside surface may occur by a different mechanism than that on the condylar surface 
because contact-induced stresses near the backside surface of the insert are much smaller 
than those observed on the condylar surface. Instead, the formation of pits or scratches 
may be due to the presence of third-body particles, such as Ti particles, produced by 
micromotion at the interface (78, 125, 126). Additionally, surface deformation on the 
backside surface was observed on 11 out of 25 of the inserts. Surface deformation, 
oftentimes referred to as cold flow in literature, was characterized by cylindrical 
protrusions of polyethylene extending from the undersurface of the insert into screw-
holes within the tibial base-plate. This method of wear has been well-documented in 
literature and has been attributed to cold flow or creep of the polyethylene under the 
action of compressive forces applied to the upper surface of the insert during weight-
bearing activities (89, 206, 210, 219). However, the results of a study by Conditt et al. 
(206) suggested that the protrusions on the underside of worn retrieved tibial components 
were not primarily due to creep or cold flow of the polyethylene through the screw-holes 
on the baseplate, but instead were primarily due to wear of the inserts. They found that 
the surfaces of all of the polyethylene material descending below the worn backside 
surface existed in a single plane, independent of the location of each individual cylinder, 
an observation unlikely to occur if the protrusions were due to cold flow or creep (206).  
 
 Another design element that contributes to the polyethylene debris burden is the 
presence of a stabilizing post in PCL-substituting designs. While PCL-substituting 
designs were developed to prevent uncontrolled sliding of the femoral component 
without requiring excessive conformity, thereby reducing wear of the condylar insert 
surface, several studies have reported that the cam-post articulation in PS implants is an 
additional source of polyethylene wear debris (32, 109, 205, 226, 227). Burnishing, 
scratching, pitting, and abrasion were the most prevalent wear modes in the current study. 
As shown in Figure 3-3, specimen RLU1121162A-R had significant damage to the 
anterior surface of the stabilizing post with little wear on the posterior surface. Wear on 
the posterior surface of the stabilizing post is expected as that is the surface where 
articulation occurs with the cam. However, many of the implants in this study exhibited 
wear of the anterior surface as well. Anterior impingement damage may occur on both PS 
and CR designs. The incidence of anterior impingement damage in PS designs has been 
reported to range from 36%  to 75% in literature (109, 228). Banks et al. (228)  suggested 
that as the femoral component moves from flexion to extension to hyperextension, the 
intercondylar notch contacts the polyethylene tibial eminence or post causing damage. 
The wear caused by anterior impingement could compromise the structural integrity of 
the stabilizing post leading to fracture and also likely generates micrometer-sized wear 
which may lead to stimulation of inflammatory processes. 
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 An important limitation of the Hood et al. (195) approach to assessing wear is that 
a high damage score does not necessarily indicate that a large amount of wear has 
occurred. Instead, this method only expresses damage in terms of the area covered by the 
defect. While thickness measurements can account for some loss of material, original 
implant thickness must be known and the irregular shape of a tibial insert likely would 
skew the measurements. Moreover, Puloski et al. (109) noted that discerning between 
mechanisms of wear in which material is lost and plastic deformation in which polymer is 
distorted without loss of material also poses another complication in quantifying or 
qualifying tibial insert wear.  
 
 Total knee arthroplasty femoral components present large metal surface areas that 
can undergo material loss due to wear and/or corrosion, generating metal particles and 
metal ions. While, historically, polyethylene debris was believed to be the primary cause 
of osteolysis and aseptic loosening, recent attention has been directed towards the role of 
metal debris in adverse events following primary total joint replacements. Possible 
corrosive mechanisms of metal debris production in primary TKAs include: direct 
inflammatory cell-induced corrosion (145, 146, 196) and degradation at the backside 
interface with the bone cement layer in the form of discoloration (196). Possible abrasive 
wear mechanisms included scratching due to third-body debris (196, 229, 230) and metal-
on-metal articulation due to complete wear-through of the polyethylene tibial insert or 
patellar button, in cases of metal-backed patellar resurfacing. In addition to generating 
debris that may incite inflammatory reactions, femoral component surfaces roughened by 
abrasive mechanisms have been shown to increase wear of the tibial insert (229-231). As 
such, wear of the femoral component may induce additional wear of the polyethylene 
insert. 
 
 Only one study was found in literature that analyzed damage of femoral 
components. Arnholt et al. (196) analyzed the aforementioned corrosive and abrasive 
wear mechanisms on 52 CoCr femoral components retrieved at time of revision. They 
found evidence of metal release of corrosive damage in 51 of the 52 (98%) femoral 
components included in their study with 98% (n=51/52) of the implants demonstrating 
third-body wear, primarily in the form of scratching. Such a high incidence of damage 
highlights the critical need for additional research that considers the role of femoral 
component damage in the failure of TKA. Using the same method employed by Arnholt 
et al. (196), the present study analyzed the damage in four quadrants of 29 well-
functioning femoral components retrieved at autopsy. While the median damage score of 
the sample population was a score of 5, mild to severe damage (score 2) was observed 
in at least one quadrant of 70% of the femoral condyles included in this study. Two 
implants in particular displayed significant abrasive damage of the femoral component. 
Specimen RLU1028161B-L, shown in Figure 3-5, had severe scratching of the bearing 
surface and received a score of 14 out of the maximum score of 16. The specimen was a 
Miller-Galante II design (Zimmer Inc.; Warsaw, IN) with a TiAlV femoral component. 
The lower modulus of elasticity of TiAlV with respect to CoCrMo makes it more prone 
to damage and wear. As such, TiAlV is not a suitable bearing material in total knee 
arthroplasty. This specimen also had significant condylar and backside wear of the tibial 
insert, which is in accordance with previous reports (229-231) of roughened femoral 
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components increasing wear of the tibial insert. Specimen RLU0426161B-L, a press-fit, 
LCS Mobile Bearing design (Depuy; Warsaw, IN) with a condylar coating of CoCr small 
beads, had moderate scratching of the bearing surface, receiving a score of 10. This 
specimen, shown in Figure 1-5, presented with metallosis which is associated with 
abnormal metallic wear (151, 152). The corresponding tibial insert condylar surface for 
specimen RLU0426161B-L demonstrated severe burnishing (22 out of 24), mild 
scratching and pitting (score 7 out of 24), mild delamination (score of 4), and some 
evidence of embedded metallic debris (score of 2).  
 
 
Tissue Metal Concentrations 
 
 While the femoral component damage scores qualitatively described the wear that 
occurred in vivo, ICP-MS analysis quantitatively measured the metallic debris that had 
accumulated in the periprosthetic tissues. Kretzer et al. (232) was the first to question 
whether wear debris-induced failure in TKA was solely due to polyethylene. Seeking to 
quantify the extent of metal debris generation in TKA, they employed a wear simulator 
with all polymer bearings allowing the resultant metallic wear to be solely from the 
CoCrMo implants. While wear of metallic components has traditionally been attributed to 
third body particles such as bone chips or bone cement, Kretzer et al. (232) observed 
wear of the metal components without the presence of these third bodies in their 
simulation. Despite the absence of these “traditional” third body particles, the metallic 
femoral components displayed pitting as well as third body and abrasive wear mainly 
originating from the cobalt-rich matrix. They postulated that the third bodies inducing the 
pitting or abrasive wear were carbides released from the bulk alloy. Carbides are known 
to be very hard and rich in Mo and Cr (233). Consequently, the higher hardness of the 
carbides or fragments within the articulation may have caused the observed abrasive and 
third body wear of the femoral components (232). Additionally, Kretzer et al. (232) noted 
the release of titanium from the tibial plateau, although that tibial plateau is not intended 
for articulation. However, TiAlV alloy has a very thin oxide layer that is sensitive to 
fretting (234). Kretzer et al. (232) stated that, even with softer material like polyethylene 
which has a lower elastic modulus than TiAlV, micromotions may cause a relevant 
release of Ti wear products. Previous wear simulator studies have also reported evidence 
of large pits where particles had been removed from the superior surface of the TiAlV 
baseplate (78, 123, 125, 126). One shortcoming of wear simulator studies is that they 
typically measure debris release over five million cycles which translate to an implant 
lifespan of approximately five years.  
 
 While there is a plethora of studies that have investigated metal release in metal-
on-metal THAs , only five previous studies were found that reported metal ion 
concentrations in serum (157, 235) and metal concentrations in synovial fluid (236, 237) 
of patients with TKA. For sake of comparison to the present study, the reported values 
were converted to g/L, as presented in Table 4-1. Three studies were identified that 
measured metal release from TKA in serum. Jacobs et al. (238) measured Ti release from 
cementless TiAlV alloy total knee replacements in three cohorts: control patients without 
implants (n=21), well-functioning, unilateral primary TKA patients (n=10), and patients  
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Table 4-1. Compilation of previous studies investigation metal concentrations 
from TKA for comparison for current study 
 
Study 
Sample 
Population 
Co 
(g/L) 
Cr 
(g/L) 
Ti 
(g/L) 
Sample 
Medium 
Implant 
Materials 
Jacobs et al.  Control -- -- 2.67 Serum TiAlV 
Stable Unilateral -- -- 3.15 
Failed Unilateral -- -- 135.57 
Luetzner et al.  Control 0.25 <0.25 -- Serum CoCrMo 
Stable Unilateral 3.27 0.92 -- 
Stable Bilateral 4.28 0.98 -- 
Savarino et al.  Control 0.26 0.24 3.20 Serum CoCrMo 
and TiAlV Stable Unilateral 0.44 0.24 2.91 
Failed Unilateral 1.10 0.45 3.05 
Cracchiolo et al.  Control 800 0 -- Synovial 
Fluid 
Unknown 
Synovitis Hinged 6,540 36,240 -- 
Synovitis 
Non-hinged 
1,230 1,930 -- 
Milosev et al.  Control <0.2 <0.02 1.92 Synovial 
Fluid 
CoCrMo 
and TiAlV Failed 1.13 5.92 2.20 
Present Study Stable Necropsy 16.36 38.54 9.62 Tissue CoCrMo 
and TiAlV 
 
Sources:  
Jacobs JJ, Silverton C, Hallab NJ, Skipor AK, Patterson L, Black J, et al. Metal release 
and excretion from cementless titanium alloy total knee replacements. Clinical 
orthopaedics and related research. 1999(358):173-80.  
 
Luetzner J, Krummenauer F, Lengel AM, Ziegler J, Witzleb W-C. Serum metal ion 
exposure after total knee arthroplasty. Clinical orthopaedics and related research. 
2007;461:136-42. 
 
Savarino L, Tigani D, Greco M, Baldini N, Giunti A. The potential role of metal ion 
release as a marker of loosening in patients with total knee replacement. Bone Joint J. 
2010;92(5):634-8. 
 
Cracchiolo A, Revell P. Metal concentration in synovial fluids of patients with prosthetic 
knee arthroplasty. Clinical orthopaedics and related research. 1982(170):169-74. 
 
Milošev I, Levašič V, Vidmar J, Kovač S, Trebše R. pH and metal concentration of 
synovial fluid of osteoarthritic joints and joints with metal replacements. Journal of 
Biomedical Materials Research Part B: Applied Biomaterials. 2017;105(8):2507-15. 
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with failed porous Ti coated patellar components (n=8). The Ti concentrations measured 
in the failed cohort was statistically greater than the control cohort (p<0.005) while the Ti 
concentrations measured in the stable cohort were not statistically different from the 
control cohort. A study by Luetzner et al. (235), using atomic absorption spectrometry, 
reported median Co serum concentrations in patients with well-functioning unilateral 
(n=18) and bilateral (n=23) TKAs. They compared these Co and Cr concentrations to a 
control group from a previous study by Witzleb et al. (239). While no differences 
between serum levels in patients with unilateral and bilateral arthroplasties were 
observed, the researchers reported elevated serum levels of Cr and Co in both study 
groups when compared to the control group (235). A cohort study performed by Savarino 
et al. (157) investigated the role of ion release in the assessment of fixation of the implant 
after unilateral TKA. Their study compared serum levels of Ti, Cr, and Co, measured by 
atomic absorption spectrometry, for three sample groups: no implants, stable implants, 
and failed implants. Evaluation of Ti was underestimated because of the high 
instrumental detection limit employed in the study. Based on the high specificity and 
positive predictive value, Savarino et al. (157) concluded that elevated Cr ion levels 
appears to be a good diagnostic indicator of loosening when clinical and radiological 
signs are unclear.  
 
 Two studies were identified that measured metal release from TKA in synovial 
fluid. Using atomic absorption spectrometry, a study by Cracchiolo et al. (236) measured 
the Co and Cr concentrations in the synovial fluid of patients with primary arthritis, 
patients with hinged (metal-on-metal) TKA prostheses, and patients with non-hinged 
(metal-on-polyethylene) TKA prostheses. Additionally, Cracchiolo et al. (236) measured 
the Co and Cr concentrations in the sera of only the control patients and patients with 
hinged prostheses. Interestingly, the only significant difference they observed was that 
the control patients had higher Co sera concentrations than the patients with hinged 
prostheses. As such, using serum as the medium for testing metal concentrations may 
underestimate the actual degree of metal debris accumulating in the joint. While 
measuring metal ion levels in serum may suit clinical detection of excessive wear, 
measuring metal debris in the synovial fluid or periprosthetic tissues is likely to be more 
indicative of how much debris has accumulated in the local periarticular environment. 
Milosev et al. (237) measured the Co, Cr, and Ti concentrations using inductively-
coupled mass spectrometry in the synovial fluid of a patients with primary OA collected 
at time of index TKA (n=2) and patients with failed primary knee arthroplasty collected 
at time of revision (n=11). Cobalt and chromium were not detected in the control group 
but were detected in 82% (n=9/11) and 45% (n=5/11) of the failed cohort. When 
measuring metal concentrations in synovial fluid, the authors (236, 237) were unable to 
identify whether the debris was in ionic or particle form; the same concept will be applied 
to the present study. 
 
 To the author’s knowledge, this is the first study to document Co, Cr, and Ti 
concentrations in the periprosthetic tissues of well-functioning TKA specimens retrieved 
at autopsy. Despite Co being the predominant element in the composition of CoCrMo 
alloys, the median Co concentration found in the periprosthetic tissues was 16.4 g/L, 
whereas the median Cr concentration was 38.5 g/L. Similarly, Ichinose et al. (240) 
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examined the metal composition in the synovial tissues surrounding failed TKAs revised 
due to unexplained pain and swelling. Using backscattered scanning electron microscopy, 
they found that the ratio of Co, Cr and Mo was 4.16:69.15:20.67, respectively, in the 
synovial cells of patients with CoCrMo TKA components. The authors speculated that 
Co may dissolve from periarticular cells, disseminating throughout the body, whereas Cr 
remains within the cells (240). Similarly, Woodman et al. (241) and Merritt et al. (242) 
indicated that Co dissolved into the fluid, ultimately removed from the body in urine, 
although Cr remained in the tissues around CoCrMo components. Taking this into 
consideration, the Co concentrations in this study may potentially underestimate the 
actual amount of Co released. Despite this potential limitation, this study presents a novel 
finding of elevated Co, Cr, and Ti concentrations in the periprosthetic tissues of well-
functioning TKA specimens.  
 
In the present study, three specimens had notably elevated Co, Cr, or Ti 
concentrations and were excluded from statistical analysis. Specimen DRLU081315-R 
had a Ti concentration of 1,136.3 g/L in the periprosthetic tissues. This implant system 
was a cemented CoCrMo alloy femoral component with TiAlV tibial baseplate. A fixed 
bearing implant system, this specimen demonstrated significant backside wear of the 
tibial insert (scratching score of 24 out of 24, pitting score of 10 out of 24, burnishing 
score of 24 out of 24, and surface deformation score of 8 out of 24) indicating 
micromotion occurred. The micromotion may have contributed to the wear of the TiAlV 
tibial baseplate. Specimen RLU0426161B-L had extremely high Co and Cr 
concentrations—28,705 g/L and 66,532 g/L, respectively. As previously stated, this 
implant also endured significant damage in vivo, receiving a femoral component damage 
score of 10 and presented with severe metallosis, as shown in Figure 1-5. Additionally, 
this implant system was uncemented with a porous coating of small beads on the femoral 
condyle and tibial baseplate; however, the material composition of the coating is 
unknown. The Co and Cr concentrations observed in this specimen were greater than the 
mean Co and Cr concentrations measured in the synovial fluid of the patients with both 
non-hinged and hinged prostheses (Table 4-1) that had suspected synovitis, which were 
the highest metal concentrations reported in the included literature. Specimen 
RLU1028161B-L, a cementless, Ti fiber mesh coated TiAlV alloy femoral component 
and tibial baseplate, had extremely elevated Ti concentrations (12775 g/L) in the 
periprosthetic tissues. This implant received the highest femoral component damage 
score (14 out of 16), the third highest wear score of the tibial insert condylar surface (57 
out of 168) with notable delamination present (score of 22 out of 24), and the highest 
wear score of the tibial insert backside surface (84 out of 168). While each of these 
outliers have periprosthetic tissue concentrations that exceed the Co, Cr, and Ti 
concentrations measured in the sera and synovial fluid of stable and failed implants in 
previous studies, the median values reported in this study, which analyzed only well-
functioning implants retrieved at autopsy, were higher than the average values reported in 
both the sera or synovial fluid.  
 
 
 
 74 
Inflammatory Cytokines 
 
 Through normal use of prosthetic joints, polyethylene and metallic wear particles 
are generated, as documented through the wear analysis of implants and measurements of 
tissue metal concentrations. These wear particles evoke an inflammatory response 
through the stimulation of macrophages and other immune cells prompting the release of 
powerful chemical mediators, which in turn may stimulate osteolysis. Inflammatory 
cytokines have been proposed as possible biomarkers for detection of TKA failure (177, 
203, 243, 244). To establish the role of certain chemical mediators in the present study’s 
cohort of well-functioning primary TKA retrieved at necropsy, a cytokine assay was 
performed for the detection of multiple analytes (TNF-, IL-1, IL-6, MCP-1, MIP-3, 
and M-CSF) in the synovial fluid samples. However, to elucidate which the significance 
of the cytokine concentration measurements, the concentrations of these inflammatory 
mediators must first be established in those without prosthetic implants to serve as a 
standard for comparison. Several studies were identified that measured the concentrations 
of TNF-, IL-1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid of patients 
diagnosed with OA or RA of the knee. While these cytokines may also play a role in the 
inflammatory processes in these conditions and are likely to elevated, these reported 
values will serve as a lower limit guideline for comparison. Additionally, a few studies 
were identified that measured the concentrations of the same cytokines in patients with 
aseptically failed total knee implants. These reported values will serve as an upper limit 
guideline for comparison.  
 
 Kahle et al. (245) measured the levels of TNF- and IL-1 in the synovial fluid of 
patients with OA, patients with RA, and healthy control patients at necropsy. The 
researchers reported the following mean TNF- concentrations in the OA, RA, and 
control cohorts: 80 pg/mL, 170 pg/mL, and 289 pg/mL. Additionally, they reported the 
following mean IL-1 concentrations in the OA, RA, and control cohorts: 21 pg/mL, 193 
pg/mL, and <20 pg/mL (245). This particular study was novel as it was the only one 
found that presented the levels of these two inflammatory cytokines in the synovial fluid 
of healthy controls at autopsy. Mabey et al. (243) sought to quantify  the concentrations 
of proinflammatory and anti-inflammatory cytokines in plasma and synovial fluid of 
primary knee OA patients (n=32) and healthy controls. As is the case with most studies, 
plasma was the only type of sample collected from the healthy controls for analysis. Due 
to this ethical constraint, it is difficult to discern the naturally occurring concentrations of 
the cytokines of interest. However, for reference, Mabey et al. (243) reported the 
following average cytokine concentrations in the cohort of OA patients—TNF-: 1.0 
pg/mL (lower detection limit: 0.20 pg/mL), IL-1: 1.9 pg/mL (lower detection limit: 0.10 
pg/mL), and IL-6: 356.5 pg/mL (lower detection limit: 0.29 pg/mL). Interestingly, Mabey 
et al. found that TNF- and IL-1 in OA plasma were significantly higher than in paired 
synovial fluid samples (p<0.001). On the other hand, Steiner et al. (246) measured TNF-
 and IL-6 in the synovial fluid from patients with RA (n=33) and reported the following 
average cytokine concentrations—TNF-: 157 pg/mL and IL-6: 4,700 pg/mL, both of 
which had a lower detection limit of 30 pg/mL. In investigating solely the role of IL-1 
in OA and RA, Richette et al. (247) reported average IL-1 concentrations of 1.0 pg/mL 
in the cohort of OA patients (n=42) and average IL-1 concentrations of 24.0 pg/mL in 
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the cohort of RA patients (n=11) in the synovial fluid, with a lower limit of detection of 
0.1 pg/mL. They detailed that detectable levels of IL-1 were found in 71% (n=30/42) of 
patients with OA and all patients with RA. In an explorative study comparing levels of 
cytokines in control and OA synovial fluid, Beekhuizen et al. (248) tested for TNF-, IL-
1, IL-6, and MCP-1. Their control cohort (n=16) consisted of synovial fluid collected 
from the patient within 24 hours post-mortem, whereas the test cohort (n=18) consisted 
of synovial fluid collected from patients with primary OA. TNF- levels in both cohorts 
were below the lower detection limit, which was not detailed. Median IL-1 
concentrations were 0.0 pg/mL in the control cohort and 4.8 pg/mL in the test cohort with 
a lower detection limit of 0.7 pg/mL. Median IL-6 concentrations were 4.8 pg/mL in the 
control cohort and 135.8 in the test cohort with a lower detection limit of 0.4 pg/mL. 
Beekhuizen and colleagues (248) reported that IL-6 was significantly elevated in the OA 
cohort when compared to the control cohort (p=0.001). Lastly, median MCP-1 
concentrations were 542.4 pg/mL in the control cohort and 824.8 pg/mL in the OA cohort 
with a lower detection limit of 1.2 pg/mL. Ruth et al. (249) measured MIP-3 in the 
synovial fluid from patients with OA (n=9) and patients with RA (n=25) and reported 
that RA synovial fluid samples exhibited significantly elevated levels of MIP-3 (3,001 
pg/mL) compared to patients with OA (100 pg/mL). Although, no value of significance 
was given.  
 
 To determine if IL-1 may be indicative of increased synovial activity, an 
inflammatory reaction, or osteolysis following TKA, Kovacik et al. (203) compared the 
IL-1 concentrations in synovial fluid aspirates from OA patients receiving primary TKA 
with patients receiving revision TKA for aseptic loosening. They reported a significant 
difference (p<0.0001) between the average IL-1 concentrations in the OA synovial fluid 
aspirates (0.25 pg/mL) compared to the revision synovial fluid aspirates (6.25 pg/mL). 
Furthermore, Kovacik et al. (203) found significantly higher IL-1 concentrations 
(p<0.0001) in the synovial fluid of the patients receiving revision for failure of a TiAlV 
component (9.92 pg/mL) versus revision for failure of a CoCrMo component (2.57 
pg/mL). Similarly, Dasa et al. (177) measured the concentrations of TNF-, IL-1, and 
MCP-1 in patients with OA (n=10), patients with RA (n=4), and patients with 
radiographic evidence of aseptic loosening undergoing revision arthroplasty (n=6). An 
average TNF- concentration of 208.0 pg/mL was reported only for the aseptically failed 
patient cohort. IL-1 was not detected (<0.6 pg/mL) in any of the patients undergoing 
revision TKA. The mean MCP-1 concentration for the revision patients was 21,233 
pg/mL. The mean MCP-1 concentration was 3012 pg/mL for the OA cohort and 690 
pg/mL for the RA cohort. Statistical analysis revealed that the mean MCP-1 
concentration in revision samples was larger than OA and RA samples (p=0.011 and 
p=0.014, respectively), but no difference existed between MCP-1 in the OA and RA 
cohorts. Moreover, Dasa et al. (177) noted that patients with OA fell into two distinct 
subsets based on MCP-1 concentration: greater than 4,000 pg/mL and less than 2,500 
pg/mL. In their investigative study of potential inflammatory biomarkers, Perkins et al. 
(244) measured TNF-, IL-1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid 
of patients with a unexplained, painful TKA (n=12) and patients receiving revision due to 
aseptic loosening (n=7). TNF- and IL-1 concentrations were below the minimum 
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detection limits in both cohorts (<8.9 pg/mL and <16.3 pg/mL, respectively). The 
average IL-6 concentration for the painful TKA cohort was 572 pg/mL and for the 
revision TKA cohort was 476 pg/mL. The average MCP-1 concentration for the painful 
TKA cohort was 4,481 pg/mL and for the revision TKA cohort was 4,726 pg/mL.  The 
average MIP-3 concentration for the painful TKA cohort was 355 pg/mL and for the 
revision TKA cohort was 40 pg/mL. Lastly, the average M-CSF concentration for the 
painful cohort was 1,559 pg/mL and for the revision TKA cohort was 1,663 pg/mL. No 
statistical differences were detected (244).  
 
 To the author’s knowledge, the present study is the first to document TNF-, IL-
1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid aspirated post-mortem from 
specimens with well-functioning primary TKAs. Ten specimens (31%, n=10/32) had 
TNF- concentrations below the minimum detection limit (8.9 pg/mL). The remaining 
69% (n=22/32) specimens had a median TNF- concentration of 12.9 pg/mL which is 
much lower than the concentration reported for the RA cohort (157 pg/mL) in the study 
by Steiner et al. (246) as well as the concentration reported for the revision cohort (208 
pg/mL) in the study by Dasa et al. (177). Whereas the previous studies reported IL-1 
concentrations ranging from 0.00 pg/mL (248) to 24 pg/mL (247) in OA, RA, and 
necropsy control patients, the present study found a median IL-1 concentration of 73.2 
pg/mL with 85% (n=28/32) of the specimens having concentrations above the minimum 
detection limit (16.3 pg/mL). TNF- and IL-1 have both been well established as 
mediators in osteolysis through modulation of the RANK/RANKL/OPG axis. These 
findings demonstrate near-basal levels present in the well-functioning necropsy 
specimens. This is expected, however, because the patients included in the present study 
were well-functioning as dictated by no evidence of radiolucencies on the fluoroscopes 
taken at retrieval. An additional factor that may modulate the activity of the cytokines is 
the fact that their presence is likely transient in the inflammatory process. Wear debris is 
generated, macrophages are stimulated, cytokines are released, macrophages and other 
immune cells travel to the site of aggravation, and eventually, anti-inflammatory, 
homeostatic mechanisms begin, restoring the equilibrium. Some of the specimens in this 
study may have been collected when they were in the aggravation time-point whereas 
others may have been collected when they were in the anti-inflammatory, homeostatic 
time-point.  
 
 IL-6, in particular, has been implicated in modulating the response to peri-
prosthetic infections in joint arthroplasties (250-252). However, IL-6 is also regarded as a 
pleiotropic cytokine whose duty is to “ramp” up the inflammatory response whether it be 
in the pro- or anti-inflammatory direction (253). Six specimens had IL-6 concentrations 
above the maximum detection limit (1180 pg/mL). The median IL-6 concentration 
reported fell between the IL-6 concentrations reported in the post-mortem control cohort 
and the OA cohort of the study by Beekhuizen et al. (248). The concentrations fell into 
two subsets: those greater than 400 pg/mL and those less than 400 pg/mL. This follows 
what was reported by Mabey et al. and Perkins et al. in which the OA, painful, and 
revision cohorts averaged around 400 pg/mL (244). IL-6 concentrations exceeding 400 
pg/mL may be indicative of the inflammatory process “ramping” up. With respect to 
MCP-1, all but one specimen had concentrations above the minimum detection limit (98 
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pg/mL). Furthermore, 8 specimens had MCP-1 concentrations over the maximum 
detection limit (7940 pg/ml). Similar to what was found in the study by Dasa et al. (177), 
the MCP-1 concentrations for these specimens seem to fall into two separate subsets: 
those greater than 4000 pg/mL and those less than 4000 pg/mL. More specifically, all of 
the specimens with MCP-1 levels greater than 4000 pg/mL surpassed the detection limit 
of the assay platform (>7940 pg/mL). This may indicate a certain stimulus threshold 
exists at which macrophages will increase the production of MCP-1.  
 
 MIP-3 is a chemokine that is strongly chemotactic for lymphocytes and has been 
implicated in modulating the adaptive immune system (254) Additionally, MIP-3 is 
chemotactic for leukocytes to joints afflicted by RA (249). As such, it follows logically 
that the MIP-3 levels reported in the present study would align with those reported in 
literature for OA , painful, or revision patients, while the MIP-3 concentrations in 
patients with RA would be elevated (244, 249). Recent research indicates that GM-CSF 
polarizes M0 macrophages into M1 (pro-inflammatory) phenotype whereas M-CSF 
polarizes M0 macrophages into M2 (healing) phenotype (255). None of the specimens of 
each sample group had GM-CSF concentrations above the minimum detection limit. 
These results are in accordance with previous studies that demonstrated negligible levels 
of GM-CSF in loosened THA and fixed THA (256, 257). On the other hand, all of the 
specimens had M-CSF concentrations that were within range. The present study found 
noticeably elevated levels of M-CSF in the synovial fluid of cadaveric primary TKAs 
compared to the painful and revision synovial fluid reported in Perkins et al. (244). Each 
cadaveric sample had M-CSF concentrations that were an order of magnitude greater than 
those observed in the living patients. While previous studies found elevated levels of M-
CSF in aseptically loosened THAs compared to well-fixed THAs, this present study does 
not support this notion with respect to TKAs (258, 259). Future research may investigate 
the roles of GM-CSF and M-CSF concentrations as indicators as to whether the body is 
entering a cyclic inflammatory cascade, which may precede failure, or if the body is 
simply going through the normal inflammation-healing sequence.  
 
 Certain limitations of cytokine and inflammatory marker measurements in clinical 
research must be acknowledged. Many cytokines have a short half-life in vivo and are 
also subject to rapid degradation in vitro following sample collection if appropriate 
storage and handling procedures are not followed (260-263). While literature has not 
elucidated the effect of processing and storage on the degradation of cytokines in 
synovial fluid, several reports on serum and plasma have indicated that most cytokines 
are prone to degradation if samples are not processed correctly and stored at -70C (264-
266). Furthermore, the amount of freeze-thaw cycles has been demonstrated to effect 
cytokine measurements. Thavasu et al. (266) found that most cytokines are stable for up 
to three freeze-thaw cycles. However, Flower et al. (267) found that TNF- concentration 
increased with each successive free-thaw cycle, becoming significant after three cycles. 
Time of day of sample collection has also been demonstrated to impact reported levels of 
circulating cytokines (262, 268-270). While every effort was taken to mitigate the 
aforementioned limitations, measured cytokine levels in the synovial fluid of this study 
cohort may not entirely reflect the presence or activity of those cytokines in vivo.  
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Joint Laxity 
 
 Suboptimal soft tissue and gap balancing, which dictate the laxity of the joint, 
may be implicated in the etiology of some of the most common indications for revision—
loosening, excessive wear, instability, and malalignment (116-122). The IE, VV, and AP 
laxity were measured using a platform that has been previously studied and utilized in 
previously published biomechanical studies of TKA kinematics (114, 184-193). Of the 
studies cited, only four provided data points that were used for comparison to the present 
study (184, 187-189). Contrary to the present study, Jojima et al. (188) evaluated the IE 
laxity at  5 Nm, VV laxity at  15 Nm, and AP laxity at  70 N. Similarly Kanamiya et 
al. (189) applied a  10 Nm torque to evaluate rotational laxity, as shown in Figures 4-1 
through 4-3. While there were great variations in IE and VV laxity, across the flexion 
angles between each of the studies, the current study follows the trend of increasing IE 
and VV laxity throughout the flexion angles. Furthermore, the current study PS implants 
had maximum AP laxity at 30, which is in accordance with the PS implants evaluated by 
Saeki et al. (187). The trend of CR implant laxity reported in the current study closely 
mimics that which was reported by Jojima et al. (188) in their evaluation of CR implant 
designs although their AP laxity was measured at  70 N. Although similar trends were 
observed, there is a significant difference between the cited studies and the present study 
which likely affects the kinematics of the specimens. The specimens used by Saeki et al. 
(187), Kanamiya et al. (189), and Jojima et al. (188) were five fresh-frozen knee 
specimens who received total knee arthroplasty post-mortem. As such, the incisions and 
trauma sustained during TKA were not healed. Additionally, the cited studies all used the 
Profix total knee system (Smith & Nephew Inc, Memphis, TN). The current study 
included several different implant designs from various manufacturers. Because knee 
kinematics is affected by the implant design (72, 271), this variation must be considered 
in the comparisons. A previous graduate student in Dr. Mihalko’s laboratory, Erik 
Woodard (184), evaluated IE, VV, and AP laxity using the same simulator and at the 
same IE and VV torque and AP force poles as the present study. However, his cohort 
included both CR and PS implant designs. As such, the comparison between his study 
and the present study is presented in Figures 4-4 through 4-6, in which the PS and CR 
designs were included together. Again, the IE, VV, and AP laxity reported for both the 
current study and the study by Woodard (184) follow the similar trends. Similar to the 
present study, Woodard (184) included a variety of implant designs from several 
manufacturers.  
 
 
Correlation of Study Parameters 
 
 
Hypothesis (a)—Laxity and Tissue Metal Concentrations 
 
 Excessive ligamentous laxity has been reported to increase AP translation and IE 
rotation which leads to force concentrations that are outside of the intended design 
parameters of the TKA components. More specifically, researchers found that these force 
concentrations exceeded the material properties of the tibial insert facilitating increased  
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Figure 4-1. IE rotational laxity comparison between the present study and Saeki 
et al., Kanamiya et al., and Jojima et al. 
 
Sources: 
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament 
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8. 
 
Kanamiya T, Whiteside LA, Nakamura T, Mihalko WM, Steiger J, Naito M. Effect of 
Selective Lateral Ligament Release on Stability in Knee Arthroplasty. Clin Orthop Relat 
Res. 2002;404:24-31. 
 
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after 
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and 
related research. 2001;392:184-9. 
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Figure 4-2. VV laxity comparison between the present study and Saeki et al. and 
Jojima et al. 
 
Sources: 
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament 
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8. 
 
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after 
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and 
related research. 2001;392:184-9. 
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Figure 4-3. Comparison of measured AP laxity between current study, Saeki et al. 
and Jojima et al. 
 
Sources: 
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament 
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8. 
 
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after 
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and 
related research. 2001;392:184-9. 
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Figure 4-4. Comparison of IE laxity between current study and Woodard  
 
Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and 
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of 
Tennessee Health Science Center; 2014. 
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Figure 4-5. Comparison of VV laxity between current study and Woodard 
 
Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and 
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of 
Tennessee Health Science Center; 2014. 
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Figure 4-6. Comparison of AP laxity between current study and Woodard 
 
Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and 
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of 
Tennessee Health Science Center; 2014. 
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UHMWPE wear (78, 123-126). However, there is a paucity of literature evaluating the 
relationship between joint laxity and metallic wear debris production following TKA. It 
was hypothesized that decreased joint laxity would increase metal concentrations in the 
periprosthetic tissue. 
 
 In the present study, decreased IE rotation at full extension was strongly 
correlated with increased Co concentrations in the periprosthetic tissues. When taking a 
closer look at the correlation, constrained external rotation specifically induced elevated 
concentrations of Co. While not statistically significant, a similar trend was observed 
between IE laxity at full extension and Cr. The PCL and the posterolateral corner work 
synergistically to control external rotation whereas the ACL is the primary stabilizer to 
internal rotation. In a normal flexion/extension cycle, the tibia externally rotates 5 in the 
last 15 of extension in the “screw home” mechanism. With the application of 1.5 Nm 
torque, this study observed that the primary TKA specimens were able to achieve a 
median external rotation of 10.18. However, when comparing the external rotation to the 
Co and Cr concentrations observed, decreased external rotation in full extension was 
associated with elevated Co and Cr concentrations. The decreased ability of the knee to 
externally rotate may have increased the contact pressures on the bearing surface 
facilitating abrasive wear of the CoCrMo bearing surface. Elevated concentrations of Co 
indicate that wear may be dominant within the cobalt rich matrix of the CoCrMo alloy. 
This agrees with observations reported by Kretzer et al. (232) in their in vitro analysis of 
metal release kinetics in TKA using a wear simulator.  
 
 Statistical significance was not detected in correlations between VV laxity and 
Co, Cr, or Ti debris. However, at full extension and 30 of flexion, the relationship 
between VV laxity and Ti debris in the periprosthetic tissues displayed an inverse trend. 
All but two implants had femoral components fabricated from CoCrMo alloy. The 
implant with TiAlV femoral component was excluded from the statistical analysis due to 
extremely elevated Ti concentrations. As such, the only material that could contribute to 
the generation of Ti debris is the baseplate. In this comparison, 6 of the 9 PS implant 
systems had CoCrMo femoral components with TiAlV tibial baseplates, while the 
remaining 3 had CoCrMo baseplates. Furthermore, 3 of 5 CR implant systems had 
CoCrMo tibial baseplates, while the remaining 2 were an all-UHMWPE monoblock 
component and TiAlV baseplate. When analyzing Figures B-11A and B-11B, the 
posterior-stabilized implants seem to be the major contributing factor to this trend. The 
primary stabilizers to VV deflection is the MCL and LCL. Additionally, the secondary 
function of the cruciate ligaments is to resist VV motion at full extension. When the ACL 
and PCL are sacrificed, as in patients receiving a PS design, the post also must resist this 
motion. In response to VV stresses, articulation of post with the medial and lateral sides 
of the femoral component between the bearing surfaces may increase loads in the 
transverse plane. This may inadvertently cause micromotion between the inferior surface 
of the tibial insert and the superior surface of the tibial baseplate, facilitating the release 
of Ti.  
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 Because the study population included both PS and CR implant designs, anterior 
translation and posterior translation were compared separately with tissue metal across 
the flexion angles. Across each flexion angle, the relationship between anterior 
translation and Co debris strongly trended towards an inverse correlation, as shown in 
Figures B-13 and B-14. Statistical analysis highlighted significance between decreased 
anterior laxity at 90 and increased Co debris. Similarly, statistical significance was 
revealed between decreased anterior laxity at 60 and 90 of flexion and increased Cr 
concentrations in the periprosthetic tissues. Most implant designs require the sacrifice of 
the ACL, creating an inherent deficiency in resisting anterior translation. To compensate 
for ACL deficiency, many designs have a more dished surface on condylar surface of the 
tibial insert. Decreased anterior translation, particularly at 60 and 90 of flexion, may 
increase wear of the femoral component causing the release of Cr-rich carbides which 
then abrade the Co-rich matrix of the CoCrMo alloy, elevating the release of Co. 
Interestingly, a strong trend of inverse correlations between posterior laxity across the 
measured flexion angles and Cr concentrations was observed. Statistical analysis 
highlighted a significant relationship between decreased posterior laxity at 90 of flexion 
and increased Cr concentrations in the periprosthetic tissues. When looking at the 
graphical representation of the correlation at 90 of flexion in Figure B-20B, both the CR 
and PS designs seem to follow the negative trend. In a cruciate-retaining TKA, the 
primary stabilizer to posterior displacement, especially at 90 of flexion, is the PCL. 
However, in a cruciate-sacrificing design, the post engages the cam at 90 of flexion, 
preventing posterior translation. Regardless if the implant is a cruciate-retaining or 
cruciate-sacrificing design, these results suggest that decreased posterior translation may 
induce increased release of Cr debris.  
 
 
Hypothesis (b)—Laxity and Inflammatory Cytokines 
 
 As previously stated, suboptimal soft tissue laxity has been demonstrated to 
influence the degree of polyethylene wear, such that excessive AP and IE laxity induced 
elevated rates of polyethylene wear due to the contact forces that exceed the design 
parameters of the insert (78, 123-126). Historically, wear-induced osteolysis and aseptic 
loosening was attributed to excessive polyethylene wear. In 2002, Sharkey et al. (272) 
reported polyethylene wear was the most common cause of failure in TKA, accounting 
for almost 25% of all revisions. Recently, however, the manufacturing of polyethylene 
has improved, with particular attention paid to the sterilization and packaging techniques. 
It was found that during shelf storage, UHMWPE inserts that were gamma sterilized in 
air-permeable packaging could undergo oxidative degradation, resulting in an increase in 
density and crystallinity; more importantly, the oxidative degradation led to a loss of 
mechanical properties associated with progressive embrittlement (213, 215, 273, 274). As 
such, air-permeable packaging was replaced by barrier packaging with a low oxygen 
environment starting during the mid 1990s (204). In 2014, Sharkey et al. (275) repeated a 
systematic retrospective review of all revisions performed at their institution to see if the 
reasons for revision have changed in the past 10 years. They found that polyethylene 
wear was no longer a major cause for failure while aseptic loosening accounted for 40% 
of all revisions at their institution (275). The reduction in polyethylene wear-related 
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failures is likely due to changes in sterilization and storage techniques and improved 
locking mechanisms. Because aseptic loosening still persists despite improvements in 
articulating materials and increased laxity has been reported to elevate polyethylene wear, 
it was hypothesized that a direct correlation would be observed between increased laxity 
and elevated inflammatory cytokines.  
 
 An inverse correlation was observed between IE rotational laxity at 60 of flexion 
and IL-1 concentrations in Figure C-4A. IL-1 is a cytokine that has been well 
established as a mediator of osteolysis (170). Furthermore, macrophages have been 
shown to release IL-1 in response to UHMWPE debris (166, 276). If increased IE laxity 
induces UHMWPE wear, then it would follow that increased laxity would also induce 
elevation of inflammatory cytokine concentrations. As such, the inverse correlation was 
unexpected. Further statistical analysis determined that this trend was strongly influenced 
by the CR implants and the trend did not persist with the removal of implant 
RLU0722161B-L, an all-polyethylene monoblock design, that had extremely restricted 
IE rotation at 60 of flexion and the highest IL-1 concentration of 962 pg/mL. This data 
point likely was pulling the trend for inverse correlation.  
 
 To date, no studies have demonstrated the relationship between degree of laxity in 
the coronal plane and wear of the TKA components. This study found that, at 60 of 
flexion, VV laxity was inversely correlated with TNF- concentrations as shown in 
Figure C-14A. However, it must be noted that levels of TNF- were barely above the 
minimum detection limit; as such, this correlation was likely clinically insignificant. 
Additionally, VV laxity was inversely correlated with IL-1 concentrations at 60 of 
flexion as shown in Figure C-16A. Again, the specimen RLU0722161B-L had extremely 
restricted VV rotation at 60 of flexion and the highest IL-1 concentration of 962 
pg/mL. This data point likely was pulling the trend for inverse correlation. At full 
extension, VV laxity was inversely correlated with IL-6 concentrations. This correlation 
seems to be due to specimens RLU0317172B-R and RLU1121161A-L which had IL-6 
concentrations above the maximum detection limit (>1180 pg/mL) and very constrained 
VV deflection at full extension. These two data points seem to be pulling the trend for 
this inverse correlation. In conclusion, none of the correlations reported between VV 
laxity and inflammatory cytokine concentrations likely have any clinical implications.  
 
 Anterior laxity was directly correlated with IL-6 and MCP-1 concentrations at 90 
of flexion, shown in Figures C-34B and C-38B, respectively. Additionally, posterior 
laxity was directly correlated with IL-6 at 30 and 90 of flexion as shown in Figures C-
35B and C-36B, respectively, although statistical significance was not detected. Both IL-
6 and MCP-1 have been implicated in the response to UHMWPE debris (166, 177). 
Kaufman et al. (166) posited that IL-6 and MCP-1 may function cooperatively at the 
periimplant tissue; MCP-1 actively recruits macrophages to the site of inflammation 
while IL-6 potently enhances the recruitment of osteoclast precursors and promotes 
osteoclastogenesis (172, 253, 277). These findings suggest that increased AP translation 
may increase the production of UHMWPE debris which incites an inflammatory response 
and the subsequent release of IL-6 and MCP-1.  
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Hypothesis (c)—Tissue Metal Concentrations and Inflammatory Cytokines 
 
 The in vivo biological response to wear debris is complex, involving a range of 
cell types, including fibroblasts, osteoclast precursor cells, and monocytes/macrophages, 
that may release a variety of inflammatory mediators including, cytokines, chemokines, 
prostanoids, reactive oxygen species, and MMPs, into the synovial fluid and 
periprosthetic tissues. To the author’s knowledge, this is the first study to measure the 
concentrations of a various inflammatory mediators in the synovial fluid of patients with 
well-functioning primary TKA at autopsy. Furthermore, this is the first study to examine 
the relationships of in vivo tissue metal concentrations and the levels of these 
inflammatory mediators. Several in vitro studies have demonstrated that macrophages 
will increase their release or expression of the cytokines included in this study when 
challenged with Ti or CoCr wear particles (150, 166, 176, 276, 278-280). Also, each of 
these cytokines or chemokines have been demonstrated in retrieved at revision in tissues 
or synovial fluid from patients with aseptically loosened primary total hip and total knee 
implants (177, 181, 203, 244, 257, 258, 281). As such, it was hypothesized that a direct 
correlation would be observed between the inflammatory cytokines and tissue metal 
concentrations.  
 
 No significant correlations were found between Co concentrations and 
inflammatory cytokines. The periprosthetic tissue Cr concentrations displayed a trend of 
inverse correlation with IL-1, IL-6, MCP-1, and MIP-3 concentrations in the synovial 
fluid, although significance was only detected for IL-6 and MIP-3. Similarly, Ti was 
trending towards an inverse correlation with IL-1 and MIP-3, although statistical 
significance was not detected. These results may be interpreted in many ways. The 
inverse trend suggests that the cytokines measured may not be particularly sensitive to 
metallic debris. However, when investigating the human macrophage response to 
UHMWPE, TiAlV, CoCrMo, and alumina particles in vitro, Kaufman et al. (166) 
reported that TiAlV debris consistently elicited the release of the cytokines of interest and 
was the second most stimulatory species behind the positive control, lipopolysaccharide 
(LPS). After TiAlV challenge, TNF- (895-fold), IL-1 (46-fold), IL-6 (20-fold), IL-8 
(5-fold), and MCP-1 (19-fold) release was increased at a statistically significant level 
when compared to the nonstimulated macrophages that served as a negative control 
(166). They found that the CoCr particles were less inflammatory than the Ti particles 
and only marginally more inflammatory than the UHMWPE particles. The CoCrMo 
particulates only elicited significant increases in TNF-, IL-6, and IL-8 release when 
compared to the nonstimulated cells; however, the fold-increase was 17-fold, 2.3-fold, 
and 2.3-fold, which is vastly lower than the fold-increase reported for TiAlV challenge 
(166). This study demonstrates that each of these cytokines are released by macrophages 
when challenged with Ti particles and CoCr particles although to varying degrees. Thus, 
it is unlikely that the Ti, Co, and Cr particles present in the tissues of the present study’s 
cohort did not stimulate an inflammatory response. Instead, some of the patients in the 
present study may not have been in an actively “stimulated” inflammatory state. The 
cycle of inflammation is transient and the levels of inflammatory cytokines will rise and 
fall as the cycle transitions from a pro-inflammatory to anti-inflammatory state. The 
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cytokine release observed by Kaufman et al. (166) was measured within a 24 hour time 
period when the macrophages were likely at their “stimulated” inflammatory peak state. 
Wang et al. (282) investigated how Ti, Cr, and Co ions modulate the release of bone-
associated cytokines by human monocytes/macrophages in vivo. Similar to Kaufman et 
al. (166), Wang and colleagues (282) demonstrated that Ti, Cr, and Co modulate cytokine 
release, specifically TNF-, IL-1 and IL-6, in LPS-stimulated cells. However, they 
reported that cytokine production was not affected by the metals in the absence of LPS. 
This finding highlights the fact that often the inflammatory process is like a light switch: 
it is either “on” or “off”. The correlations observed in the present study may have been 
induced by prior stimulation by other types of wear debris in the periarticular 
environment.  
 
 
Limitations 
 
 While some meaningful relationships were observed in this study, there were 
several limitations that must be noted. Firstly, this study had a relatively small sample 
size. Furthermore, not every specimen underwent each of the analyses or tests. As such, 
some important correlations may have not been recognized in statistical analysis or the 
power of the observations may not be clinically significant. Secondly, the cohort included 
a wide range of implants including cruciate-retaining, posterior-stabilized, fixed bearing, 
mobile bearing, monoblock, and modular designs. Each of these design variations have 
been shown to affect the kinematics of the knee joint. As such, it is difficult to determine 
how the design may have affected the measured laxity of the joint or the degree of wear 
debris generated. Furthermore, one of the specimens included was produced in the late 
1980s or early 1990s by a manufacturer that no longer exists. Additionally, the implants 
included were fabricated with different materials. However, every effort was made to 
take into account these variations and discuss how the different designs may have 
impacted the results of the study. Thirdly, because the Hood et al. (195) method for wear 
analysis is essentially qualitative, it was impossible to take into account how the degree 
of polyethylene debris produced from the tibial insert may have altered the cytokine 
measurements or even the laxity. Again, every effort was made to note instances of 
excessive wear when meaningful relationships were observed. Fourthly, many variables 
were uncontrollable in the collection of the synovial fluid and measurement of 
inflammatory cytokines. These limitations were previously discussed and every effort 
was taken to mitigate them. Lastly, the state of the measured metal debris (e.g. large 
metal particulate or metal oxide) could not be elucidated with the current methods 
represented in this study. The ICP-MS analysis technique ionizes all metal present and 
reports a final concentration; it does not differentiate between larger particles or ions.  
 
 
Future Research 
 
 Dr. Mihalko’s laboratory has obtained institution review board approval and has 
begun to collect revision devices. Currently, the sample size is small, but is anticipated to 
expand in the upcoming months. Once a sufficient sample size is achieved, the graduate 
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student researchers at University of Tennessee Health Science Center and Drexel 
University will begin assessing the wear and damage of these devices. Furthermore, a 
cytokine analysis will be performed to measure the levels of inflammatory cytokines and 
ICP-MS analysis will be conducted to measure the concentrations of metal debris in the 
collected tissues. Future comparisons between the two cohorts will hopefully elucidate 
what factors are instrumental in mediating negative outcomes so that one day a treatment 
modality, alternate bearing surface, or improved surgical technique may be developed to 
improve patient outcomes following total knee arthroplasty. 
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APPENDIX A. FLUOROSCOPIC ANALYSIS OF POST MORTEM RETRIEVED 
IMPLANTS 
 
 
 
 
Figure A-1. Fluoroscopic A) AP and B) lateral views of specimen DRLU051714-L 
 
 
 
 
 
Figure A-2. Fluoroscopic A) AP and B) lateral views of specimen DRLU081315-R 
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Figure A-3. A) Medial and B) lateral views of specimen DRLU081315-R on a 
fluoroscopy-guided radiograph 
 
 
 
 
 
Figure A-4. Fluoroscopic A) AP and B) lateral views of specimen DRLU121515-R 
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Figure A-5. Fluoroscopic A) AP and B) lateral views of specimen DRLU010416-R 
 
 
 
 
 
Figure A-6. Fluoroscopic A) AP and B) lateral views of specimen DRLU112815-R 
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Figure A-7. Fluoroscopic A) AP and B) lateral views of specimen DRLU101615-R 
 
 
 
 
 
Figure A-8. Fluoroscopic views of specimen RLU1016151A-L 
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Figure A-9. Fluoroscopic A) oblique posterior condylar and B) lateral views of 
specimen 2013-678L 
 
 
 
 
 
Figure A-10. Fluoroscopic A) AP and B) lateral views of specimen RLU0510162A-
R 
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Figure A-11. Fluoroscopic A) AP and B) lateral views of specimen RLU0728161A-L 
 
 
 
 
 
Figure A-12. Fluoroscopic A) AP and B) lateral views of specimen RLU0309161B-L 
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Figure A-13. Fluoroscopic A) AP and B) lateral views of specimen RLU0722161B-L 
 
 
 
 
 
Figure A-14. Fluoroscopic A) AP and B) lateral views of specimen RLU0126161C-L 
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Figure A-15. Fluoroscopic A) AP and B) lateral views of specimen RLU0510161A-L 
 
 
 
 
 
Figure A-16. Fluoroscopic A) AP and B) lateral views of specimen RLU0426161B-L 
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Figure A-17. Fluoroscopic A) AP and B) lateral views of specimen RLU0126162C-
R 
 
 
 
 
 
Figure A-18. Fluoroscopic A) AP and B) lateral views of specimen RLU0720161B-L 
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Figure A-19. Fluoroscopic A) AP and B) lateral views of specimen RLU1028161B-L 
 
 
 
 
 
Figure A-20. Fluoroscopic A) AP and B) lateral views of specimen RLU1115162B-R 
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Figure A-21. Fluoroscopic A) AP and B) lateral views of specimen RLU0913162A-
R 
 
 
 
 
 
Figure A-22. Fluoroscopic A) AP and B) lateral views of specimen RLU0426162B-R 
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Figure A-23. Fluoroscopic A) AP and B) lateral views of specimen RLU0829162C-
R 
 
 
 
 
 
Figure A-24. Fluoroscopic A) AP and B) lateral views of specimen 16-04-765R 
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Figure A-25. Fluoroscopic A) AP and B) lateral views of specimen 16-10-1103R 
 
 
 
 
 
Figure A-26. Fluoroscopic A) AP and B) lateral views of specimen 16-10-1103L 
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Figure A-27. Fluoroscopic A) AP and B) lateral views of specimen RLU0204172A-
R 
 
 
 
 
 
Figure A-28. Fluoroscopic A) AP and B) lateral views of specimen RLU0317172B-R 
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Figure A-29. Fluoroscopic A) AP and B) lateral views of specimen RLU0319171A-L 
 
 
 
 
 
Figure A-30. Fluoroscopic A) AP and B) lateral views of specimen RLU1121161A-L 
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Figure A-31. Fluoroscopic A) AP and B) lateral views of specimen RLU1121162A-
R 
 
 
 
 
 
Figure A-32. Fluoroscopic A) AP and B) lateral views of specimen RLU1125161A-L 
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Figure A-33. Fluoroscopic A) AP and B) lateral views of specimen RLU1125162A-
R 
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APPENDIX B. CORRELATIONS BETWEEN LAXITY AND TISSUE METAL 
CONCENTRATIONS 
 
 
 
 
Figure B-1. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and Co concentrations in periprosthetic tissue 
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Figure B-2. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and Co concentrations in periprosthetic tissue 
 
 
 
E  
 
Figure B-3. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and Cr concentrations in periprosthetic tissue  
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Figure B-4. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and Cr concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-5. Relationship between IE rotational laxity at (A) 0and (B) 30 of 
flexion and Ti concentrations in periprosthetic tissue  
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Figure B-6. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and Ti concentration in periprosthetic tissue 
 
 
 
 
 
Figure B-7. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Co 
concentrations in periprosthetic tissue  
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Figure B-8. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
Co concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-9. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Cr 
concentrations in periprosthetic tissue  
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Figure B-10. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
Cr concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-11. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Ti 
concentrations in periprosthetic tissue  
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Figure B-12. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
Ti concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-13. Relationship between anterior displacement at (A) 0 and (B) 30 of 
flexion and Co concentrations in periprosthetic tissue  
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Figure B-14. Relationship between anterior displacement at (A) 60 and (B) 90 of 
flexion and Co concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-15. Relationship between posterior displacement at (A) 0 and (B) 30 of 
flexion and Co concentrations in periprosthetic tissue  
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Figure B-16. Relationship between posterior displacement at (A) 60 and (B) 90 of 
flexion and Co concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-17. Relationship between anterior displacement at (A) 0 and (B) 30 of 
flexion and Cr concentrations in periprosthetic tissue  
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Figure B-18. Relationship between anterior displacement at (A) 60 and (B) 90 of 
flexion and Cr concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-19. Relationship between posterior displacement at (A) 0 and (B) 30 of 
flexion and Cr concentrations in periprosthetic tissue  
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Figure B-20. Relationship between posterior displacement at (A) 60 and (B) 90 of 
flexion and Cr concentrations in periprosthetic tissue 
 
 
 
 
 
Figure B-21. Relationship between anterior displacement at (A) 0 and (B) 30 of 
flexion and Ti concentrations in periprosthetic tissue  
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Figure B-22. Relationship between anterior displacement at (A) 60 and (B) 90 of 
flexion and Ti concentrations in periprosthetic tissue 
 
 
 
 
Figure B-23. Relationship between posterior displacement at (A) 0 and (B) 30 of 
flexion and Ti concentrations in periprosthetic tissue  
 138 
 
 
Figure B-24. Relationship between posterior displacement at (A) 60 and (B) 90 of 
flexion and Ti concentrations in periprosthetic tissue 
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APPENDIX C. CORRELATIONS BETWEEN LAXITY AND INFLAMMATORY 
CYTOKINES 
 
 
 
 
Figure C-1. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and TNF- concentrations in synovial fluid 
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Figure C-2. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and TNF- concentrations in synovial fluid 
 
 
 
 
 
Figure C-3. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and IL-1 concentrations in synovial fluid  
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Figure C-4. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and IL-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-5. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and IL-6 concentrations in synovial fluid  
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Figure C-6. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and IL-6 concentrations in synovial fluid 
 
 
 
 
 
Figure C-7. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and MCP-1 concentrations in synovial fluid  
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Figure C-8. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and MCP-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-9. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and MIP-3 concentrations in synovial fluid  
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Figure C-10. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and MIP-3 concentrations in synovial fluid 
 
 
 
 
 
Figure C-11. Relationship between IE rotational laxity at (A) 0 and (B) 30 of 
flexion and M-CSF concentrations in synovial fluid  
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Figure C-12. Relationship between IE rotational laxity at (A) 60 and (B) 90 of 
flexion and M-CSF concentrations in synovial fluid 
 
 
 
 
 
Figure C-13. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
TNF- concentrations in synovial fluid  
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Figure C-14. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
TNF- concentrations in synovial fluid 
 
 
 
 
 
Figure C-15. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
IL-1 concentrations in synovial fluid  
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Figure C-16. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
IL-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-17. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
IL-6 concentrations in synovial fluid  
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Figure C-18. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
IL-6 concentrations in synovial fluid 
 
 
 
 
 
Figure C-19. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
MCP-1 concentrations in synovial fluid  
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Figure C-20. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
MCP-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-21. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
MIP-3 concentrations in synovial fluid  
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Figure C-22. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
MIP-3 concentrations in synovial fluid 
 
 
 
 
 
Figure C-23. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and 
M-CSF concentrations in synovial fluid  
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Figure C-24. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and 
M-CSF concentrations in synovial fluid 
 
 
 
 
 
Figure C-25. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and TNF- concentrations in synovial fluid  
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Figure C-26. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and TNF- concentrations in synovial fluid 
 
 
 
 
 
Figure C-27. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and TNF- concentrations in synovial fluid  
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Figure C-28. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and TNF- concentrations in synovial fluid 
 
 
 
 
 
Figure C-29. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and IL-1 concentrations in synovial fluid  
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Figure C-30. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and IL-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-31. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and IL-1 concentrations in synovial fluid  
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Figure C-32. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and IL-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-33. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and IL-6 concentrations in synovial fluid  
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Figure C-34. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and IL-6 concentrations in synovial fluid 
 
 
 
 
 
Figure C-35. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and IL-6 concentrations in synovial fluid  
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Figure C-36. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and IL-6 concentrations in synovial fluid 
 
 
 
 
 
Figure C-37. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and MCP-1 concentrations in synovial fluid  
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Figure C-38. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and MCP-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-39. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and MCP-1 concentrations in synovial fluid  
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Figure C-40. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and MCP-1 concentrations in synovial fluid 
 
 
 
 
 
Figure C-41. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and MIP-3 concentrations in synovial fluid  
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Figure C-42. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and MIP-3 concentrations in synovial fluid 
 
 
 
 
 
Figure C-43. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and MIP-3 concentrations in synovial fluid  
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Figure C-44. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and MIP-3 concentrations in synovial fluid 
 
 
 
 
 
Figure C-45. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion 
and M-CSF concentrations in synovial fluid  
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Figure C-46. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion 
and M-CSF concentrations in synovial fluid 
 
 
 
 
 
Figure C-47. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion 
and M-CSF concentrations in synovial fluid  
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Figure C-48. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion 
and M-CSF concentrations in synovial fluid 
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APPENDIX D. CORRELATIONS BETWEEN TISSUE METAL 
CONCENTRATIONS AND INFLAMMATOR CYTOKINES 
 
 
 
 
Figure D-1. Relationship between Co concentrations in periprosthetic tissue and 
TNF- concentrations in synovial fluid  
 
 
 
 
 
Figure D-2. Relationship between Co concentrations in periprosthetic tissue and 
IL-1 concentrations in synovial fluid  
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Figure D-3. Relationship between Co concentrations in periprosthetic tissue and 
IL-6 concentrations in synovial fluid  
 
 
 
 
 
Figure D-4. Relationship between Co concentrations in periprosthetic tissue and 
MCP-1 concentrations in synovial fluid  
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Figure D-5. Relationship between Co concentrations in periprosthetic tissue and 
MIP-3 concentrations in synovial fluid  
 
 
 
 
 
Figure D-6. Relationship between Co concentrations in periprosthetic tissue and 
M-CSF concentrations in synovial fluid  
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Figure D-7. Relationship between Cr concentrations in periprosthetic tissue and 
TNF- concentrations in synovial fluid  
 
 
 
 
 
Figure D-8. Relationship between Cr concentrations in periprosthetic tissue and 
IL-1 concentrations in synovial fluid  
  
 168 
 
 
Figure D-9. Relationship between Cr concentrations in periprosthetic tissue and 
IL-6 concentrations in synovial fluid  
 
 
 
 
 
Figure D-10. Relationship between Cr concentrations in periprosthetic tissue and 
MCP-1 concentrations in synovial fluid  
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Figure D-11. Relationship between Cr concentrations in periprosthetic tissue and 
MIP-3 concentrations in synovial fluid  
 
 
 
 
 
Figure D-12. Relationship between Cr concentrations in periprosthetic tissue and 
M-CSF concentrations in synovial fluid  
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Figure D-13. Relationship between Ti concentrations in periprosthetic tissue and 
TNF- concentrations in synovial fluid  
 
 
 
 
 
Figure D-14. Relationship between Ti concentrations in periprosthetic tissue and 
IL-1 concentrations in synovial fluid  
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Figure D-15. Relationship between Ti concentrations in periprosthetic tissue and 
IL-6 concentrations in synovial fluid  
 
 
 
 
 
Figure D-16. Relationship between Ti concentrations in periprosthetic tissue and 
MCP-1 concentrations in synovial fluid  
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Figure D-17. Relationship between Cr concentrations in periprosthetic tissue and 
MIP-3 concentrations in synovial fluid  
 
 
 
 
 
Figure D-18. Relationship between Ti concentrations in periprosthetic tissue and 
M-CSF concentrations in synovial fluid  
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